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ABSTRACT 
 
Within the field of asymmetric catalysis, many researchers have been inspired by 
the multifaceted structures and corresponding catalytic activity and selectivity of enzymes. 
One approach to mimicking the important characteristics of enzymes is to develop peptide-
based catalysts for asymmetric transformations. Peptides containing even a small number 
of amino acids are able to provide an environment, rich with chiral information, that is 
adequate for the transfer of chirality. The overall goal of the presented research is to 
combine peptide-mediated asymmetric catalysis with hypervalent iodine (HI) chemistry in 
order to develop new and highly modular peptide catalysts for a variety of HI-mediated 
enantioselective transformations. HI compounds are recognized as valuable and attractive 
reagents due to their mild reactivity, high selectivity, and commercial availability as 
oxidants and electrophiles, while also reducing the overall negative environmental impact 
of these transformations. In particular, the emergence of catalytic and enantioselective 
processes with iodine(III) species is starting to make these compounds competitive with 
metal catalysts. Thus, one could imagine that the incorporation of an iodine(III) active site, 
such as an iodoarene moiety, into a peptide scaffold would result in asymmetric catalysts 
well suited for organic transformations such as the α-oxytosylation of propiophenone and 
oxylactonization of 5-oxo-5- phenylvaleric acid. While, these two reactions represent 
broadly studied catalytic iodine(III)-mediated transformations, they have yet to reach 
synthetically useful levels of enantioselectivty. 
The second part of this dissertation pivots to focus on the implementation of 
functional materials for environmental remediation techniques, such as, the capture of 
 iii 
volatile organic compounds and pesticide degradation. Polyethylenimine (PEI) 
functionalized kaolinite clay was successfully prepared, characterized, and assessed for the 
remediation of volatile organic compounds (VOCs). A gas chromatographic vapor capture 
assay evaluated the capability of unmodified and modified clay material to capture 
representative aldehyde, carboxylic acid, and sulfur VOCs in a laboratory setting. 
Unmodified kaolinite clay was moderately effective at remediating these VOCs, while the 
amine functionalized kaolinite was exceptionally successful at selectively capturing 
organics in the vapor phase. Further, a series of amine-functionalized cellulose nanocrystal 
materials were successfully synthesized, characterized, and evaluated for the remediation 
of pesticide contaminants from organic and aqueous media.  Their ability to degrade 
malathion in organic systems has been examined, resulting in up to 100% degradation of 
malathion into detectable lower molecular weight by-products. A poly(ethyleneimine)-
grafted cellulose nanocrystal material was also effective at degrading malathion, 
deltamethrin, and permethrin in aqueous systems with 100%, 95%, and 50% reduction, 
respectively. Thus, these materials can potentially serve as a new and viable remediation 
technique based on their ability to effectively degrade various pesticides. The reusability 
of the amine-modified cellulose nanomaterial was also explored. 
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 1 
CHAPTER ONE 
 
INTRODUCTION AND REVIEW OF ASYMMETRIC PEPTIDE CATALYSIS AND 
HYPERVALENT IODINE CHEMISTRY 
1.1.1. Introduction  
 Organocatalysis is a synthetic technique used to facilitate chemical transformations 
through the use of substoichiometric amounts of metal-free organic reagents. Recently, 
hypervalent iodine (HI) compounds have emerged as valuable and versatile 
organocatalysts due to their ability to successfully catalyze a wide array of chemical 
reactions.  The main attraction of HI compounds derives from their ability to act as viable 
alternatives to heavy metals due to their inexpensive cost, environmentally benign nature, 
and similar reactivity patterns in comparison to toxic transition metals.  In the last decade, 
considerable attention has been focused on utilizing HI reagents and catalysts in several 
synthetically useful electrophilic and oxidative reactions. Nevertheless, a common 
difficulty has been promoting these types of transformations in a highly reactive and 
enantioselective fashion. Our strategy to impart enantiocontrol in these reactions is to 
attach the active iodane site to molecular architecture bearing chiral information, such as a 
short peptide sequence consisting of 5 to 6 amino acids residues. Peptides can serve as an 
advantageous source of ligands and organocatalysts for a variety of organic 
transformations. Their modularity and facile preparation following standard Fmoc-solid-
phase peptide synthesis (SPPS) techniques facilitates the synthesis and evaluation of 
numerous catalyst structures in a timely manner. The intention of this chapter is to provide 
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an introduction to the flourishing fields of peptide-mediated asymmetric catalysis as well 
as hypervalent iodine chemistry.  
1.1.2. Asymmetric Synthesis  
 There is an undeniable demand for methods focused on the synthesis of chiral 
compounds in their single enantiomeric form. Industries, such as, pharmaceutical, 
agrochemical, fragrance, materials, etc. have an increased need for synthetic protocols in 
which the formation of one stereoisomer is favored over the other. Of note, upwards of 
two-thirds of all pharmaceuticals are chiral, with many being prescribed as a single 
enantiomer.  This, in addition to the importance of chirality in biological systems, makes 
the efficient production of enantiomerically pure compounds a prime goal in synthetic 
organic chemistry.1-11  
 Traditionally, enantiomerically pure compounds are acquired via chemical 
transformations of enantioenriched substrates or by the resolution of racemic mixtures.  
While successful, these approaches are not ideal due to the need for stoichiometric amounts 
of substrate and maximum yields around 50% of the preferred enantiomer, respectively.2-4 
The emergence of asymmetric catalysis offers a suitable and effective alternative by 
employing a chiral catalyst that controls the formation of one stereoisomer during the 
course of a reaction with a non-chiral substrate. The obvious advantage of this method over 
a non-catalytic alternative is the regeneration of substoichimetric amounts of the catalyst, 
resulting in decreased waste and higher atom economy.2-6  
 Asymmetric catalysis has the potential to yield a myriad of chiral products in high 
yields and enantiomeric excesses (ee). Regarded as the two most prevailing facets of 
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asymmetric catalysis, enzyme- and transition metal-mediated catalysis are widely applied 
for the generation of chiral organic products.1-6 Nature has beautifully evolved enzymes 
with the ability to catalyze chemical transformations in a highly reactive and selective 
fashion. This can partially be attributed to their well-defined, folded structures. These 
folded structures help to orient the substrate of interest within the enzyme, creating a 
preorganized and thus highly stable transition state. The subsequent transformation is then 
promoted by a few amino acid catalytic residues that are embedded within the active site 
of the enzyme. Generally, chiral biological molecules are synthesized in living cells by 
enzymes by means of an asymmetric catalysis mechanism. Chemists also employ enzymes 
or even whole cells to synthesize these chiral compounds. Further, such biological catalysis 
is increasingly used on an industrial scale and is particularly preferred in hydrolytic 
reactions.5,6,9 
 Beyond biological catalysis, transition metal catalysts have proven to be 
exceptionally useful for asymmetric transformations. Historically, however, not all 
reported catalytic asymmetric transformations rivals the levels of selectivity characteristic 
of chiral information transfer in enzymatic catalysis. This reality was challenged in the 
early 1970s by William Knowles and co-workers, upon their disclosure detailing the use 
of rhodium complexes containing chiral phosphine ligands to catalyze the addition of H2 
selectively to one face of a prochiral olefinic substrate, so generating a new chiral C—H 
center. This method was later used for the commercial production of the anti-Parkinson 
drug, L-dopa, as well as many other laboratory and industrial scale processes. This as well 
as other noteworthy advances from Ryoji Noyori and K. Barry Sharpless were recognized 
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in 2001 with the Nobel Prize in Chemistry, for their work on catalytic asymmetric 
hydrogenation and catalytic asymmetric oxidation, respectively.1-4 Collectively, their work 
toward highly enantioselective reactions benchmarked the synthetic utility and practicality 
of enantioselective catalysis in the context of synthetic organic chemistry. However, 
transition metal catalysis comes with its own unique issues as it has the potential to leave 
traces of toxic heavy metals in the product.  
1.1.3. Asymmetric Organocatalysis 
 Defying the traditional view of using metal complexes or enzymes for efficient 
asymmetric catalysis, organocatalysts have emerged as a contending third option for highly 
selective catalytic transformations. Asymmetric organocatalysis is described as the use of 
small, purely organic molecules as catalysts to effect organic transformations in an 
enantioselective fashion.9-12 The implementation of organocatalysts has not only enriched 
the field of asymmetric catalysis; it has also provided a highly attractive alternative. In 
comparison to enzymes, small 
organic catalysts tolerate a 
broader range of solvents and 
substrates. Organocatalysts are 
also generally less-toxic and 
less-sensitive towards oxidation and moisture as compared to organometallic reagents. 9-12 
Scheme 1.1. Hajos-Parrish-Sauer-Wiechert protocol for 
the symmetric intramolecular reaction of di- and tri-
ketones, such as, compound I-I.  
O
O
O
I-I
N
H
COOH
I-2 L-proline (3-45 mol%)
CH3CN, RT, - 80 °C
O
I-3
O
83 - quant. % yield
71-93% ee
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 The emergence of synthetically useful asymmetric organocatalysis can be 
benchmarked in 1971 by the concomitant reports of Eder et al. and Hajos and co-workers, 
wherein L-proline was employed as a catalyst for intramolecular asymmetric aldol 
reactions. The aptly named Hajos-Parrish-Eder-Sauer-Wiechert protocol was used to 
promote the cyclization of di- and tri-ketones to generate the corresponding diketones in 
high yield and enantiomeric excess (Scheme 1.1).13-15 This pioneering work was followed 
by further examples of intramolecular aldol reactions, such as the D-proline-catalyzed aldol 
reaction toward the synthesis of erythromycin disclosed by Woodward.16-18 Despite this 
discovery, over three decades passed before proline and proline derivatives were 
successfully applied as catalysts for intermolecular reactions.  This application prompted 
the spectacular growth of these organocatalysts as one of the most widely applied and 
versatile scaffolds in the field. Barbas, Lerner, and List initially disclosed an intermolecular 
aldol reaction wherein acetone participated in an aldol condensation with aryl- and alkyl-
substituted aldehyde acceptors. Upon the addition of 30 mol % proline (I-2), the desired 
aldol products were obtained in moderate to excellent yields (i.e. 54–97%) and 
enantioselectivities ranging from 60 to 96% ee (Scheme 1.2).19 The significance of proline-
catalyzed reactions was continually highlighted following numerous reports for 
asymmetric transformations beyond aldol condensations including Mannich reactions, 
amination, aminoxylation, and Michael 
additions. 17-25 
 MacMillan also reported a method 
detailing the use of chiral imidazolidinone 
Scheme 1.2. Asymmetric intermolecular 
aldol reaction reported by List et al.  
O
H
O O H OH+ I-2 (30 mol%)
DMSO, RT
I-6
97% yield, 96% ee
I-4 I-5
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I-9, for the iminium-type catalytic 
asymmetric Diels-Alder reaction between 
cyclopentadiene I-7 and cinnamaldehyde I-
8 (Scheme 1.3). This report, in conjunction 
with L-proline catalysis, helped to launch 
the field of asymmetric organocatalysis as 
well as reinforce these strategies as viable synthetic routes by providing thoroughly 
investigated mechanistic insight. Today many synthetic chemistry groups are actively 
working in this field, resulting in numerous examples of powerful and noteworthy 
examples of organocatalysts, such as, cinchona alkaloids, MacMillan’s imidazolidinones, 
Jacobsen’s thiourea catalysts, DMAP catalysts reported by Fu et al., and Shi and Yang’s 
catalysts for asymmetric epoxidations.26-38  
1.1.4. Peptides in Asymmetric Catalysis 
 Within the field of asymmetric catalysis, many have been inspired by the 
multifaceted structures and corresponding catalytic activity and selectivity of enzymes.39-42 
The individual building blocks of peptides, i.e. amino acids, have provided routes to several 
attractive organic transformations in asymmetric synthesis, as both auxiliary scaffolds and 
catalysts. Landing in the middle of the catalyst size gamut, peptides composed of two to 
ten amino acids have emerged as simple, yet still well-defined chiral catalysts for various 
enantioselective methods.43-49  
 One of the first examples was reported in the early 1980s when Inoue and co-
workers demonstrated the use of a diketopiperazine cyclo(Phe-His) dipeptide for the 
Scheme 1.3. Asymmetric Diels-Alder reaction 
catalyzed by imidazolidinone I-7.  
H
O
Ph
N
H
N
O
Ph
I-7 I-8
I-9 (5 mol%)
MeOH-H2O Ph
CHO
I-10
99% yield
1:3:1 dr
er (exo) = 96.5:3.5
+
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catalytic cyanation of benzaldehyde (Scheme 1.4A).50 Soon after, the Juliá-Collona 
epoxidation was disclosed, wherein polymers of leucine or alanine were employed as 
asymmetric catalysts for the epoxidation of chalcones (Scheme 1.4B). Mechanistic 
investigations for this transformation ultimately revealed two possible enantioinduction 
models: 1) transfer of chiral information via H-bond interactions between the substrate the 
N-terminal amide protons of the polypeptide a-helix, or 2) an H-bond promoted binding 
between the peroxide nucleophile and the peptide. Regardless, the peptide is able to transfer 
chirality to the chalcone by means of a non-covalent mechanism. 51,52  Despite this 
intriguing work, the use of peptides as asymmetric catalysts remained rather dormant for 
almost two decades. In 1998, Miller et al. disclosed a methylimidazole-containing peptide 
catalyst for the asymmetric kinetic resolution of alcohols, ultimately, providing excellent 
enantioselectivities (Scheme 1.4C).53 This contribution from Miller’s group helped 
establish the use of peptides as asymmetric catalysts as an intriguing area research. 
Throughout the past 30 years, an array of new and exciting peptide catalyst structures have 
been reported, and cannot be thoroughly reviewed here.53-56  Therefore, a brief summary of 
select reactions are discussed below.   
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(A) 
(B) 
H
O
H
CNHON
H
H
NO
O N
H
N
HCN (2 eq), toluene, -20 °C
2 mol%
97 % conv., 97 %ee
O O
H
O H30 % aq. H2O2, NaOH
poly(L-Leu), RT, 24 h
85 % conv., 93 %ee
(C) 
Scheme 1.4. Initial reports for asymmetric peptide catalyzed reactions: (A) The asymmetric 
cyanation of benzaldehyde to a cyanohydrine (B) the enantioselective epoxidation of 
chalcones. (C) Peptide-mediated kinetic resolution of alcohols.  
OH
NHAc
racemic, anti
OAc
NHAc
OH
NHAc
+
Ac2O
0.05 mol % Peptide
PhCH3, 0 °C
N
N
H
O
O
NO
BocHN
N
N
H
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Peptide-Mediated Asymmetric Epoxidations 
 Beyond Juliá and Colonna’s disclosure of poly(alanine) and poly(leucine) catalysts, 
many have reported improved reaction conditions and solid-supported peptide catalysts for 
asymmetric epoxidations. Originally, this epoxidation protocol only tolerated substrates 
that were not sensitive to the highly basic conditions provided by the triphasic reaction 
system of an organic solvent, an aqueous basic oxidant, and an insoluble homo-
oligopeptide.51,52 Thus, there was a need for milder and more environmentally benign reaction 
conditions that also tolerate a wider substrate scope.57 Initially, the scope of this reaction was 
expanded to include enones substituted with one aromatic moiety, such as subtrate I-11, when 
Roberts and coworkers employed a biphasic system of an urea-H2O2 terminal oxidant in THF 
(Scheme 1.5A).58 Previously, substrates such as enolizable ketones and other aqueous base-
sensitive starting 
materials could not be 
used in the presence of 
excess oxidant and 
NaOH base. This resin-
bound peptide catalyst I-
12 could also be 
recycled following a 
regeneration protocol 
consisting of washing with 4 M NaOH and a small addition of fresh catalyst (10% of the original 
catalyst weight). Itsuno et al. also reported a recyclable solid-supported polyamino acid for 
Ph
O
Ph
O O
Peptide catalyst I-12
urea・H2O2(1.2 equiv.)
DBU (1.2 equiv.)
THF, RT, 4 hI-11 I-13
70% yield
83% ee
N
H
H
N H
O
iBu
n
I-12 n = 33
Scheme 1.5.  Polymer supported peptide catalysts for the asymmetric 
epoxidation of alkenes reported by (A) Roberts et al. and (B) Itsuno et al.  
Ph
O O Ph
H
H
O
Ph
I-14 I-16
Peptide I-15 
toluene
H2O2/aq. NaOH
94% yield
97% ee
Ph
(CHCH2)
N
H
H
N
O
H
n
I-15 n= 33
(A) 
(B) 
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the enantioselective epoxidation of chalcones and α, β-unsaturated carbonyl compounds.59 
They prepared poly(L-leucine) cross-linked with amino methylated polystyrene, which 
provided the desired enantioenriched epoxide product I-16 in 94% yield and 97% ee  
(Scheme 1.5B). The resin-supported catalyst could be recovered and reused for up to 12 
cycles, while maintaining a 94% ee of product I-16.  
  Later, peptide oxidation catalyst I-18 was reported by Miller and co-workers. This 
catalyst was designed around a known β-turn peptide sequence to include an aspartic acid 
residue necessary for formation of the reactive peracid I-18’. This protocol tolerated a 
variety of urethane-substituted 
olefins, such as I-17, which in the 
presence of DIC, hydrogen 
peroxide, and DMAP was easily 
converted to epoxide I-19 in a 99% 
yield (Scheme 1.6).56 Lastly, a 
resin supported oligo-L-Leu-
peptide I-21 was disclosed by 
Kudo for the enantio- and 
diastereoselective epoxidation of α,β-unsaturated aldehydes (I-20). The introduction of a 
sterically bulky and hydrophobic amino acid residue, such as 3-(1-pyrenyl)alanine, led to 
increased rate and enantioselectivity in aqueous media (Scheme 1.7) .It was also noted that 
peptide catalyst I-21 promoted an asymmetric epoxidation that resulted in opposite 
enantioselectivity to that of the traditional Juliá–Colonna reaction.60-62 
O N
H
O
Ph O N
H
O
Ph
O
Peptide I-18 (10 mol%)
DIC, H2O2
DMAP (10 mol%)
CH2Cl2/H2O (1:1)I-17 I-19
99% yield
92% ee
N
N
H
O
OBocHN
O
HN
Ph
I-18HOOC
N
N
H
O
OBocHN
O
HN
Ph
O
H O O
I-18’
Scheme 1.6. β-turn peptide-mediated asymmetric 
epoxidation reported by Miller et al. This reaction proceeds 
via reactive peracid peptide intermediate I-18’.  
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Peptide-Mediated Enantioselective Aldol Reactions 
Asymmetric aldol reactions, whether intra- or intermolecular, represent an essential 
route to the formation of carbon-carbon bonds. Enzymatic transformations promoted by 
aldolases of Type I and Type II exist in nature whereby Type I reacts via an enamine 
pathway while the latter proceeds via the coordination of Zn (II) ions. Therefore, enamine 
catalysis has served as an effective mechanistic pathway for peptide catalyzed 
enantioselective aldol reactions. Short peptide catalysts consisting of 2-4 amino acid 
residues in length, as well as a secondary amine at the N-terminus, have been successfully 
employed as effective catalysts for asymmetric aldol condensations. The first peptide-
catalyzed aldol reaction was reported in 2003 by Reymond and co-workers, wherein, the 
reaction between acetone and p-nitrobenzaldehyde proceeded in the presence of a proline-
based peptide and a mixture of acetone and DMSO in excellent yields and moderate 
enantioselectivities.63 Further, this disclosure examined various classes of peptide catalysts. 
R2
R1
O
R1 = NO2, CF3, Cl, Br
R2 = Me, Et, Pr
I-20
R2
R1
O
I-22
70-90% yield 
71-88% ee
Peptide I-21
urea-H2O2
THF-H2O (1:20), 40 °C
O
H-Ala(1-Pyn)-Pro-(Leu-Leu-Aib)2
Ala(1-Pyn):
H2N COOH
I-21
Scheme 1.7. Resin-supported peptide I-21 for the asymmetric epoxidation of enones bearing 
electron withdrawing groups on the  aryl moiety.  
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Specifically, class 
IA and IB contain 
primary amines, 
while class IIA and 
IIB contain 
secondary amines 
(Figure 1.1).63 It was found that class IIB peptide catalysts, containing N-terminal prolines 
as the secondary amine substituent, performed the best in terms of yield and 
enantioselectivity (Scheme 1.8A). Similarly, di- and tri-peptides have also been successful 
as enantioselective catalysts for aldol reactions between p-nitrobenzaldehyde and acetone, 
generating the desired product in up to 91% yield and 77% ee. The substrate scope for this 
reaction was expanded to unmodified ketones and aldehydes in aqueous media. In this case, 
di-peptide I-26, containing a  proline and a serine amino acid residue, furnished the desired β-
hydroxy ketone I-25 in 87% yield and 77% ee in DMSO (Scheme 1.8B).64  
NO2
H
O
NO2
OH OPeptide catalyst I-24 (40 mol%)
NMM (1 equiv)
DMSO:Acetone (4:1), 18 h
I-25
96% yield
66% ee
I-23
O
N
H NH
H
N
O
N
HO
H2N O
OH
O
Class II-B Peptide I-24
NO2
H
O
NO2
OH O
O Pro-Ser I-26 (30 mol%)
DMSO, RT, 18 h
I-4 I-23 I-25
87% yield
77% ee
+
Scheme 1.8. Peptide catalyzed enantioselective aldol reactions of p-nitrobenzaldehyde and acetone 
reported by (A) Reymond and (B) Martin and List.  
(A) 
(B) 
PeptideN
O
PeptideH2N
O
R2
Peptide
H
N
O
R2
Peptide
H
N
O
H2N
R1
R1R1
HO
O
HO O
R3
Peptide
HO OO
N
H
Class I-A Class I-B Class II-A Class II-B
R1 = hydrophobic 
R2 = any amino acid side chain
R3 = alaphatic or aromatic
Figure 1.1. Classes of peptides for asymmetric aldol reactions reported by 
Reymond and co-workers.  
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 A regioselective direct aldol transformation was realized by  Gong et al. with the 
use of a proline based catalyst, H-Pro-Phe-Phe-Phe-OMe (I-28) (Scheme 1.9).  They 
explored the reaction 
between hydroxy 
acetone and various 
electron-deficient 
aromatic aldehydes in 
the presence of di-, tri-, 
tetra-, penta- and hexa-peptide catalysts.65 Tetra peptide I-28 proved the most effective, 
providing the desired aldol regioisomer in 82 yield, and 82 %ee. Recyclable, solid-
supported peptides have also been reported for the direct asymmetric aldol reaction of 
acetone with various aldehydes. For example, Kudo reported a recyclable polyethylene 
glycol grafted on cross-linked polystyrene (PEG-PS)-immobilized peptide/ zinc chloride 
aqueous catalyst system. In the presence of a 20 mol % loading of the peptide catalyst, H-
D-Pro-Tyr-Phe-(PEGPS), 20 mol % ZnCl2, H2O/THF (1:1), at 0° C, nitro- and chloro-
substituted benzaldehydes and ketones smoothly reacted to furnish the desired aldol adduct 
in up to 100% yields and 84% ee.66 
 Later, Wennemers et al.  reported a 
‘catalyst-substrate co-immobilization’ 
strategy for probing peptides from split-
and-mix libraries for catalytic activity 
applications in bimolecular reactions. 
Scheme 1.9. Proline-based tetra-peptide (I-28) for the regioselective 
aldol reaction of  electron-deficient aromatic aldehydes and hydroxy-
acetone.   
R H
O O
OH
I-27
Peptide I-28  (20 mol%)
THF:H2O (1:1), 0 °C
+
R
OH
OH
O
R
O
OH
OH
+
I-29
82% yield
82% ee
NH
N
H
H
N
O Ph
O Ph
N
H
O Ph
OMe
O
R = EWG
N
H
N
O
NH
O
NH2
O
COOH
N
H
HN
O
NH
O
NH2
O
O
HO
I-30 I-31
Figure 1.2. Wennemer’s peptide catalysts 
discovered from a split-and-mix library.  
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These efforts led to the discovery of catalysts structures I-30 and I-31 for the aldol reaction 
of acetone with various aldehydes (Figure 1.2). With as little as 1 mol % loading of peptide 
catalyst I-30, the (S)-aldol product was accessed, while, 10 mol % of I-31 provided the 
(R)-counterpart in up to 91% ee. 67,68 Recently, Kokotos et al. reported a Pro-Glu(OtBu)-
OtBu catalyst that promoted the aldol condensation of a variety of cyclic/acyclic ketones 
and substituted benzaldehydes in the presence of MeCN, 
H2O, and 20 mol % 4-nitrobenzoic acid.  The proposed 
transition state model (Figure 1.3) consists of the dipeptide 
activation of a ketone substrate via enamine formation, 
with concomitant activation of the electrophile by means 
of H-bonding from the amide proton.70  
Michael or 1,4-Conjugate Addition Reactions  
 Often, the enantioselective 1,4-addition of α, β-unsaturated carbonyl or nitrile 
compounds with enolate ions or enamines requires the use of chiral auxiliaries, phase-
transfer catalysts, or chiral imines/enamines. Amino acid and small peptide catalysts have 
also served as efficient enantioselective catalysts for Michael additions. For example, the 
asymmetric addition of various nitroalkanes to cyclic enones was promoted by an L-
proline catalyst to generate the Michael addition product (I-32) in moderate yields and  
enantioselectivities 
(Scheme 1.10). This 
transformation likely 
occurs via an iminium 
N N
O
H O
O
CO2tBu
R2
R1
O
H
R
Figure 1.3. Putative 
transition state model of 
dipeptide ketone activation.  
O
NO2
+
O
O2N
L-proline (3-7 mol%)
CHCl3, RT
NH
HN I-32
71% yield
87% ee
N
Nu
Iminium Ion 
Intermediate
Scheme 1.10. L-proline catalyzed Michael addition of nitroolefins to 
cyclic enones via an iminium ion intermediate. 
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ion intermediate that forms following conversion of the carbonyl moiety (Scheme 1.10). 
Further, the chiral diamine, trans-2,5-dimethylpiperazine, functions as a basic and 
stereodefining additive that led to increase ee values.64   
Beyond proline, Martin and List initially reported peptide catalyst scaffolds for the 
asymmetric addition of acetone and trans-β-nitrostyrene. Cordova also prepared a small 
suite of alanine containing di- and tripeptides catalysts for the asymmetric Michel addition 
of ketones to nitroolefins, generating the desired nitroketone product in high 
stereoselectivities up to 68:1 dr and 97% ee (Scheme 1.11).71  
In 2009, Wennemers et al. also employed tri-peptides as asymmetric catalysts for 
the 1, 4-addition of aldehydes to trans-nitroolefins. Notably, all hit peptide scaffolds, such 
as I-36, included a D-Pro-Pro amino acid motif, known to nucleate a secondary turn 
structure and improve stereoselectivity and catalytic activity 
(Figure 1.4).72,73 The correlation between peptide secondary 
structure and increased levels of enantioinduction was supported 
by Miller’s β-turn peptides containing a τ-(benzyl)-His residue 
NH
O
N
H
N
O
NH2
O
CONH2
I-36
Figure 1.4. D-Pro-Pro 
containing peptide for 
1,4-conjugate additions.  
O
NO2
+
O
NO2
Dipeptide Catalyst I-33 (30 mol%)
or I-34 (45 mol%)
DMSO:NMP(1:1)
10 equiv. H2O I-35
67% yield, 91% ee with I-33
62% yield, 97% ee with I-34
H2N N
H
O
OH
O
H2N N
H
O
OH
O
I-33 I-34
Scheme 1.11. Cordova and co-workers di-peptide catalyzed 
asymmetric Michael addition.  
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(i.e. I-38), which promoted the conjugate addition of azides to α,β-unsaturated compounds 
(Scheme 1.12). Upon treatment with 2.5 mol% of peptide catalyst I-38 and TMSN3, 
substrate I-37 was converted to its corresponding azide product (I-39) in 97% yield and 
63% ee.74,75  
 
Kinetic Resolutions and Desymmetrizations Promoted by Peptide Catalysts 
Peptides have also been utilized as catalysts for the kinetic resolution of racemic 
mixtures and the desymmetrization of meso compounds.76,77 Currently, most peptide-based 
approaches for kinetic resolution center around bromination and acylation reactions. In 
2010, Miller’s group communicated the dynamic kinetic resolution (DKR) of biaryl 
atropisomers following a bromination reaction. More specifically, this method takes 
advantage of molecules that contain a mode of chirality known as atropisomerism. Briefly, 
atropisomers are compounds that contain an axis of chirality about a bond with hindered 
rotation.  Energy differences, due to steric strain, result in a barrier of rotation that is high 
enough to allow for isolation of individual conformers. Treatment of biphenols, such as 
compound I-40, with 10 mol% of peptide catalyst I-41, N-bromophthalimide (NBP), in a 
N
O O
N
O O N3
I-37
Peptide I-38 (2.5 mol%)
TMSN3
tBuCOOH/toluene
I-39
97% yield
63% ee
N
O
N
N
Bn
H
NBoc
N
H
O
O
HN
tBu
I-38
Scheme 1.12. Asymmetric addition of azides to α,β-unsaturated compounds, 
promoted by β-turn peptide I-38.  
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3 % acetone/DCM solvent system resulted in successful DKR, yielding the resolved 
product I-42 in up to 94% ee (Scheme 1.13).53,77  
  
Miller and co-workers continued to make impressive strides to fortify peptides as 
powerful and versatile asymmetric catalysts. Their efforts have resulted in various peptide-
mediated acylation reactions for the kinetic resolution of racemic mixtures of alcohols.56 
For instance, peptides containing a nucleophilic, alkylated histidine residue at the N-
terminus react via an acyl transfer (i.e. reactive intermediate I-50); wherein, chirality is 
induced via interactions such as hydrogen bonding, pi-stacking, ion pairing, etc. between 
the peptide backbone amides and amino acid side chains that stabilize the transition state 
of one enantiomer over the other. Meso-diols, such as I-43, can undergo desymmetrization 
employing a 5 mol % loading of peptide catalyst I-44, which upon selective acylation of 
one alcohol, results in  product I-45 in 80% yield and excellent enantioselectivity (Scheme 
1.14A). Additional peptides, such as I-47, that were designed around amino acid sequences 
that adopt a b-hairpin secondary structure in solution also served as efficient catalysts for 
the kinetic resolution of amino alcohols by means of enantioselective acylation (I-46) 
(Scheme 1.14B).78  
CO2H
OHR
CO2H
OHR
Br Br
Br
N
O
O
Br
I-40
Peptide I-41
NBP
3% acetone in CHCl3
25 °C, 18 h
I-42
up to 85% yield
94% ee
N
N
H
O
NMe2
O
N
H
Me2N
O
BocNBP I-41
Scheme 1.13. Kinetic resolution of atropisomer (I-40) via a peptide-mediated asymmetric 
bromination. 
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O
Scheme 1.14. Alkyl-histidine based peptides reported by Miller’s group for the kinetic 
resolution of racemic alcohols via an acyl-transfer mechanism.    
(A) 
(B) 
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  Other noteworthy asymmetric peptide-mediated organocatalytic reactions not 
discussed above include: phosphorylations and Acyl-Pictet Spengler reactions (Scheme 
1.15 A and B).74,79  
 Ultimately, rendering a catalytic reaction highly enantioselective remains an 
important and yet challenging task in chemical synthesis. However, many reports detailing 
the success of peptide scaffolds as highly reactive and enantioselective catalysts support 
the importance and potential of this area of asymmetric organocatalysis. Further, major 
advantages of peptide-mediated asymmetric catalysis over conventional approaches 
toward catalyst design are apparent when one considers their modularity, ease of 
preparation, and the ability to evaluate a multitude of catalyst structures in a timely manner. 
The ease of preparation and modularity is facilitated by access to a large number of natural 
and unnatural amino acid building blocks as well as well-known solid-phase-peptide 
synthesis (SPPS) techniques. Furthermore, peptide structures can be iteratively modified 
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Scheme 1.15. Peptide-catalyzed asymmetric (A) phosphorylation and (B) acyl-Pictet Spangler  n 
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by simply replacing a single amino acid residue in order to alter the reactivity and/or 
enantioselectivty. The main disadvantage is highlighted by the infinite number of amino 
acid sequences available, leading to increased screening demands. 
 It can be imagined that a catalytic residue can easily be incorporated into a chiral 
peptide backbone in order to generate asymmetric peptide catalysts. In other words, chiral 
information can be installed onto a well-established catalyst framework via a chiral peptide 
scaffold. Hypervalent iodine catalysis represents such an area in which many effective and 
widely applicable catalytic structures have been explored, yet many of these reactions have 
yet to succumb to synthetically useful levels of enantioselectivity. The study described in 
this thesis sought to develop iodoarene-containing peptide catalysts for asymmetric 
hypervalent iodine (III)-mediated  organic transformations. Therefore, the remainder of 
this introduction will focus on the development and application of hypervalent iodine 
reagents in a stoichiometric, catalytic, and asymmetric fashion.  
1.2. Hypervalent Iodine Chemistry  
 
1.2.1. Iodine  
 French chemist Bernard Courtois first noticed the purple-black metallic sheen of 
crystalline iodine in 1811 when he treated seaweed with an excess of sulfuric acid and 
collected the resulting crystals arising from the condensed vapor. Since this discovery, 
iodine has been found to be biologically and chemically important, playing a vital role in 
stimulating cell and tissue growth. Moderate iodine deficiencies can lead to multifocal 
autonomous growth of the thyroid, resulting in thyrotoxicosis. Severe deficiencies can 
cause hypothyroidism, leading to impaired somatic growth and motor development in 
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children. Iodine also represents a significant element in organic synthesis. For example, the 
bond dissociation energy of a C-I bond is around 55 kcal/mol, positioning organoiodine 
compounds as important intermediates that can easily be formed or undergo facile 
cleavage. Thus, they have been utilized in a variety of reactions such as Hofmann’s 
alkylation of amines, the Wurtz coupling reaction, and Williamson ether synthesis.80  
1.2.2. Hypervalent Iodine Compounds  
 Over the past 200 years, 
it has also been realized that 
iodine-containing compounds 
can serve as versatile reagents 
in organic synthesis, leading to 
synthetically valuable products. In comparison to other halogens, iodine’s unique 
properties can be attributed to it being the largest, least electronegative, and most 
polarizable nonradioactive nonmetal. Due to its large size and high degree of polarizability, 
iodine displays polyvalent bonding that differs from other light main-group elements, 
existing in an expanded octet as well as a number of different oxidation states (–1, +1, +3, 
+5, +7), much like transition metals. The most predominant structural arrangement of an 
iodine (III) compound consists of a central iodine atom bonded between two heteroatom 
ligands and an aryl functionality (aryl-λ3-iodanes) within a pseudotrigonal bipyramidal 
geometry (Figure 1.5). The equatorial aryl group and the central iodine atom engage in a 
classical two-center two-electron (2c-2e) covalent σ-bond. In contrast, the bonding 
between the orbitals of the two apically positioned heteroatom ligands and the central 
Figure 1.5.  Hypervalent iodine(III) structure and molecular 
orbital bonding. 
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iodine atom necessitate a 3c-4e hypervalent bond. The molecular orbital diagram of this 
3c-4e bond shows that the lower energy molecular orbitals (bonding and nonbonding) are 
completely filled, creating a node, and thus a partial positive charge, on the central iodine 
atom (Figure 1.5). Consequently the presence of a more electropositive central atom is 
energetically favorable for a hypervalent species. In general, the rich chemistry of 
hypervalent iodine can primarily be attributed to its inherently strong electrophilic 
character.80-85  
The first polyvalent iodine compound was reported in 1886 by the German chemist 
Conrad Willgerodt, who synthesized (dichloroiodo)benzene from iodobenzene and 
chlorine gas.86 Since then, a multitude of synthetically useful and commercially available 
polyvalent I(III) and I(V) compounds have been realized (Figure 1.6). Representative 
examples include, (diacetoxyiodo)benzene (PIDA) which is commonly used to oxidize 
IodineIII 
IodineV 
Figure 1.6. Examples of commonly recognized and 
employed polyvalent I(III) and (V) reagents.  
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carbonyl compounds, hydroxy(tosyloxy)iodobenzene (HTIB or Koser’s reagent) often 
used to functionalize the a-carbons of carbonyls and Dess-Martin periodinane (DMP) used 
for mild oxidation of primary and secondary alcohols to aldehydes and ketones 
respectively.80-88  
 1.3. Hypervalent Iodine Reagents in Organic Transformations   
1.3.1. Stoichiometric Applications  
 In the last three decades, considerable attention has been focused on utilizing 
organohypervalent iodine reagents in several synthetically useful reactions. While 
traditionally being recognized as selective oxidants and electrophiles, HI reagents have also 
proven useful in the formation of carbon-carbon bonds, carbon-heteroatom bonds, and 
rearrangement reactions.  
 A representative example of HI reagents being applied to effect the oxidation of 
alcohols to their corresponding carbonyl products under simple, selective, and mild 
conditions includes the use of iodoxybenzene (IBX) and its DMP derivative for the 
oxidation of 1,2-diols. It was first reported in 1994, by Santagostino, that IBX could be 
used to oxidize alcohols in DMSO.89 Since 
then, IBX has been used to prepare a-
ketols and a-diketones from glycol starting 
materials (Scheme 1.16A). DMP also 
shows useful reactivity towards 1, 2-diols, Scheme 1.16. 1,2-diol oxidation with A) IBX or  B) DMP. 
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typically producing the C-C bond cleavage product of the glycol (Scheme 1.16B).90,91  
 The formation of carbon-carbon bonds is undoubtedly a useful organic 
transformation. When HI reagents are used to effect such a transformation, it typically 
proceeds via the generation of a carbon-centered reactive intermediate (free radicals, 
carbocations, carbenes, etc.) followed by trapping with an organic substrate or by a ligand 
coupling mechanism. Kita et al. reported the successful intramolecular carbon-carbon bond 
coupling reaction of phenolic 
compound I-51 in the presence of PIFA 
and solid acid additive MK10 (Scheme 
1.17A). This transformation gives rise 
to the spirodienone derivative I-52 and 
represents an important synthetic step 
toward Discorhabdin natural products 
and other related alkaloids.92 Further, 
an intermolecular carbon-carbon bond formation example is the oxidation of 2-
alkylnapthols in the presence of PIFA and an allyl silane or silyl enol ether nucleophile 
(Scheme 1.17B).85 Other functionalities, such as fluoride ions, alcohols, amides, and 
electron-rich aromatic rings, can also serve as appropriate nucleophiles for C-C bond 
formation reactions.  
OH
OMe Me3Si
O
OMe
69% yield
PIFA
CH2Cl2+
Scheme 1.17. Stoichiometric application of PIFA 
promoted carbon-carbon bond formation examples. 
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 Lastly, the literature is also rich with 
examples of HI reagents being applied to carbon-
heteroatom bond formation reactions with a high 
tolerance for a variety of substrates. Many of these 
cases include the halogenation of carbonyl 
compounds. The Fluoro-Pummerer reaction involves the α-fluorination of sulfur- and 
selenium-containing carbonyl substrates. The corresponding mono- and di-substituted α-
fluoro sulfides or selenides are generated in the presence of (difluoroiodo)toluene in good 
to excellent yields (Scheme 1.18).93-95  There are a plethora of other hypervalent iodine 
mediation reactions in the literature; however, the focus of this dissertation is on 
asymmetric organocatalytic processes. Therefore, the author directs the reader to reviews 
pertaining to the synthesis and application of HI reagents by Wirth, Zhdankin, Varvoglis, 
and Koser.82-85, 96, 97 
 
1.3.2. Hypervalent Iodine Reagents and Catalysts in Asymmetric Organic Transformations 
 
 There are numerous publications describing the use of substoichiometric quantities 
of PhI to catalyze organic transformations in the presence of a terminal oxidant to promote 
the in situ regeneration of the iodine(III) species. Considerable progress has been made 
toward the development of iodoarene catalysts with the use of easily accessible and 
economical co-oxidants, such as, Oxone, H2O2, mCPBA, etc. However, much of previously 
developed hypervalent iodine chemistry has yet to yield highly reactive and 
enantioselective chiral HI catalysts.98, 99 Typically, asymmetric hypervalent iodine 
compounds are synthesized by attaching chiral information via a chiral acid or alcohol in 
ER1 R2
O
ER1 R2
O
F
IF2
E =S or Se
Scheme 1.18. HI-mediated 
fluorination of sulfur or selenium 
compounds.  
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proximity to the iodine center following ligand exchange or by inclusion of axial chirality 
through the backbone of the iodoarene (Figure 1.7).  
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iodine(III)-mediated asymmetric organic transformations.  
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  As previously mentioned, most of the I(I) precatalysts are then oxidized in situ to 
their hypervalent I(III) counterpart by means of an appropriate terminal oxidant. Such 
chiral HI-mediated transformations include, but are not limited to, asymmetric oxidative 
dearomatizations, functionalization of alkenes, rearrangements, and α-functionalizations. 
Select examples of each transformation are briefly detailed below as well as in Chapter 2 
of this thesis.  
 In 2008, the first chiral I(III) catalysts were reported by Kita et al. for the 
asymmetric oxidative dearomatization of phenolic derivatives by means of 
spirolactonization. This disclosure represents one of the most versatile and useful chiral 
HI-mediated transformations as it 
gives access to dearomatized 
products that can be incorporated 
into stereochemically and 
structurally complex molecules.100 
The rigid spirocyclic backbone of catalyst I-53, proved essential to yield dearomatized 
compounds I-67 in enantioselectivities up to 92% ee (Scheme 1.19). The addition of steric 
bulk on the arene in the ortho/ortho′ positions with respect to the iodine moiety (i.e. R = 
Et in I-53) led to increased selectivity. More recently, this same group has developed a 
binaphthyl-based chiral I(III) prereagent I-54 for the spirocyclization of napthol carboxylic 
acids upon treatment with mCPBA.101  
Scheme 1.19. Oxidative dearomatization of substituted 
phenolic carboxylic acid substrates. 
OH
CO2H
R
O
R
O
O
I-67
up tp 86% ee when R = H
up to 92% ee when R = Et
I-66
I-53 (5-15 mol%)
mCPBA (1.3 equiv.)
CHCl3, 0°C, 8-12h
 28 
A major breakthrough in this field came when a library of C2-symmetric chiral 
iodoarene reagents were reported by Ishihara et al. This family of chiral pre-catalysts was 
examined in the oxidative o-lactonization of naphthols, similar to the transformation 
reported by Kita et al. (Scheme 
1.20).102 Naphthol derivatives were 
converted to spirocyclic lactones I-
68 in the presence of 10 mol % of 
chiral (R,R)-I-55 and mCPBA as co-oxidant for the in situ generation of the I(III) catalyst. 
High levels of enantioselectivity were promoted by intramolecular interactions between 
iodine(III) atom and the two oxygen atoms at the carbonyl groups, and the hydrogen-
bonding interactions between the iodine(III) ligands and the NH from the amide groups. 
This methodology was further leveraged for the dearomatization of phenols followed by 
the reaction with various dienophiles for the synthesis of enantioenriched Diels-Alder 
adducts. In this case, it was noted that the chiral iodine precatalyst I-56 engaged in 
intramolecular H-bonding with achiral alcohol additives (MeOH, HFIP) resulting in 
excellent enantioselectivities (i.e. 99% ee) and lower catalyst loadings.102  
Scheme 1.20.  C2-symmetric iodoarene I-55 for the 
catalytic oxidative o-lactonization of I-66 to I-68.  
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 Other groups have made 
thoughtful modifications to previously 
disclosed catalysts in hopes to generate 
new and more selective chiral iodine 
precatalyst scaffolds. For example, 
Ciufolini et al. reported structural changes to the chiral center located next to the amide 
NH moiety in compound I-56. The altered precatalyst, I-57, containing iPr or tBu moieties 
resulted in increased hydrogen-bonding and thus increased catalytic activity compared to 
that seen with I-56 in Ishihara’s reports.103 Further, there was no longer a need for an achiral 
alcohol additive and the oxidative cyclization of phenolic derivatives I-69 was done in the 
presence of 1.3 equiv. of mCPBA to afford 
spirocyclic compounds such as I-70 in 98% ee 
(Scheme 1.21).  The incorporation of binaphthyl 
backbones into various chiral HI precatalysts was 
explored by Quideau and co-workers, resulting in 
I(I)-structure I-58.104 Upon in situ oxidization of 
the iodobiarene in the presence of mCPBA, its reactive I(III)-reagent counterpart promoted 
the hydroxylative naphthol dearomatization to afford the desired α-hydroxylation products 
in moderate enantioselectivities (i.e. 50% ee). Lastly, the Harned group has more recently 
disclosed new chiral HI pre-catalyst I-59 for the asymmetric oxidation of a various phenols. 
Once again mCPBA (2.2 equiv) was utilized as a co-oxidant for the in situ generation of 
the active I(III)-catalyst, which allowed for the oxidation of phenols I-71 to chiral p-quinols 
OH O
O
I-70
up to 98% ee
I-69
I-57 (20  mol%)
mCPBA (1.3 equiv.)
CH2Cl2, -20°C
 12-30 hR R
OH
Scheme 1.21. Catalytic I(III)-mediated transformation 
of phenol derivative I-69 to I-70.  
O
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*
Scheme 1.22. Harned and co-workers 
synthesis of hydroxylated quinones.   
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I-72 in moderate to good yields (Scheme I-22). While, low levels of enantioselectivities 
(i.e. <60% ee) were observed, this report represents the first time chiral hypervalent 
iodine(III) catalysts were examined for this particular reaction.105  
In 1997, Wirth et al. disclosed three new 
chiral hypervalent iodine(III) compounds I-60a-c 
(Figure 1.7), for the asymmetric dioxytosylation 
of styrene.106 This seminal work detailed the 
synthesis and investigation of these reagents for 
the enantioselective synthesis of di-oxytosylated 
I-74, resulting in a low selectivity of only 21% ee. However, their efforts did eventually 
lead to the discovery of HI reagent I-61, which promoted the desired alkene deoxygenation 
in up to 65% ee (Scheme 1.23).107, 108  
Progress in this area continued with the exploration of chiral HI reagents for the 
diacetoxylation of alkenes. Fujita and co-workers developed reaction conditions that 
included chiral HI reagent I-62 in combination with a Lewis acid co-reagent for the 
intramolecular oxyarylation of alkenes I-75 to I-76 (Scheme 1.24). It is proposed that the 
silyoxy substituent on I-75 serves as a Lewis acid to activate iodoarene I-62, which can 
subsequently add to one enantiotopic face of the alkene substrate. Notably, high levels of 
Scheme 1.23.  Enantioselective 
dioxytosylation of styrene with HI 
reagents.  
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Scheme 1.24.  Intramolecular oxyarylation of silyoxy-olefins reported by Fujita et al.  
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enantioselectivity were not achieved with reagents lacking the silyoxy moiety. This 
reaction also tolerated substrates with silyl-protected amines.109  
 Difluorination reactions are also accessible via chiral HI reagents and catalysts. For 
example, Nevado and colleagues reported the lactate-derived I(III) reagent (I-63) for the 
asymmetric aminofluorinaion of substituted styrene and alkene substrates via the chiral 
difluoroiodonium salt I-63.110 Jacobsen et al. also applied C2-symmetric chiral iodine 
precatalysts, such as I-64, for the I(III)-mediated 1,2-difluorination, 1,1-difluorination and 
fluorolactonization of alkenes using pyr•HF as a nucleophilic fluoride source. These 
reactions produced the desired products in excellent enantioselecitivities, up to 93, 97, and 
96% ee, respectively.111 
 Lastly, precatalyst I-55 was utilized for the enantioselective diacetoxylation of 
styrene derivatives. The in situ activation of the I(I) precatalyst to its active I(III) 
counterpart was achieved following exposure to peracetic acid. The oxidized hypervalent 
catalyst promoted the synthesis of a variety of vicinal diacetoxylation products (I-79) 
(Scheme 1.25). Muñiz and Ishihara et al. reported that increased levels of selectivity are 
promoted by intramolecular hydrogen bonding interactions between the amide moieties in 
the iodoarene catalyst and the acetoxy ligands on the active I(III) center represented by 
complex I-80 (Scheme 1.25).112  
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 Chiral HI reagents have also proven useful for stereoselective oxidative 
rearrangement reactions. For instance, Wirth et al. used I(III) reagent I-55 to  transform 
α,β-unsaturated carbonyls to their corresponding α-arylated carbonyls  in up to 97% ee.106 
This same approach was also applied to asymmetric oxidative rearrangements of 1,1-
disubstituted olefins I-81 
using HI reagent I-65 
(Scheme 1.26). This reaction 
proceeds via the formation of 
a conformationally restricted 
cyclic iodonium-intermediate I-83, allowing the generation of the desired enantioenriched 
α-arylated ketone products.113 Typically, access to α-arylated ketones requires the use of  
transition metals such palladium or nickel. Therefore, chiral HI reagents have once again 
been demonstrated as attractive metal-free alternatives for synthetically useful 
transformations.114, 115  
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Scheme 1.25.  Catalytic asymmetric diacetoxylation of styrene promoted by the in situ 
oxidation of I-55 to its active I(III) counterpart.  
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1.4. Objectives and Conclusions  
 
 Information obtained from research in the field of hypervalent iodine chemistry 
has revealed their utility as very versatile and mild reagents that can replace toxic heavy 
metal-containing reagents, thus providing more environmentally friendly reaction 
conditions. Nonetheless, this area of research is still in its infancy and many efforts are 
being put forth to realize highly reactive and enantioselective derivatives, poising HI 
reagents as suitable candidates for incorporation into a chiral peptide scaffold. 
 Further, traditional approaches toward catalyst design often rely on timely step-
by-step modifications of an initial “hit” structure. Therefore, we envisaged that the 
modularity and facile preparation of short peptide sequences would aid in the 
development of a library of iodoarene-containing peptide scaffolds. A major objective of 
the work described in this thesis was to prepare libraries of peptide precatalysts bearing 
iodo arenes following Fmoc-SPPS protocols and to screen these peptide libraries in 
catalytic hypervalent I(III)-mediated reactions to probe their ability to impart 
enantiocontrol in the reaction. 
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Chapter Two 
 
FUNCTIONAL PEPTIDES FOR ENANTIOSELECTIVE HYPERVALENT 
IODINE(III)-MEDIATED CHEMISTRY 
 
2.1. Introduction: Hypervalent Iodine(III)-Mediated Reactions of Interest  
 
 As previously described in Chapter One of this thesis, the research detailed by 
Ochai, Kita, Togo, and Yamamoto leading to the in situ generation of a Koser-type species 
from an iodoarene compound in the presence of a co-oxidant has laid the groundwork for 
many other hypervalent iodine-mediated reactions to be conducted in a catalytic fashion. 
Further efforts toward rendering such iodoarene catalysts enantioselective have positioned 
chiral hypervalent iodine (HI) catalysts 
as synthetically useful compounds to 
effect fundamental asymmetric organic 
transformations.1-10 Two such reactions 
are the a-oxytosylation of 
propiophenone and the oxidative 
cyclization of 5-oxo-5-phenylvaleric acid (Scheme 2.1).  
 
The a-Oxytosylation of Propiophenone  
 The a-functionalization of carbonyl compounds is a central component of any 
organic chemist’s synthetic tool box. Specifically, the a-oxytosylation reaction effectively 
installs a new stereocenter, equipped with an excellent leaving group, in the a-position 
Scheme 2.1. Hypervalent I(III)-mediated organic 
transformations of interest. A) a-oxytosylation of 
propiophenone B) oxidative cyclization of 5-oxo-5-
phenylvaleric acid.  
O O
OTs
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relative to the carbonyl moiety. This valuable product, in turn, can be utilized in 
nucleophilic displacement reactions, providing a facile method to access a wide variety of 
a-substituted ketones.  
 Koser et al. first disclosed the use of a stoichiometric amount of PhI(OH)(OTs) or 
HTIB as an oxidant for the generation of a-oxytosyl ketones in moderate to good yields 
(40 – 100%).1 This methodology was later expanded to other oxysulfonyl moieties 
(Scheme 2.2).1-3 The use of HI reagents renders 
this transformation environmentally more 
moderate in comparison to the traditionally 
employed thallium-mediated process. Moriarty 
was also successful in promoting the indirect a-
oxytosylation of  ketones in excellent yields (78 – 92%) by using trimethylsilyl enol ethers 
as a ketone substitute and HTIB in CH2Cl2 at RT.5 An increase in reactivity was later 
noticed by Togo and Nabana with the implementation of substituted 
[hydroxy(tosyloxy)iodo]arenes. Specifically, arenes bearing trifluoromethyl moieties 
produced the desired α-oxytosylated propiophenone product in a 96% yield.11 
 Previously, the use of stoichiometric amounts of HI reagents had been essential for 
mediating such transformations; however, within the last few decades, considerable 
attention has been focused on applying these reagents in a catalytic fashion.12, 13 A major 
breakthrough in this field came when Ochai and Kita concurrently reported the use of a 
terminal oxidant for the in situ generation of the HI(III) species.14, 15 More specifically, 
Ochai and coworkers demonstrated the a-acetoxylation of ketones using iodobenzene as 
R1 R
2
O
R1 R
2
O
OSO2R3
PhI(OH)OSO2R3
R1, R2 = alkyl, aryl
R3 = Me, p-Tol
Scheme 2.2. Representative a-
functionalization of ketones in the 
presence of 
[hydroxy(organosulfonyloxy)iodo] arenes, 
first reported by Koser et. al.   
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the precatalyst, and meta-chloroperoxybenzoic acid (mCPBA) as the terminal oxidant, 
resulting in moderate isolated yields of 43 – 63% (Scheme 2.3 A). Kita et al. also employed 
mCPBA as a suitable co-oxidant to perform the catalytic oxidative spirocyclization of 
phenols (Scheme 2.3 B). 
 Yamamoto and Togo extended this work when they established the in situ 
generation of a Koser-type reagent by exposing an iodoarene compound to mCPBA and 
para-toluenesulfonic acid monohydrate (pTSA•H2O), thus providing the oxidized, 
catalytically active aryl-iodo(III) species. Using these conditions, a variety of α-
oxytosylketones were accessed in moderate to good yields of 63 – 88% (Scheme 2.3 C).16 
This work represents considerable progress toward the development of iodoarene catalysts 
as viable alternatives to transition metal catalysts.17 
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The Asymmetric a-Oxytosylation of Propiophenone 
 The scope of this transformation was further broadened following reports of the 
attempted asymmetric a-functionalization of carbonyl compounds, achieved by attaching 
chiral information in the ortho position relative to the iodoarene moiety. Initially, Koser 
and Wirth independently published ortho-substituted iodoarene structures; however, it was 
Wirth that first  implemented chiral iodanes for the enantioselective a-oxytosylation of 
ketones in 1998.2  
Scheme 2.3. Representative catalytic a-
functionalization of ketones.  
R1 R
2
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R1 R
2
O
OAc
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 Since then, extensive research and time has been put into rendering these reactions 
highly enantioselective. Figure 2.1 represents a series of the most selective catalysts (II-5 
– II-8) reported thus far for the direct enantioselective a-oxytosylation of propiophenone. 
Catalyst structures II-5, II-6, and II-8 represent iodoarene structures developed by Wirth 
and Legault that position the chiral information in the ortho position on the iodoarene 
relative to the iodine moiety.12,18-19 These three catalysts were able to achieve 
enantioselectivities for the a-oxytosylation of propiophenone in 39, 48, and 27% ee, 
respectively. Zhang disclosed catalyst II-7, an axially chiral aryl-iodo compound, capable 
of effecting the a-oxytosylation of propiophenone in 53% ee.20 The most recent catalyst 
structure (II-9) was reported by Legault in 2015, in which the a-oxytosylated product was 
generated as its (S)-enantiomer in 90% ee and a 70% yield. This is impressive considering 
O O
OTs
 Chiral HIR *
IOO
I
Cl
I
O
N
Ph
IOMe
Et I
O O
N
O
N
O
II-5 
Wirth, 42 % yield
39 %ee
II-6
Legault, 80 % yield
48 %ee
II-7
Zhang, 53 % yield
53 %ee
II-8
Wirth, 78 % yield
27 %ee
II-9
Legault, 70 % yield
90 %ee
Figure 2.1. Current catalyst structures for the a-oxytosylation of 
propiophenone, pictured with their  corresponding author, product 
yield, and enantioselectivity.  
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that the highest levels reported prior to that disclosure were not greater than 55% ee.21,22 It 
is important to note that the direct a-oxytosyation of propiophenone was not achieved, 
rather Legault employed a (Z)-enol acetate derivative of the propiophenone starting 
material (Scheme 2.4). Additionally, accessing the C2-symmetric catalyst II-9 requires a 
synthetic protocol consisting of five linear synthetic steps, with a majority requiring 
column purification.  The reaction also requires the rather tedious, slow addition of the enol 
acetate starting material over a 13 h time period using a syringe pump. Finally, only one 
catalytic example was reported in the manuscript, and the substrate scope was explored 
using a stoichiometric loading of II-9.  This may suggest a lack of catalytic utility upon 
application to substrates other than the (Z)-enol acetate congener of propiophenone. 
Nevertheless, the asymmetric variant of the a-
oxytosylation of propiophenone has yet to 
succumb to synthetically useful levels of 
enantioselectivity when using iodoarene chiral 
catalysts. 
Oxidative Lactonization of Keto-Acids  
 Hypervalent I(III)-mediated chemistry can also be applied to the oxidative 
cyclization of keto acids to their corresponding lactones. The ability to efficiently access 
varying lactone products represents a significant transformation due to the prevalence of 
this moiety in nature as well as their utility in synthetic and medicinal communities.23,24 
For example, the lactone motif is present in innumerable natural products with select aryl-
substituted γ-lactones demonstrating interesting biological activities such as human 
OAc O
OTs
II-9 Catalyst (20 mol %)
mCPBA: TsOH (1:1 equiv)
H2O (1.1 equiv)
slow addition
MeCN, RT, 13 h
II-2II-10
slow addition
Scheme 2.4. Conditions for Legault’s II-9 
catalyzed a -oxytosylation of enol acetate II-
10. 
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neutrophil elastase (HNE) and chitin synthase inhibition, as well as anti-inflammatory 
properties.25-29 
 Lactones can be synthesized via their carboxylic acid starting materials upon a 
direct oxidative C-O coupling reaction. Many of the previously reported coupling reactions 
involve the use of metal oxidants under harsh conditions. Additionally, these reactions 
often have a limited substrate scope, low product yields, and/or result in undesired side 
reactions such as ring oxidations and decarboxylations.30-33 Alternatively, HI reagents 
could serve as mild alternatives to these traditionally required metal oxidants while also 
promoting direct lactone formation. Koser initially reported the use of HTIB in CH2Cl2 for 
the synthesis of oxytosyl-substituted lactones from various alkenoic acids in moderate 
yields.2 Similarly, Moriarty also employed HTIB in refluxing CH2Cl2 for the 
oxylactonization of carboxylic acids.34 Nearly two decades later, Wirth et al. demonstrated 
that aryl-λ3–iodanes, such as PIDA, PIFA, and HTIB, could promote the lactonization of 
4-aryl-4-pentenoic acids.35  Kita and co-workers presented a direct lactonization route, 
involving a benzylic C-H bond abstraction in the presence of a stoichiometric amount of 
(diacetoxyiodo)benzene, PIDA, and KBr for the synthesis of aryl lactones from their 
corresponding carboxylic acids. Methoxy-, nitro-, fluoro-, bromo- and phenyl-substituted 
aryl functionalities were all tolerated under these conditions producing the desired cyclic 
ether product in moderate to good yields (61 – 91 %).7,15 
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 Great strides were made when the catalytic HI-mediated oxylactonization was 
realized by Ishihara and co-workers in 2009 with the in situ generation of HTIB from 
iodobenzene in the presence of a substoichiometric amount of tosic acid (TsOH) and 
mCPBA as a stoichiometric co-oxidant (Scheme 2.5A).36 Soon after, tetrabutylammonium 
iodide was employed, as the pre-catalyst for the oxylactonization of various carboxylic 
acids, and was efficiently oxidized to its I(III)-catalytic state upon treatment with aqueous 
hydrogen peroxide (Scheme 2.5B).37 Currently, most of the research surrounding this 
reaction of interest is focused on rendering it highly enantioselective.  
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Scheme 2.5. Notable work by Ishihara and co-workers for the HI-
mediated catalytic oxidative lactonization of carboxylic acids. 
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The Asymmetric Oxidative Cyclization of 5-oxo-5-Phenylvaleric Acid 
 In comparison to the asymmetric a-oxytosylation of propiophenone, even less 
success has been realized with the enantioselective oxidative cyclization of 5-oxo-5-
phenylvaleric acid. Moran reported catalyst structures II-11 and II-12, which promoted the 
highest levels of enantioselectivity, 12% ee and 47% ee, respectively (Figure 2.2).38 
Additionally, the yields for the reaction 
are fairly low, providing the lactone in 
only 31% and 47% yields, respectively. 
Further efforts were made by Ishihara 
and Wirth, yet these studies were also 
unsuccessful, resulting in 
enanatioselectivities no greater than 
3% ee.2,36,37 While these catalyst structures represent the most successful compounds for 
the two catalytic hypervalent I(III)-mediated asymmetric processes of interest, they only 
represent one approach to catalyst design. The major disadvantages of traditional catalyst 
design stems from lengthy synthetic protocols to prepare just one structure and the typically 
time consuming, step-by-step modification required to generate derivatives of an initial 
“hit” scaffold.39 Furthermore, all of the catalysts described above position the chiral 
information in the ortho position relative to the iodine atom. Having only one position 
relative to the active I(III) site where chiral information can be communicated may 
represent a limiting factor in developing a highly reactive and enantioselective catalyst.  
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Figure 2.2. Catalyst structures for the oxidative 
cyclization of 5-oxo-5-phenylvaleric acid, pictured 
with their corresponding author, product yield, and 
enantioselectivity.    
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2.2. Hypervalent Aryl-Iodo Peptides for Asymmetric Catalysis 
 
 Another potential mode for installation of chiral information onto a catalyst 
framework is the use of a chiral peptide scaffold.39-41 Thus, we were intrigued by the 
possibility of short-chain peptides serving as viable alternatives to the previously described 
low molecular weight HI catalysts. Specifically, we hypothesized that the unique reactivity 
of hypervalent iodine in conjunction with the structural complexity and chiral space 
provided by short peptides ultimately might allow for the construction of catalysts suitable 
for enantioselective iodine(III)-mediated organic transformations.   
 The initial search for a synthetically useful HI peptide based catalyst centered 
around three initial scaffolds (Figure 2.3). Peptide catalysts possessing only a few amino 
acid residues have been shown to adopt a secondary structure suitable for the transfer of 
chirality.42-49  Thus, Scaffolds A and B were both designed around a known b-turn 
secondary structure induced by a proline-D-alanine sequence.45,46 More specifically, this 
sequence nucleates the b-turn via hydrogen bonding between the carbonyl oxygen of one 
residue with the amide proton of an amino acid three residues down the chain. One could 
hypothesize that the inclusion of this type of secondary structure would impart some 
rigidity into the peptide scaffold, possibly enhancing the enantioselectivity.50-56 Scaffold C 
serves as a necessary linear comparison, as it possesses no amino acid residue sequence 
that is known to induce a secondary structure. Further Scaffold C, was designed using  
peptidic ligands published by Hoveyda and Snapper as inspiration.39-42 The active 
iodoarene site (highlighted in blue) can easily be incorporated into Scaffolds B and C by 
capping the N-terminus of the peptides with commercially available 2-iodobenzoic acid 
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(2-IBA). The iodo-aryl portion in Scaffold A can be installed by inserting the commercially 
available Fmoc-4-iodophenyl alanine residue into the middle of the growing peptide 
sequence.  
 
Fmoc-Solid Phase Peptide Synthesis: 
 Solid-Phase Peptide Synthesis (SPPS) was developed for the purpose of providing 
a rapid, simplified, and effective route to prepare oligopeptides. Briefly, it involves a 
heterogeneous reaction mixture composed of an insoluble resin-bound peptide chain, a 
soluble activated amino acid derivative and an appropriate solvent. This method of linking 
an amino acid to an insoluble support, then condensing it with a second amino acid 
followed by a third, and thus stepwise elongating the peptide chain was a monumental 
development in the field of peptide synthesis.  
 Fluorenylmethyloxycarbonyl- (Fmoc) SPPS is the most frequently used methods to 
prepare short peptide sequences. It features a base labile a-amino Fmoc-protecting group 
along with acid labile a-R-side chain protecting groups and peptide resin linkages. Our 
Figure 2.3. Peptide pre-catalyst scaffolds A-C, iodoarene sites are highlighted in blue. 
Scaffolds A and B contain a proline-D-alanine sequence, known to nucleate a b-turn 
secondary structure. Scaffold C will serve as a linear comparison, with no known secondary 
structure.  
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group specifically used a Rink amide MBHA resin that is pre-loaded with an Fmoc-
protected amine. After peptide assembly this resin yields C-terminal amide peptides, an 
attractive attribute due to the desire to synthesize a peptide library that will not exist in the 
typically charged state of free C-terminal carboxylate anions.57,58  
Peptides in this study were assembled in disposable fritted syringes using the 
following general sequence. Following swelling of the resin in DCM, the base-labile group 
was removed with triple treatments of 20% (v/v) 4-methylpiperidine in DMF thus revealing 
the free amine available for amino acid coupling. Amino acid couplings were achieved by 
double two-minute treatments of the deprotected resin with 5 equiv of the coupling reagent 
O-(1H-6-Chlorobenzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate 
(HCTU), N,N-diisopropylethylamine (DIPEA), and the desired Fmoc-protected amino acid 
residue. This deprotection followed by coupling sequence was then repeated until the 
desired peptide sequence was assembled on the resin. The resin-bound, protected peptide 
sequence was then be cleaved and side-chain deprotected by treatment with a trifluoracetic 
acid (TFA) cleavage cocktail (TFA:H2O:tri-iso-propylsilane, 95:4.5:0.5, v/v) and isolated 
upon evaporation of the TFA cocktail and precipitation with ice-cold diethyl ether (Figure 
2.4).  The successful preparation of all isolated peptide sequences were confirmed via 
MALDI-TOF mass spectrometry analysis.  
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2.3. Results and Discussion  
 
1st Generation Peptide Catalyst Screening Results for the a-Oxytosylation of 
Propiophenone 
  An initial 420-member iodoarene peptide catalyst library was prepared and 
screened as potential enantioselective catalysts for the a-oxytosylation of propiophenone. 
Briefly, this library resulted from the synthesis of amino acid sequences that were 
determined at random with varying commercial available Fmoc-protected amino acids, 
including basic, acid, polar, aromatic, and non-polar side chains. Cysteine, methionine, and 
arginine were not incorporated into the iodoarene peptides due to their highly susceptibility 
toward oxidation, which would complicate the study of our reactions of interest.57,58 
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 This initial library consisted of 90 peptides of Scaffold A, 280 from Scaffold B, 
and only 50 from linear Scaffold C. Throughout the screening process, it was quickly 
realized that linear peptides from Scaffold C were not promoting selective reactions, 
therefore, the focus shifted mainly to the synthesis of bent peptides of Scaffold A and B. 
These aryl-iodo peptides were screened utilizing the reaction conditions previously 
disclosed by Togo. Namely, 3 equiv. of mCPBA was used as the co-oxidant and 3 equiv. 
of pTSA·H2O was used as the nucleophile in MeCN at RT for 24 hours (Scheme 2.6).11,16 
The success of enantioinduction for each catalyst was determined by means of chiral HPLC 
analysis and reported as % enantiomeric excess (% ee), calculated by taking the difference 
of the two enantiomeric peak areas divided by the sum of the peak areas, multiplied by a 
factor of 100. No attempts to quantify 
reaction yields were made due to the small 
scale and the desire conduct rapid screening 
of a large library of peptide structures.  
Scheme 2.6. Reaction screening conditions for 
the a-oxytosylation of propiophenone.   
O O
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HI Peptide (0.1 equiv.)
mCPBA (3 equiv.)
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*
II-1 II-2
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 From this large screen, only two “hit” peptide structures emerged, II-13 and II-14 
(Figure 2,5). For optimization purposes a “hit” peptide was taken to be a pre-catalyst 
capable of effecting the oxytosylation of propiophenone with levels of enantioselectivity 
above 20% ee. Peptide structure II-13, with an amino acid sequence of 2-IBA-Ile-Pro-D-
Ala-Asp-Gln, successfully catalyzed the a-oxytosylation of propiophenone to generate the 
desired product with 48% ee. Catalyst II-14, with the primary sequence of 2-IBA-hPhe-
Pro-D-Ala-Phg-Asp, produced the a-oxytosylated ketone with in 23% ee. 
 
1st Generation Peptide Catalyst Screening Results for the Oxidative Cyclization of 5-oxo-
5-Phenylvaleric Acid 
 For the oxylactonization of 5-oxo-5- phenylvaleric acid, a much smaller library of 
peptide structures were screened. 
Namely, 100 precatalysts, pulled from 
Scaffold A and Scaffold B libraries, 
were assessed using almost identical 
conditions to those of the a-oxytosylation of propiophenone but at elevated temperatures,  
Figure 2.5. Two lead peptide structures emerging from initial 420-member 
iodoarene peptide catalyst library screen for the a-oxytosylation of 
propiophenone.   
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i.e. 3 equiv. of mCPBA, 3 equiv. of pTSA·H2O in MeCN at 50 ˚C for 24 hours (Scheme 
2.7). Unfortunately, levels of stereoinduction greater than 18% ee were not realized from 
this 1st generation peptide library screen for the oxylactonization reaction of interest.  
(Figure 2.6).  
 
Despite the low levels of enantioselectivity, three lead peptide structures were realized as 
a result of their ability to catalyze the reaction of interest and impart a modest degree of 
enantioinduction. More specifically, peptide II-15, with an amino acid sequence of 2-IBA-
Ile-Pro-D-Ala-Asp-tPhe, produced the lactonization product (II-4) in 10% ee. Further, 
precatalysts II-16 and II-17 with primary structures from scaffold A, generated II-4 in 18 
and 16% ee, respectively. For optimization purposes, peptide structure II-16 will be 
referred to as the “hit” peptide from this 1st generation library screen for the oxidative 
lactonization of 5-oxo-5-phenylvalaric acid.  
 
 
 
 
Figure 2.6. Three lead peptide structures emerging from the initial 100-member iodoarene peptide 
catalyst library screen for the oxidative lactonization of 5-oxo-5-phenylvalaric acid.  
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“Hit” Precatalyst Peptide Primary Structure Optimization  
 Following the completion of the 1st generation peptide library screening campaign, 
efforts were focused on optimizing the amino acid sequences of our best “hit” peptide 
precatalysts II-12, II-13, and II-16. Peptide derivatives of each “hit” scaffold were 
iteratively optimized in  
positions i, i+4, and i+5 for peptides sequences from scaffold A and i+1, i+4,  i+5 for 
“hits’ from scaffold B (Figure 2.7). Positions i+2 and i+3 were not altered in order to 
preserve the b-turn secondary structure nucleated by the Pro-D-Ala sequence. Also, the 
active iodoarene sites, namely the 4-iodo-phenylalanine residue and the 2-iodoarene cap 
on scaffold A and B, respectively, were not varied. Peptide derivatives were synthesized 
using 31 different Fmoc-protected L-amino acids with R-side chains. The modularity of 
using short peptide sequences is highlighted by the ability to swap out an amino acid 
residue for one of similar or vastly different chemistry such as alkyl, aryl, acidic, basic and 
or polar character (Figure 2.8).  
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 Peptide structure II-12 
was fully modified at the 
i+1, i+4, i+5 amino acid 
residue positions, resulting 
in an additional 90 
precatalysts to screen in 
the a-oxytosylation of 
propiophenone. Structure 
II-13 was only modified at 
positions i+4 and i+5 
resulting in 60 additional 
catalyst structures. Despite 
this effort that resulted in a 
150-member 2nd generation   iodoarene peptide library, enantioselectivities greater than the 
initial “hits” of 48 and 23% ee, respectively, were not achieved for the a-oxytosylation of 
propiophenone.  
 Similarly, the systematic replacement of amino acid residue positions i and i+4 on 
peptide II-16, resulted in a new 2nd generation library of 60 peptides that were screened for 
their enantioselectivity in the lactonization of 5-oxo-5-phenylvaleric acid. Three new 
peptide structures emerged II-18, II-19, and II-20, generating the desired lactonization 
product in -22, -20, and -24% ee, respectively. The levels of enantioinduction obtained 
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Figure 2.8. Available amino acid residue R-side chains.  
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with these new precatalysts are only slightly increased from the previous -18% ee seen 
from the 1st generation II-16 aryl-iodo peptide.  
 
 
 
 
2.4. Conclusions and Future Directions  
 
 With their ease of preparation, modularity, and accessible secondary structure (e.g. 
β-turn),1st and 2nd generation iodoarene peptide scaffold libraries were synthesized and 
screened for catalytic activity and enantioinduction in two test reactions hinging on 
hypervalent iodine catalysis. The results obtained for the a-oxytosylation of 
propiophenone and for the oxidative cyclization of 5-oxo-5-phenylvaleric acid clearly 
demonstrate that our iodoarene peptides have the potential to serve as asymmetric catalysts 
for I(III)-mediated processes. It is also worth highlighting that “hit” peptide II-13 was able 
to impart levels of enantioselectivity on par with the current most successful chiral HI 
catalysts, for the a-oxytosylation transformation, reported by Wirth, Legault, and Zhang 
Figure 2.9. Peptide precatlayst structures emerging from the 2nd generation screen for oxidative lactonization of 
5-oxo-5-phenylvalaric acid.  
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(II-5-II-8). 
Nonetheless, the overall aim of this research is to develop chiral hypervalent iodine 
peptide catalysts that ensure exceptionally high levels of enantioselectivty; thus, it is 
noticeable that despite the large number of peptides screened (>650) we were unable to 
break the 50% ee selectivity barrier for our two reactions of interest.  The natural 
progression of this work was to investigate and improve upon the initial “hit” peptide 
scaffolds by iteratively optimizing selective amino acid residues in hopes that a new, more 
selective peptide would emerge. The likelihood of this approach being successful is not 
unreasonable due to the vast amount of chiral space provided and explored by our peptide 
library as well as similar approaches bearing highly reactive and enantioselective catalysts 
in the past.59 In our case, this approach was unsuccessful; therefore, investigations into the 
mode of stereoinduction will be considered as well as the structure-enantioselectivity 
relationship of our iodoarene peptide catalysts.  
 
2.5. Experimental Methods 
 
2.5.1. General Materials and Methods 
 All chemicals were purchased from commercial suppliers and used without further 
purification. Following isolation, synthesized products were purified by flash column 
chromatography using silica gel SDS 60 C.C. 40- 63 microns. 1H and 13C NMR spectra 
were collected on a 500 MHz Bruker NMR spectrometer at ambient temperature. Chemical 
shifts are reported in parts per million (ppm) and referenced to residual solvent peaks (i.e. 
δ 7.28 ppm for 1H NMR, 77 ppm for 13C NMR) in CDCl3. Data is presented as follows: 
chemical shift, integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br 
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= broad, m = multiplet), and coupling constants (J) are given in Hz. All synthesized 
peptides were characterized via MALDI-TOF mass spectrometry.   
 Enantiomeric excess (% ee) of products were II-2 and II-4 determined using chiral 
high performance liquid chromatography (HPLC).  Chiral samples were run on an Agilent 
1260 Infinity system equipped with a diode array detector (G4212-60008), and an Agilent 
1260 Infinity auto sampler. The chiral stationary column used was a Chiralpak-AD 
(250mm X 4.6 mm). The mobile phase consisted of iso-propyl alcohol/hexanes mixture 
(50:50). The flow rate was set at 1 mL/min and the elution of analytes was monitored at 
254 nm.  
2.5.2. Fmoc-SPPS Synthetic Methods: 
 
 Following standard Fmoc-SPPS protocols, iodoarene peptide precatalysts were 
prepared on solid support using the commercially available Rink Amide MBHA resin (200 
mg, 0.3–0.8 meq/g, 200-400 mesh). Rink Amide MBHA resin comes pre-loaded with an 
Fmoc-protected amine for the preparation of C-terminal amide peptides. Therefore, amino 
acid residues were built on the solid support beginning at the C-terminus. Peptides from 
Scaffold A were N-caped with an acetate group while peptides from Scaffolds B and C 
were N-capped with the appropriate iodobenzoic acid. Double amino acid couplings were 
achieved using a 5 equiv. excess of the appropriate Fmoc-amino acid, HCTU as the 
coupling agent, and DIPEA in DMF as the solvent. Fmoc-deprotections were completed 
upon treatments with a basic solution of 20% 4-methylpiperidine in DMF. The fully 
assembled aryl-iodo peptide were cleaved from the resin and side-chain deprotected using 
a standard trifluoroacetic acid (TFA) cleavage cocktail and isolated following evaporation 
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of the TFA solution followed by precipitation with ether and centrifugation. All peptide 
precatalyst structures were confirmed via MALDI-TOF MS analysis (See Appendix A for 
full table of synthesized peptides). A step-wise procedure for the Fmoc-solid-phase 
synthesis of peptide II-13 is described below. 
Resin Swelling: The Rink Amide MBHA resin (200 mg) was added to the barrel of a 10 
mL fritted syringe and swelled by a 4 mL DCM wash, followed by soaking for 5 min in an 
additional 5 mL of DCM. The residual DCM was purged from the syringe and the resin 
was washed with DMF (3 x 4 mL).  
Fmoc-Deprotection: The initial Fmoc-deprotection of the Rink Amide resin was performed 
by means of three sequential one-min treatments with 2 mL of a 20% 4-methylpiperidine 
in DMF solution. The deprotected resin was then washed three times with 5 mL of DMF, 
resulting in a free amine ready for the first amino acid coupling.  
Amino acid couplings: Peptide II-13 was assembled on the solid-support beginning at the 
C-terminus. Therefore, 5 equiv. (relative to resin loading) of Fmoc-L-Gln, HCTU, and 
DIPEA were added to a 3 mL screw-top vial. The solids were then dissolved in 1 mL of 
DMF. This prepared mixture was then taken up into the fritted syringe, containing the resin, 
and agitated for 2 min. This first coupling mixture was then ejected into a waste container. 
The resin was subsequently treated with a second aliquot of the Fmoc-L-Gln amino acid 
mixture for 2 min. Following this double amino acid coupling procedure, the resin was 
once again washed with DMF (3 x 5 mL). The Nα-Fmoc group was then removed following 
the  previously described Fmoc-deprotection protocol in order to achieve the next amino 
acid residue coupling of an Fmoc-L-Asp residue. This deprotection-coupling pattern was 
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repeated until the desired amino acid residues were assembled as follows: Resin-Gln-Asp-
D-Ala-Pro-Ile-2-IBA.  
N-terminal Acetate Capping: Where appropriate (Scaffold A), the fully assembled peptide, 
was N-capped with an acetate group following double, 5 min treatments with a 4 mL 
aliquot of a 5% acetic anhydride in DMF solution. After the allotted time for the double 
treatment, the solution was ejected from the syringe and the resin was washed with DMF 
(3 x 5 mL).  
Peptide Cleavage and Isolation: Following N-terminal capping of the resin-bound peptide, 
the resin was washed with DCM (3 x 5 mL), and de-swelled with methanol (3 x 5 mL). 
The resin was dried in a vacuum oven at room temperature for 24 h. The resin-bound 
peptide was then cleaved and the acid-labile R-side chains were deprotected via a 2 h 
treatment with an acidic cleavage cocktail of trifluoroacetic acid: H2O: tri-iso-propylsilane 
(95:4.5:0.5). Following evaporation of the cleavage cocktail and precipitation with ice cold 
ether, the peptide was isolated as a white powdery solid and characterized by MALDI-TOF 
mass spectrometry: (m/z) calcd for C30H42NaIN7O4 [MNa]+ 794.1981, found 794.1976. 
2.5.3. Screening Reaction Protocols:  
 
 Chiral HPLC analyses of the crude reaction mixtures were completed to determine 
enantiomeric excesses for the a-oxytosylation of propiophenone and the oxidative 
lactonization of 5-oxo-5-phenylvaleric acid.  Pure racemic samples were first prepared 
following protocols found in section 2.5.4. of this chapter and used as chiral HPLC 
standards to determine the retention times of product enantiomers.  
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General Procedure for the a-Oxytosylation of Propiophenone 
 Iodoarene peptide precatalysts were evaluated in the asymmetric α-oxytosylation 
of propiophenone using the following representative procedure: A 3 mL screw-capped vial 
was charged with propiophenone (4 µL, 0.01 mmol, 1.0 equiv), pTSA•H2O (17.1 mg, 0.03 
mmol, 3 equiv), mCPBA (19.1 mg, 0.03 mmol, 3 equiv), the appropriate iodoarene peptide 
precatayst (0.01 mmol, 0.1 equiv) and a small stir bar. The reagents were dissolved in 1 
mL of acetonitrile and the reaction was stirred for 24 h at RT. Following the allotted 
reaction time, the crude solution was concentrated by rotary evaporation and prepared for 
chiral HPLC analysis.  
  
General Procedure for the Oxidative Cyclization of 5-oxo-5-Phenylvaleric Acid 
 Iodoarene peptide precatalysts were evaluated in the asymmetric oxylactonization 
of 5-oxo-5-phenylvaleric acid using the following representative procedure: a 3 mL screw-
capped vial was charged with 5-oxo-5-phneylvaleric acid (1.9 mg, 0.01 mmol, 1.0 equiv), 
pTSA•H2O (17.1 mg, 0.03 mmol, 3 equiv.), mCPBA (19.1 mg, 0.03 mmol, 3 equiv), the 
appropriate iodoarene peptide precatayst (0.01 mmol, 0.1 equiv) and a small stir bar. The 
reagents were dissolved in 1 mL of acetonitrile and the reaction was stirred for 24 h at 50 
˚C. Due to the two enatiomeric product peaks eluting around the same retention time as 
residual pTSA•H2O all crude reaction mixtures were washed with a saturated sodium 
bicarbonate solution (2X). The aqueous layer was extracted twice with ethyl acetate and 
the combined organic layers were washed once more with sat. aq. NaHCO3 followed by 
sat. aq. brine.  
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2.5.4. Synthesis of Racemic Products  
 The corresponding racemic products from our two reactions of interest were 
synthesized and purified to serve as chiral HPLC standards for the determination of each 
enantiomeric peak retention times.  
General procedure for α-oxytosylation of propiophenone, II-2. 
  A flame dried, 100 mL round-bottom flask was charged with propiophenone II-1 
(132 µL, 1 mmol, 1.0 equiv), para-toluenesulfonic acid monohydrate (0.571 g, 3 mmol, 3 
equiv), meta-chloroperoxybenzoic acid (0.702 g, 3 mmol, 3 equiv), and 4-iodotoluene 
(0.637 g, 1.5 mmol, 1.5 equiv). The reagents were dissolved in 10 mL of acetonitrile and 
the resulting solution was allowed to stir under N2 at 50 ˚C for 24 h.  The reaction mixture 
was concentrated by rotary evaporation, followed by dilution in DCM, and the organics 
were washed three times with an aqueous saturated sodium bicarbonate solution.  The 
combined organic layers were dried over sodium sulfate, filtered, and concentrated by 
rotary evaporation. The crude product was purified by column chromatography on silica 
gel (20:80 EtOAc:hexanes) to give a light brown solid II-2 (0.274 g, 94%). Rf = 0.22 (20:80 
EtOAc:hexanes) 1H NMR (500 MHz, CDCl3): δ 7.90, 7.88 (2H, d, J= 7.0 Hz), 7.78, 7.76 
(2H, d, J = 8.3 Hz), 7.62-7.59 (1H, t, J= 7.4 Hz), 7.55-7.49 (2H, m), 7.29-7.27 (2H, t, J= 
8.0 Hz), 5.82-5.78 (1 H, q, J= 7.0 Hz), 2.424 (3 H, s), 1.62, 1.60 (3 H, d, J= 7.0 Hz) ppm. 
13C NMR (125 MHz, CDCl3): δ 194.8, 144.9, 133.8, 133.6, 130.2, 129.8, 128.8, 128.7, 
128.6, 128.5, 127.9, 76.6, 21.6, 18.7 ppm. 
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General procedure for oxylactonization of 5-oxo-5-phenylvaleric acid, II-4. 
 The substrate 5-oxo-5-phenylvaleric acid, II-3, (0.192 g, 1 mmol, 1.0 equiv), 
mCPBA (0.702 g, 3 mmol, 3.0 equiv),  pTSA•H2O (0.571 mg, 3 mmol, 3.0 equiv), and 4-
iodotoluene (0.637 g, 1.5 mmol, 1.5 equiv) were dissolved in MeCN (10 mL) and stirred 
for 24 h at 50 ˚C under nitrogen in a flame dried round-bottom flask. Following rotary 
evaporation, the reaction mixture was diluted in DCM and washed three times with 
aqueous saturated sodium bicarbonate.  The organic layers were collected and dried over 
anhydrous sodium sulfate, filtered, and concentrated by rotary evaporation. The crude 
product was purified via silica gel column chromatography (20:80 EtOAc:hexanes) to give 
a white solid II-4 (0.176 g, 92%) 1H NMR (500 MHz, CDCl3): 8.00 (2H, d, J = 7.4), 7.67 
(1H, t, J 7.4 Hz), 7.54 (2H, t, J = 7.6 Hz), 5.85-5.82 (1H, m), 2.62-2.48 (4H, m) ppm. 13C 
NMR (125 MHz, CDCl3): 19.3, 176.2, 134.3, 133.6, 129.0, 128.9, 78.3, 26.8, 25.0 ppm. 
2.6. Supplementary Information  
Appendix A contains this chapter’s corresponding chiral HPLC chromatograms, 1H 
and 13C NMR spectra as well as all a catalog of the libraries of synthesized 1st and 2nd 
generation peptides and their corresponding MALDI-TOF characterization data.  
 
 
 
 
 
 
 
 
 
 
 74 
2.7. References  
 
1. Moriarty, R. M.; Vaid, R. K.; Koser, G. F. 
 [Hydroxy(organosulfonyloxy)iodo]arenes in Organic Synthesis. Synlett 
 1990, 365-383. 
2. Wirth, T.; Hirt, U. H. Hypervalent Iodine Compounds: Recent Advances in 
 Synthetic Applications. Synthesis 1999, 8, 1271-1287.  
3. Wirth, T.; Ochiai, M. Ed. Hypervalent Iodine Chemistry, Springer: Berlin 
 (Germany), 2003, Vol. 224, pp 5-68. 
4. Hirt, U. H.; Schuster, M. F. H.; French, A. N.; Wiest, O. G.; Wirth. T. Chiral 
 Hypervalent  Organo-Iodine(III) Compounds. Eur. J. Org. Chem. 2001, 
 2001, 1569- 1579. 
5. Moriarty, R. M. Organohypervalent iodine: development, applications, and future  
 directions. J. Org. Chem. 2005, 70, 2893-2903. 
6. Zhdankin, V. V.; Stang, P. J. Recent Developments in the Chemistry of Polyvalent 
 Iodine Compounds. Chem. Rev. 2002, 102, 2523-2584.  
7. Tohma, H.; Kita, Y. Hypervalent Iodine Chemistry; Wirth, T. Ed.; Springer: Berlin, 
 2003; pp 209.  
8. Varvoglis, A. Hypervalent Iodine in Organic Synthesis; Academic Press: London, 
 1997.  
9. Varvoglis, A. Commentary: organic hypervalent iodine chemistry spanning three 
 centuries—a historical overview. Tetrahedron 2010, 66, 5739-5744.  
 75 
10. Wirth, T. Hypervalent Iodine Chemistry; Ochiai, M., Ed.; Springer: Berlin 
 (Germany), 2003, Vol. 224, pp 5-68.  
11. Nabana, T.; Togo, H. Reactivities of Novel [Hydroxy(tosyloxy)iodo]arenes and 
 [Hydroxy(phosphoryloxy)iodo]arenes for α-Tosyloxylation and α-
 Phosphoryloxylation of Ketones. J. Org. Chem. 2002,  67, 4362–4365.  
12. Wirth, T. Catalytic Enantioselective α-Oxysulfonylation of Ketones Mediated by 
 Iodoarenes. Eur. J. Org. Chem. 2008, 2008, 5315-5328. 
13. Altermann, S. M.; Richardson, R. D.; Page, T. K.; Schmidt, R. K.; Holland, E.; 
 Mohammed, U.; Paradine, S. M.; French, A. N.; Richter, C.; Bahar, A. M.; 
 Witulski, B.; Wirth, T. Catalytic Enantioselective α-Oxysulfonylation of 
 Ketones Mediated by Iodoarenes. Eur. J. Org. Chem. 2008, 2008,  5315-
 5328. 
14. Ochiai, M.; Takeuchi, Y.; Katayama, T.; Sueda, T.; Miyamoto, K. Iodobenzene-
 catalyzed alpha-acetoxylation of ketones in situ generation of hypervalent 
 (diacyloxyiodo)benzenes using m-chloroperbenzoic acid. J. Am. Chem. 
 Soc. 2005, 127, 12244-12245.  
15. Dohi, T.; Maruyama, A.; Yoshimura, Y.; Morimoto, K.; Tohma, H.; Kita, Y. 
 Versatile hypervalent-iodine(III)-catalyzed oxidations with m-
 chloroperbenzoic acid as a cooxidant. Angew. Chem., Int. Ed. 2005, 44, 
 6193-6196.  
16. Yamamoto, Y.; Togo, H. PhI-catalyzed α-tosyloxylation of ketones with m-
 chloroperbenzoic acid and p-toluenesulfonic acid. Synlett 2006, 798-800. 
 76 
17. Dohi, T.; Kita, Y. Hypervalent iodine reagents as a new entrance to organocatalysts. 
 Chem.  Comm. 2009, 2073-2085. .  
18. Guilbault, A.-A.; Basdevant, B.; Wanie, V.; Legault, C. Y.  Catalytic 
 Enantioselective α-Tosyloxylation of Ketones Using 
 Iodoaryloxazoline  Catalysts: Insights on the  Stereoinduction 
 Process. J. Org. Chem. 2012, 77, 11283-11295. 
19. Guilbault, A.-A.; Legault, C. Y. Drastic Enhancement of Activity in Iodane-Based 
 α-Tosyloxylation of Ketones: Iodine(III) Does the Hypervalent Twist. ACS 
 Catalysis 2012, 2, 219-222.  
20. Yu, J.; Cui, J.; Hou, X. S.; Liu, S. S.; Gao, W. C.; Jiang, S.; Tian, J.; Zhang, C. 
 Enantioselective α-tosyloxylation of ketones catalyzed by spirobiindane 
 scaffold-based chiral iodoarenes. Tet. Asym.  2011, 22, 2039-2055.  
21. Basdevant, B.; Legault, C. Y. Enantioselective Iodine(III)-Mediated Synthesis of 
 α- Tosyloxy Ketones: Breaking the Selectivity Barrier. Org. Lett. 2015, 
 17,  4918- 4921.  
22. Basdevant, B.; Legault, C. Y. Study of the Reactivity of 
 [Hydroxy(tosyloxy)iodo]benzene Toward Enol Esters to Access α-
 Tosyloxy  Ketones. J. Org. Chem. 2015, 80, 6897-6902. 
23. Collins, I. Saturated and Unsaturated Lactones. J. Chem. Soc., Perkin Trans. 1.  
 1998,  11, 1869-1888.  
24. Donnelly, D. M. X.; Meegan, M. J. Comprehensive Heterocyclic Chemistry; 
 Katritzky, A.  R., Ed.; Pergamon: New York, 1984; Vol. 4, p 657.  
 77 
25. Devon, T. K.; Scott, A. I. In Handbook of Naturally Occurring Compounds; 
 Academic Press: New York, 1975; Vol. 1, 249.  
26. Katzenellenbogen, J. A.; Rai, R.; Dai, W. Enol lactone derivatives as inhibitors of 
 human  neutrophil elastase and trypsin-like proteases. Bioorg. Med. Chem. 
 Lett. 1992, 2,  1399.  
27. Hwang, E.-I.; Yun, B.-S.; Kim, Y.-K.; Kwon, B.-M.; Kim, H.-G.; Lee, H.-B.; 
 Jeong,  W.J.; Kim, S.-U. Chaetoatrosin A, a Novel Chitin Synthase II 
 Inhibitor  Produced by Chaetomium atrobrunneum F449.  J. Antibiot. 
 2000,  53, 248-255.  
28. Husain, A.; Khan, M. S. Y.; Hasan, S. M.; Alam, M. M. 2-Arylidene-4-(4-phenoxy-
 phenyl)but-3-en-4-olides: synthesis, reactions and biological activity. Eur. 
 J. Med. Chem. 2005, 40, 1404. 
29.  Lambert, J. D.; Rice, J. E.; Hong, J.; Hou, Z.; Yang, C. S. Synthesis and biological 
 activity of the tea catechin metabolites, M4 and M6 and their methoxy-
 derivatives. Bioorg. Med. Chem. Lett. 2005, 15, 873-876. 
30. Brauman, J. I.; Pandell, A. J. Mechanism of Permanganate Oxidation of Tertiary 
 Hydrogen to Hydroxyl. J. Am. Chem. Soc. 1970, 92, 329-335.  
31. Nagarajan, A.; Porchezhiyan, V.; Srinivasaramanujam; Balasubramanian, T. R. 
 Synthesis of γ-Phenyl-γ-butyrolactone. Ind. J. Chem. 1985, 24B, 1202.  
32. Irie, H.; Maruyama, J.; Shimada, M.; Zhang, Y.; Kouno, I.; Shimamoto, K.; 
 Ohfune, Y. Use of Potassium Peroxodisulfate for Benzylic  Oxidation and 
 Oxidative Coupling of Benzoylacetates. Synlett 1990, 421.  
 78 
 
33. Jevric, M.; Taylor, D. K.; Greatrex, B. W.; Tiekink, E. R. T. DDQ induced 
 oxidative cyclisations of 1,2-dihydronaptho[2,1-b]furans. 
 Tetrahedron 2005, 61, 1885-1891. 
34. Moriarty, R. M.; Vaid, R. K.; Hopkins, T. E.; Vaid, B. K.; Prakash, O. Conversion 
 of h lactones to the higher homologous α, β-unsaturated lactones v/a 
 hypervalent iodine  oxidation of 1-trimethylsilyloxy-2-oxa[n.1.0] 
 cycloalkanes. Tetrahedron Lett. 1990, 31, 197-200. 
35. Farooq, U.; Schäfer, S.; Shah, A. A.; Freudendahl, D. M.; Wirth, T. Synthesis of 
 New Enantiomerically Pure Organoiodine Catalysts and Their Application 
 in the α-Functionalization of Ketones. Synthesis 2010, 1023-1029.  
36. Uyanik, M.; Yasui, T.; Ishihara, K. Hypervalent iodine-catalyzed oxylactonization 
 of ketocarboxylic acids to ketolactones. Bioorg. Med. Chem. Lett.  2009, 
 19, 3848-3851. 
37. Uyanik, M.; Okamoto, H.; Yasui, T.; Ishihara, K. Quaternary ammonium 
 (hypo)iodite  catalysis for enantioselective oxidative cycloetherification. 
 Science 2010, 328, 1376-1379.  
38. Rodriguez, A.; Moran, W. J. Chiral Aryl Iodide-Catalyzed Enantioselective α-
 Oxidation of Ketones. Synthesis 2012, 44, 1178-1182. 
39. Hoveyda, A. H. Catalyst discovery through combinatorial chemistry. Chem. Biol. 
 1998, 5, 187-191. 
 79 
40. Hoveyda, A. H.; Hird, A. W.; Kacprzynski, M. A. Small peptides as ligands for 
 catalytic asymmetric alkylations of olefins. Rational design of catalysts or 
 of searches that lead to them? Chem. Commun. 2004, 1779-1785. 
41. Kuntz, K. W.; Snapper, M. L.; Hoveyda, A. H. Combinatorial catalyst discovery. 
 Curr. Opin. Chem. Biol. 1999, 3, 313-319. 
42. Shimizu, K. D.; Snapper, M. L.; Hoveyda, A. H. High-throughput strategies for the 
 discovery of catalysts. Chem. Eur. J. 1998 , 4 , 1885-1889. 
43. Oku, J.; Inoue, S. Asymmetric cyanohydrin synthesis catalyzed by synthetic 
 dipeptides, 2.  Makromol. Chem. 1979, 180, 1089. 
44. Berkessel, A. The discovery of catalytically active peptides through combinatorial 
 chemistry. Curr. Opin. Chem. Biol. 2003, 7, 409-419.  
45. Miller, S. J. In Search of Peptide-Based Catalysts for Asymmetric Organic 
 Synthesis. Acc. Chem.  Res. 2004, 37 , 601–610. 
46. Blank, J. T.; Miller, S. J. Studies of folded peptide-based catalysts for asymmetric 
 organic synthesis. Biopolymers 2006, 84, 38-47. 
47. Dalko, P. I.; Moisan, L. Enantioselective organocatalysis. Angew. Chem., Int. Ed. 
 2001, 40, 3726−3748. 
48. Jarvo, E. R.; Miller, S. J. Amino acids and peptides as asymmetric organocatalysts. 
 Tetrahedron 2002, 58, 2481-2495. 
49. Wennemers, H. Asymmetric catalysis with peptides. Chem. Commun. 2011, 47, 
 12036- 12041. 
 80 
50. Wilmot, C. M.; Thornton, J. M.  Analysis and prediction of the different types of 
 beta-turn in proteins. J. Mol. Biol. 1988, 203, 221-231. 
51. Hutchinson, E. G.; Thornton, J. M. A revised set of potentials for beta-turn 
 formation in proteins. Protein Sci. 1994, 3, 2207-2216.  
52. Haque, T. S.; Little, J. C.; Gellman, S. H. Stereochemical requirements for β-
 hairpin  formation: model studies with four-residue peptides and 
 depsipeptides.  J. Am.  Chem. Soc. 1996, 118, 6975-6985. 
53. Haque, T. S.; Little, J. C.; Gellman, S. H. Insights on β-hairpin stability in aqueous 
 solution from peptides with enforced type i 'and type ii 'β-turns.  J. Am. 
 Chem.  Soc. 1997, 119, 2303–2304. 
54. Liang, G.-B.; Rito, C. J.; Gellman, S. H.  Thermodynamic analysis of .beta.-turn 
 formation in Pro-Ala, Pro-Gly, and Pro-Val model peptides in methylene 
 chloride. J. Am. Chem. Soc. 1992, 114, 4440-4442.  
55. Metrano, A. J.; Abascal, N. C.; Mercado, B. Q.; Paulson, E. K.; Miller, S. J. 
 Structural studies of β-turn-containing peptide catalysts for atroposelective 
 quinazolinone  bromination. Chem. Commun. (Camb). 2016, 52, 4816-
 4819.  
56. Ravi, A.; Venkataram Prasad, B. V.; Balaram, P. Cyclic peptide disulfides. Solution 
 and solid-state conformation of Boc-Cys-Pro-Aib-Cys-NHMe with a 
 disulfide bridge from Cys to Cys, a disulfide-bridged peptide helix. J. Am. 
 Chem.  Soc. 1983, 105, 105-109. 
 81 
57. Fields, G. B.; Noble, R. L. Solid phase peptide synthesis utilizing 9-
 fluorenylmethoxycarbonyl amino acids. J. Pept. Protein Res. 1990, 35, 161-
 214. 
58. Chan, W. C.; White, P. D. Fmoc Solid Phase Peptide Synthesis: A Practical 
 Approach; Oxford University Press: Oxford, UK, 2000. 
59. Davie, E. A.; Mennen, S. M.; Xu, Y.; Miller, S. J. Asymmetric catalysis mediated 
 by synthetic peptides. Chem. Rev. 2007, 107, 5759-5812.  
 
 82 
CHAPTER THREE 
 
HYPERVALENT IODOARENE PEPTIDES FOR THE a-OXYTOSYLATION OF 1-
INDANONE 
 
3.1. Introduction 
 
 After the evaluation of a library consisting of 420 different peptide catalysts, no 
significant breakthroughs were realized; therefore, it was crucial to begin exploring the 
underlying nuances of the enantioinduction observed for the two reactions of interest. The 
initial, “hunt-and-peck” approach that we applied early-on has been successful in the past, 
with many examples of groups screening large pools of potential catalysts, finding an initial 
“hit” scaffold, and then optimizing the catalyst structure from the primary lead. Nonetheless, 
the a-oxytosylation of propiophenone and the oxidative cyclization of 5-oxo-5-
phenylvaleric acid did not succumb to this approach in our early efforts.  
 In order to postulate what may be the foundation for the observed low levels of 
enantiocontrol, one must consider the proposed mechanistic pathways for the iodine(III)-
mediated a-oxytosylation of propiophenone (Figure 3.1). Currently, two mechanistic 
pathways have been suggested, both commencing with the acid-catalyzed enolization of the 
ketone followed by its reaction with a Koser-type I(III) reagent.1-5 If the reaction proceeds 
via pathway 1, pictured on the left, the enol oxygen atom will attack the electrophilic I(III) 
center of the Koser-type reagent to generate an iodo-enolate (III-1). Upon the loss of a water 
molecule and subsequent nucleophilic attack by a tosylate anion, the desired a-oxytosylated 
product can be achieved by an SN2’ displacement reaction. If the reaction does proceed by 
this pathway, it can be suggested that low levels of enantioselectivity could be caused by 
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the large distance between the chiral information on the iodoarene and the newly forming 
a-stereocenter. This obstacle would add to the difficulty associated with effectively 
controlling the stereoinduction process.3-5 Alternatively, if pathway 2 is operative, the I(III) 
reagent will undergo nucleophilic attack by the a-carbon of the enol to generate a C-I 
bonded intermediate (III-2). This species can then eject water and subsequently undergo 
SN2 displacement by the tosylate anion to generate the a-functionalized ketone.  
 
 
 
 
Figure 3.1. Two possible mechanistic pathways for the I(III)-mediated a-oxytosylation of 
propiophenone.  
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 Regardless of which pathway the reaction proceeds through, both begin with an 
acid-catalyzed enolization of the ketone that results in a mixture of (E/Z) enol stereoisomers. 
Specifically, there are two mechanistic obstacles to overcome in terms of achieving high 
levels of enantioselectivity. The iodoarene peptide catalyst must deliver the iodine active 
site to only one enantiotopic pi face of the enol ether as well as selectively add to the (E)- 
or (Z)-enol. In other words, even if the peptide catalyst can exclusively select one pi face of 
the enol to deliver the tosylate in an SN2’ fashion the overall enantioselectivity will only be 
as good as the (E/Z)-enol ratio. This is also the case if the a-carbon of the (E/Z) enol mixture 
traps the (III) reagent through the C-I bonded intermediate (III-2). The enantioselectivity of 
the reaction will depend on the relative ratio of the two enol geometries.  
 There is experimental evidence that supports the concern that the enol geometry 
plays a pivotal role in the overall reaction enantioselectivity. Under conventional acid 
promoted equilibria, the (Z/E) ratio of the enol tautomers is 63:37 in the presence of 
trimethyl orthoformate and a catalytic 
amount of tosic acid (Scheme 3.1 A).4 It 
can reasonably be suggested that a 
similar distribution of (Z)- and (E)-enols 
(E/Z= ~60:40) might be present at 
equilibrium under the acidic reaction 
conditions for the catalytic a-
oxytosylation reaction (i.e. 3 equiv. each 
II-1 III-3 III-4
III-5 III-6
Scheme 3.1. A) Experimental (Z)-methyl enol ether 
and (E)-methyl enol ether Z/E ratio = 63:37  B)  
Theoretical (Z)-enol and (E)-enol ; Z/E ratio = ~ 60:40 
in iodoarene peptide catalyzed system . 
 85 
of mCPBA and pTSA•H2O) (Scheme 3.1 B). This represents a need to not only understand 
the effect that the enol geometry has on the enantioinduction process but to also devise a 
strategy to control the (E/Z) enol ratio of the starting material.  
As is well appreciated, the enol geometry of the starting material following acid-
catalyzed tautomerization presents a significant challenge. Therefore, this chapter will focus 
on the implementation of a stereochemically restricted starting material in place of 
propiophenone for the I(III)-mediated a-oxytosylation reaction. These efforts ultimately led 
to various “hit” peptide scaffolds, thus the this chapter will also focus on optimization of 
reaction conditions with the ultimate goal to achieve increased levels of enantioselectivity. 
In conjunction, the observations gleaned from the efforts help to shed light on the catalyst 
and reaction condition requirements for this system.  
3.2. Results and Discussion 
 
3.2.1. Controlling the Enol Geometry  
 
 One way to quickly address the issue of fluxional enol geometry was to investigate 
ketone substrates that only adopt one enol geometry owing to the presence of an additional 
ring. For instance, 1-indanone (III-7) can be used as an alternative starting material for the 
Scheme 3.2. A) Iodoarene peptide-
mediated  a-oxytosylation of 1-indanone. 
B) Acid-catalyzed tautomerization of 1-
indanone, resulting in only the E-enol.  
O O
OTs
HI Peptide (0.1 eq)
mCPBA (3 eq)
pTSA·H2O (3 eq)
MeCN, RT, 24 h
O OHH+
III-7 III-8
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a-oxytosylation of ketones. In the presence of the previously described reaction conditions 
(3 equiv. mCPBA, 3 equiv. pTSA•H2O, RT, 24 h) the acid catalyzed enolization of this 
alternative starting material will result solely in the (E)-enol stereoisomer (Scheme 3.2). 
Screening this substrate would provide the opportunity to evaluate the enantioselectivity of 
the catalysts in the absence of the potentially confounding (E/Z)-enol isomerization event.  
 An initial screen consisting of 50 random iodoarene 
peptides pulled from libraries of Scaffold A and B, resulted in   
a “hit” peptide, III-10, with a primary sequence of 2-IBA-
Orn-Pro-D-Ala-Ile-Tle (Figure 3.2). This catalyst, emerging 
from Scaffold B, provided the a-oxytosylated product, III-8,  
in 48% ee. This exciting result encouraged the iterative 
optimization of  “hit” peptide structure III-10.  
3.2.2. Optimization of “Hit” Peptide Structure III-10 
 The iterative optimization of amino acid residues in positions i+1, i+4, i+5 was 
completed by synthesizing peptide derivatives using the 31 different Fmoc-protected L-
amino acids previously described in Chapter 2 of this 
thesis (Figure 3.3). Once again, methionine, cysteine, 
and arginine amino acids were not used due to the  
potential difficulties associated with these residues in 
conventional Fmoc-SPPS. Further, no attempts to 
optimize positions i+2 or i+3 were made in order to 
maintain the Pro-D-Ala b-turn sequence. Pleasingly, 
N NH
HN
NH
H2N
O
O
CH3
O
O
NH
O
O
I
H2N
II-10
2-IBA-Orn-Pro-D-Ala-Ile-Tle
48% ee
Figure 3.2. “Hit” peptide III-
10 for the a-oxytosylation of 1-
indaone.  
N NH
HN
NH
H2N
O
O
CH3
O
O
NH
O
R3
O
I
R1
R2
i
i+1
i+2 i+3
i+4
i+5
Figure 3.3. Generic peptide structures 
of Scaffold B with amino acid residue 
positions available for iterative 
optimization indicated as i, i+1, i+2, 
i+3, i+4, and i+5.  
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eight additional “hit” peptides were discovered upon screening the second generation library 
as catalysts for the enantioselective a-oxytosylation of 1-indanone . These “hit” precatalyst 
structures III-11 – III-18 gave the desired product III-8 in >30% ee (Figure 3.4). 
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Figure 3.4. “Hit” peptides for the a-oxytosylation of 1-indanone from  from the iterative optimization of 
peptide III-10. 
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2-IBA-Orn-Pro-D-Ala-Tle-Ile 
40% ee 
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III-12 
2-IBA-Orn-Pro-D-Ala-Ile-Ile 
32% ee 
III-13 
2-IBA-Orn-Pro-D-Ala-Asp-Tle 
32% ee 
III-16 
2-IBA-Orn-Pro-D-Ala-tPhe-Tle 
40% ee 
III-14 
2-IBA-Orn-Pro-D-Ala-Ile-Abu 
30% ee 
III-15 
2-IBA-Orn-Pro-D-Ala-Val-Tle 
38% ee 
III-17 
2-IBA-Orn-Pro-D-Ala-Ile-2-Nap 
30% ee 
III-18 
2-IBA-Orn-Pro-D-Ala-hPhe-Tle 
37% ee 
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Overall, it was noticed that all the “hit” peptides contain sterically bulky alkyl and/or 
aromatic R-side chains in positions i+4 and i+5, such as Ile, Tle, and hPhe.  Further, when 
position i+1 was optimized, no additional “hit” peptides emerged following this iteration. 
This potentially suggests that the i+1 position, containing the ornithine residue, plays a 
critical role in the selectivity of the reaction. Further comparisons between other basic amino 
acid residues, such as lysine (Lys), diamino propionic acid (Dap), and histidine (His) in the  
i+1 position, revealed lower levels of enantioselectivity (Figure 3.5). For example, peptides 
III-10, III-19 and III-20 all contain amine-terminated alkyl side chains, yet they display 
different levels of stereoinduction. It is possible that the number of methylene units between 
the α-carbon of the i+1 amino acid residue and the side chain amine significantly influences 
the observed % ee. It was also interesting to compare peptides structures resulting from 
modifications at the i+1 position that promoted the lowest levels of selectivity.  In addition 
to Dap-containing peptide III-20, eight additional peptides gave III-8 in ≤5% ee (Figure 
3.6, Structures III-23-29). Not including precatalysts III-20, III-26, and III-27, the peptides 
that generated product III-8 all have aromatic side chains, such as, Phe, tPhe, Bip, Tyr, 1-
Nap, and 2-Nap in the i+1 position. This observation highlights the need for further 
Figure 3.5. Comparison of peptide structures with basic amino acid residues in the i+1 position.  
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investigations into the possible intermolecular interactions between the peptide and 
substrate of interest. There are numerous possibilities for hydrogen bonding, pi-stacking, 
ion pairing, etc. interactions that could aid or hinder the enantioselectivty of the 
transformation.  
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Figure 3.6. Peptides from i+1 iterative modification of parent III-10 that gave product III-8 in ≤5% ee a-
oxytosylation of 1-indanone 
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3.2.3. Reaction Condition Optimization 
 The promising results arising from this most recent peptide library screening in the 
a-oxytosylation of 1-indanone prompted a reaction condition optimization campaign. 
Initially, factors such as oxidant, solvent, time, and temperature were probed. First, an 
oxidant screen was conducted in which various potential co-oxidants at various equivalents 
were explored in place of mCPBA (3 equiv). Reports predominantly feature mCPBA as a 
suitable co-oxidant for the catalytic a-oxytosylation of propiophenone.6-17 In fact, the 
utilization of mCPBA as a co-oxidant for the in situ oxidation of I(I) species to its I(III) 
derivative reported by Ochai and Kita, is regarded as a pioneering moment in hypervalent 
iodine chemistry.6,7 Previously, the stoichiometric application of an hypervalent iodoarene 
(ArIX2) reagent would produce at least an equimolar amount of the reduced iodoarene (ArI), 
as well as the two ligands (X). These by-products not only represent waste but also the free 
ligands would often end up incorporated into the product. An ideal co-oxidant for the 
transformation would also be inert to the substrate and desired product, or the rate of 
regeneration for the I(III) catalyst should be faster than any undesired side reactions. 
Ultimately, the catalytic application of iodoarene reagents (ArIX2) is made possible by the 
in situ oxidation of the I(I)-precatalyst to the I(III)-catalyst, subsequent reaction with the 
substrate, which upon release of the iodoarene I(I) must be successfully reoxidized in situ 
to continue the catalytic cycle (Figure 3.7).17  
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 We sought to explore various oxidants such as, peroxides, Oxone® 
(2KHSO5•KHSO4•K2SO4), Triazox (2-hydroperoxy-4,6-diphenyl-1,3,5-triazine), and 
NaBO3•4H2O. Often, altering the terminal oxidant from mCPBA to a different reagent, such 
as H2O2•Urea or H2O2, resulted in no product; in these instances “NP is used to denote that 
the desired III-8 product was not detected via chiral stationary-phase HPLC analysis (Table 
3.1 A, Entries 6-8). Presumably, reagents that resulted in no product (Entries 6-8) did not 
serve as appropriate oxidants for the in situ oxidation of the I(I) precatalyst peptide III-10 
to its active I(III) catalytic derivative. Employing Oxone®, sodium perborate tetrahydrate, 
and Triazox all resulted in an observed decrease in the reaction enantioselectivity. For 
example, applying 3, 1.5, or 6 equiv of Oxone® all led to decreased enantioselectivities of 
22, 20, and 25% ee, respectively (Table 3.1 A, Entries 1-3). This was surprising due to the 
many successful examples of the use of Oxone® as a co-oxidant in I(III)-mediated 
IAr
X
X
IAr
Substrate 
Desired Oxidation 
Product  
Regeneration 
of Catalyst 
Oxidation 
Reaction 
Figure 3.7. General catalytic cycle for the in situ oxidation of an I(I) precatalyst 
to its active I(III) counterpart.   
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reactions.18-24 Sodium perborate (NaBO3) is an inorganic oxidant that has been used to 
prepare ArIX2 reagents in the past; though, it has often been deemed unsatisfactory for the 
in situ oxidation of I(I) precatalysts due to its poor solubility in organic solvents.17 Triazox 
was explored due to its ease of synthesis from 2-chloro-4,6-diphenyl-1,3,5-triazine (CDPT) 
as a bench-stable, water-free oxidant.25 Nonetheless, the use of NaBO3•4H2O and Triazox 
did not promote increased enantioselectivity (Table 3.1, Entries 10-15). Further, decreasing 
or increasing the equivalents of mCPBA also resulted in decreased enantioselectivities, 
displaying 23 and 16% ee for 1.5 and 6 equiv, respectively (Table 3.1, Entries 16-18).  
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O O
OTs
oxidant (X eq)
pTSA•H2O (3 eq)
Peptide III-10 (0.1 eq)
MeCN (1 mL) 
RT, 24 hIII-7 III-8
Table 3.1 A: Oxidant Screen    
Entry Oxidant (eq) Solvent % ee of III-8a
1 Oxone (3) Dry MeCN 22
2 Oxone (1.5) Dry MeCN 20
3 Oxone (6) Dry MeCN 25
4 H2O2•Urea (3) Dry MeCN 13
5 H2O2•Urea (1.5) Dry MeCN 9
6 H2O2•Urea (6) Dry MeCN NP
7 30% H2O2 (3) Dry MeCN NP
8 30% H2O2 (1.5) Dry MeCN NP
9 30% H2O2 (6) Dry MeCN 6
10 NaBO3•4H2O (3) Dry MeCN 13
11 NaBO3•4H2O (1.5) Dry MeCN 14
12 NaBO3•4H2O (6) Dry MeCN 15
13 Triazox (3) Dry MeCN 26
14 Triazox (1.5) Dry MeCN 14
15 Triazox (6) Dry MeCN 24
16 mCPBA (3) Dry MeCN 50
17 mCPBA (1.5) Dry MeCN 23
18 mCPBA (6) Dry MeCN 16
aDetermined by Chiral HPLC
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Throughout the oxidant screen, varying reaction solubilities were noted. For 
example, mCPBA is fully soluble in the reaction medium upon addition of MeCN solvent 
but, Oxone® and NaBO3•4H2O were not fully solubilized until after sonication . Therefore, 
1,2-dimethoxyethane (DME) and 1,4-dioxane were explored as alternative solvents due to 
their use in the literature as successful solvents for Oxone®-promoted enantioselective 
oxidation reactions.26,27 Unfortunately, these alternative solvents did not prove effective: in 
all cases decreased enantioselectivities or no reaction turnover was observed (Table 3.1 B). 
Lastly, mCPBA (3 equiv) in DME and 1,4-dioxane was examined to serves as a control, and 
in both instances, decreased enantioselectivities were observed (Table 3.1 B, Entries 1 and 
6).  
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1 B: Oxidant Screen
Entry Oxidant (eq) Solvent % ee of III-8a
1 mCPBA (3) DME 19
2 Oxone (3) DME 0
3 H2O2•Urea (3) DME NP
4 NaBO3•4H2O (3) DME NP
5 Triazox (3) DME 18
6 mCPBA (3) 1,4-dioxane 27
7 Oxone (3) 1,4-dioxane NP
8 H2O2•Urea (3) 1,4-dioxane 9
9 NaBO3•4H2O (3) 1,4-dioxane 8
10 Triazox (3) 1,4-dioxane 15
aDetermined by Chiral HPLC
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After determining that mCPBA (3 equiv) served as the best co-oxidant for the in situ 
oxidation of the iodoarene peptides to their active I(III) species for the catalytic and 
enantioselective a-oxytosylation of 1-indanone, a solvent screen was conducted.  First, 
other polar aprotic solvents such as DCM, EtOAc, THF, ether, and acetone were explored. 
In all cases, except with ether, lowered enantioselectivities, in comparison to MeCN, were 
noticed. The use of ether resulted in no detectable III-8 product, presumably due to poor 
reagent solublitly (Table 3.2 A, Entries 1-5). The addition of molecular sieves to dry MeCN 
generated the desired III-8 producted in an increasd 65% ee. 
 Next, polar protic solvents were probed, including MeOH, EtOH, and nitromethane. 
Polar protic solvents would undoubtedly increase the solubilty of the reagents and so 
possibly increase the reactivity and selectivity of the reaction. Contrary to this, the use of 
MeOH and EtOH as solvents in our system, significantly decreased the enantioselectivity, 
providing III-8 in only 12 and 18% ee, respectively (Table 3.2A, Entries 8 and 7). 
Conversely, the use of nitromethane resulted in a 53% ee (Table 3.2 A, Entry 10). 
  Further, protic fluorinated solvents, such as TFE and HFIP, are documented as 
useful solvents for the stablilization of anions, in comparison to other alcohols, thus serving 
as useful solvents in reactions with anionic intermediates. Therefore, they are often applied 
to enantioselective reactions in hopes that this stablization will support increased levels of 
enantioselectivity. In our case, increased levels of enantioselectivity were not observed 
(Table 3.2 A, Entries 6 and 7). Lastly, nonpolar solvents were examined. Hexanes, toluene, 
chloroform, and DME did not proove advantageous for the a-oxytosylation of 1-indanone. 
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In all cases, decreases in reaction enantioselectivity was observed, especially in chloroform, 
which gave the a-oxytosylated product in only 4% ee (Table 3.2 A, Entries 12-15). Poor 
solubility of the reagents in all the nonpolar solvents was noted throughout the course of the 
reaction. While, no attempts were made to quantify reaction yields, the intensity of the 
enantiomeric product peaks on the HPLC chromatograms can give an indication as to the 
overall reaction yield. With the nonpolar solvents, very little product was detected in 
comparison to the other solvents.  
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O O
OTs
mCPBA (3 eq)
pTSA•H2O (3 eq)
Peptide III-10 (0.1 eq)
Solvent (1 mL) 
RT, 24 hIII-7 III-8
Table 3.2 A: Solvent Screen
Entry Solvent % ee of III-8a
1 DCM 23
2 EtOAc 22
3 THF 19
4 Ether NP
5 Acetone 16
6 MeOH 12
7 EtOH 18
8 TFE 22
9 HFIP 36
10 Nitromethane 53
11 Dry MeCN, 4Å Mol Sieves 65
12 Hexanes 17
13 Toluene 20
14 Chloroform 4
15 DME 13
aDetermined by Chiral HPLC
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Additionally, co-solvent systems were explored, yet, none led to increased levels of 
stereoinduction of the desired a-oxytosylated product (Table 3.2 B). For example, aprotic 
polar solvents MeCN and DCM were used in a 1:1 ratio with DCM, EtOAc, ether, HFIP, 
and TFE to probe wheter mixed solvent systems of similair or different polarity would affect 
the observed product enantioselectivity. The largest hit to the reaction enantioselectitivy 
was seen with co-solvent systems of MeCN/MeOH and MeCN/EtOH, wherein,  the addition 
of these polar protic solvents generated III-8 in only 6% ee (Table 3.2 B, Entries 6 and 7). 
Mixed solvent systems of ether and MeCN or DCM did generate the desired product in 21 
and 17% ee, respectively, whereas, ether alone did not (Table 3.2 B, Entries 3 and 8). Based 
on the results observed from this solvent screens, dry MeCN with  4 Å molecular sieves was 
determined to be the best solvent system for the a-oxytosylation of 1-indanone. This could 
suggest that the presence of water is negatively influencing the reaction selectivity.  
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Table 3.2 B: Mixed Solvent Screen
Entry Solvent (Ratio) % ee of III-8a
1 MeCN/DCM (1:1) 27
2 MeCN/EtOAc (1:1) 28
3 MeCN/Ether (1:1) 21
4 MeCN/HFIP (1:1) 34
5 MeCN/TFE (1:1) 15
6 MeCN/MeOH (1:1) 6
7 MeCN/EtOH (1:1) 6
8 DCM/EtOAc (1:1) 22
9 DCM/TFE (1:1) 37
10 DCM/Ether (1:1) 17
11 DCM/HFIP (1:1) 25
12 DCM /TFE (1:1) 25
aDetermined by Chiral HPLC
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Simultaneously, a time screen 
was conducted in order to probe the 
relationship between reaction time and 
enantioselectivity. When 1-indanone 
is treated with mCPBA, pTSA•H2O, a 
catalytic amount of III-10 in MeCN at 
RT, no significant increase or decrease 
in selectivity was noticed. With 
regards to overall enantioselectivity 
and completing screening reactions in 
a timely and logistically simple 
fashion, a 24 h reaction time was 
deemed the most appropriate (Table, 
3.3, Entry 8).  
The effect of temperature on 
the a-oxytosylation of III-7 was next investigated. Often, altering the reaction temperature 
will promote increased levels of steroinduction. For example, some temperature-dependent 
asymmetric transformations will experience greater stereoinduction at lower temperatures. 
It is proposed that at lower temperatures, the formation of one product enantiomer over the 
other will be favored due to an enhanced Boltzman distribution bias for the lower energy 
enantiomeric complex in the transition state.28 There are also reports of increased % ee with 
increased temperatures, as is the case with asymmetric addition of diethylzinc to 
Table 3.3: Time Screen  
O O
OTs
mCPBA (3 eq)
pTSA•H2O (3 eq)
Peptide III-10 (0.1 eq)
Dry MeCN (1 mL)
RT, X hIII-7 III-8
Entry Time (h) % ee of III-8a
1 0 46
2 2 48
3 4 43
4 6 48
5 8 50
6 10 46
7 12 53
8 24 56
9 36 41
10 48 46
aDetermined by Chiral HPLC
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benzaldehyde, asymmetric borane reduction of ketones, and in Rh(I) complex-catalyzed 
hydrogenation of unsaturated amino acids.30-37 
 In the context of asymmetric hypervalent iodine chemistry, Ogasawara, Dohi, and 
co-workers, recently applied this approach to the asymmetric dearomatizing 
spirolactonization of 3-(1-hydroxy-2-naphthyl)propionic acid. Their axially-chiral diodo-
tertalin catalysts garnered higher reaction yields and enantioselectivities at 0 °C and even 
better results at –20 °C, providing the desired product in 64 and 73% ee, respectively.38 
Therefore, we first conducted the a-oxytosylation of 1-indanone at lowered temperatures 
ranging from –50 to 10 °C. Unfortunately, only decreased enantioselectivities were realized 
(Table 3.4, Entries 1-8).  The freezing point of MeCN is –45° C, so at –40 °C a mixed 
solvent system of MeCN/DCM (1:1) was employed as well as dry DCM at –50°C. It was 
quickly realized that decreasing the reaction temperature significantly decreased the 
observed levels of enantioselectivity (Table 3.4, Entries 8). It is possible that longer reaction 
times may be necessary at these lower temperatures in order for the transformation to reach 
completion. Additional studies are being conducted to explore this possibility.  
Further, even slight increases in reaction temperature decreased enantioselectivity. 
For example, at RT a 65% ee of III-8 was obtained but at 40 °C only a 22% ee  was achieved. 
It can be suggested that increasing the temperature may also increase the overall rate of the 
reaction, thus decreasing the selectivity.  
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O O
OTs
mCPBA (3 eq)
pTSA•H2O (3 eq)
Peptide III-10 (0.1 eq)
Dry MeCN (1 mL)
4  Å MS
X °C, 24 h
III-7 III-8
Entry Temp (°C) Solvent % ee of III-8a
1 -50 Dry DCM 19
2 -40 Dry MeCN/Dry DCM 15
3 -40 Dry MeCN 18
4 -30 Dry MeCN 14
5 -20 Dry MeCN 8
6 -10 Dry MeCN 10
7 0 Dry MeCN 15
8 10 Dry MeCN 28
9 20 Dry MeCN 41
10 30 Dry MeCN 43
11 RT Dry MeCN 65
12 40 Dry MeCN 22
13 45 Dry MeCN 27
14 50 Dry MeCN 26
15 55 Dry MeCN 28
16 60 Dry MeCN 28
17 70 Dry MeCN 34
18 80 Dry MeCN 38
aDetermined by Chiral HPLC
Table 3.4: Temperature Screen  
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Additives are often employed in asymmetric organocatalytic reactions with the 
intent of reducing the reaction time, improving the overall yield, and/or increasing the 
enantioselectivity.39,40 There are numerous examples wherein  the introduction of an additive 
to an organocatalytic system substantially increases the reactivity and/or the selectivity of 
the transformation; such as, the addition of water to proline-catalyzed aldol reactions will 
typically result in higher yields and enantioselectivities.41-44 In general, an additive can 
activate the substrate, promote the formation of a favorable transition state, block side-
reactions, and/or aid in the regeneration of the catalysts. 39,40   
There are not many mechanistic studies fully detailing the role of additives. Further, 
it is difficult to predict which additive(s) will prove effective in a given reaction. Therefore, 
various additives were explored using the established optimized conditions for the a-
oxytosylation of 1-indanone (III-7). Namely, treatment of 1-indanone with 3 equiv of 
mCPBA as the co-oxidant, 3 equiv of pTSA·H2O as the nucleophile, 4 Å molecular sieves 
in dry MeCN at RT for 24 h (Table 3.5). Throughout, this additive screen, the focus was on 
changes to the observed enantioselectivty of product III-8, once again no attempts to 
quantify reaction yield were made.  
 First, the addition of alcohols, capable of hydrogen bonding, such as MeOH, EtOH, 
HFIP, and TFE were investigated. Previously, the addition 10 and 25 equiv of MeOH and 
EtOH to the hypervalent iodine-mediated asymmetric oxidative dearomatization of phenols 
was explored by Ishihara and co-workers. In this study, it was suggested the presence of 
MeOH as a protic polar solvent increased the reaction rate of the oxidation as well as 
improved the enantioselectivity of the reaction by functioning as a ligand on the I(III) chiral 
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catalysts.45 Reactions containing MeOH and EtOH did not generate III-8 in 
enantioselectivities higher than 65% ee. It was noted that as the equivalents of each alcohol 
was increased from 10 to 25, the selectivity also increased, with 25 equiv. of MeOH 
resulting in 50% ee (Table 3.5, Entries 1-4). Further, fluorinated alcohols HFIP and TFE 
were investigated due to their noted reactivity and stereoinduction benefits in hypervalent 
iodine processes.46-52 These also did not serve as effective additives for increased 
stereocontrol (Table 3.5, Entries 5-8). The addition of DCE (2 and 5 equiv), as a non-polar 
additive, led to a decreased selectivity, producing III-8 in 30 and 38% ee, respectively 
(Table 3.5, Entries 12 and 13). Lastly, the use of acid additives for the a-oxytosylation of 
1-indanone was explored. Boron trifluoride diethyl etherate (BF3·Et2O) has been readily 
applied as an activator to promote the oxidation of stoichiometric amounts of hypervalent 
iodine reagents as well as a Lewis acid additive in catalytic I(III)-mediated processes.4, 53-56 
It was quickly apparent that care needed to be taken when using BF3·Et2O because when 
directly added to the reaction, no product was detected via HPLC analysis (Table 3.5, Entry 
9). Therefore, BF3·Et2O, mCPBA, pTSA·H2O, and the peptide was allowed to stir for 30 
min prior to the dropwise addition of the 1-indanone substrate dissolved in MeCN. Using 
this protocol, product III-8 was detected upon the addition of 2 and 5 equiv of BF3·Et2O 
but only at 18 and 23% ee, respectively. (Table 3.5, Entries 10 and 11). Further, inorganic 
and organic acids also proved ineffective, as the addition of 10 equiv. of HCl and TFA 
yielded III-8 in 48 and 45 % ee (Table 3.5, Entries 12 and 13).57, 58 
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O O
OTs
Peptide III-10 (0.1 eq)
mCPBA (3 eq)
pTSA•H2O (3 eq)
Dry MeCN (1 mL)
4  Å MS, Additive
RT, 24 h
III-7 III-8
Table 3.5: Additive Screen  
Entry Additive (equiv) % ee of III-8a
1 EtOH (10) 30
2 MeOH (10) 31
3 EtOH (25) 48
4 MeOH (25) 50
5 EtOH (50) 20
6 MeOH (50) 14
7 EtOH (100) 17
8 MeOH (100) 7
9 HFIP (10) 36
10 HFIP (25) 34
11 TFE (10) 44
12 TFE (25) 46
12 BF3Et2O (2) NP
14b BF3Et2O (2) 18
15b BF3Et2O (5) 23
16 DCE (2) 30
17 DCE (5) 38
18 HCl (10) 48
19 TFA (10) 45
aDetermined by Chiral HPLC; b1-indanone was added after reagents 
were allowed to stir for 30 min. 
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Upon analysis of the results obtained from the various reaction conditions employed during 
the aforementioned optimization experiments, it was apparent that very slight changes, such 
as a small increase in temperature or solvent switch, had the potential to greatly impact the 
overall enantioselectivty of the reaction. These data also suggest that the presence of water 
may hinder the enantioselectivity of the process.  
3.2.4 Non-Polar Co-Solvent System Screens  
 Despite the numerous reaction conditions explored in hopes of achieving increased 
levels of enantioselectivity for the a-oxytosylation of 1-indanone, the mere addition of 
molecular sieves to the reaction led to a substantial increase from 48 to 65% ee for product 
III-8. This may suggest that a more non-polar solvent system may be appropriate for 
stereoinduction. Previously, we have only examined non-polar solvents, such as hexanes 
and toluene, on their own. Therefore, it was deemed prudent to explore mixed solvent 
systems of MeCN/hexanes and MeCN/toluene. Various ratios of MeCN and hexanes or 
toluene were evaluated; however, decreased enantioselectivities of product III-8 were 
observed in all cases (Table 3.6.).  
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3.2.5. Alternative Nucleophiles for the a-Oxytosylation of Ketones 
 Each HI-mediated asymmetric a-functionalization reaction screened thus far has 
utilized pTSA·H2O as the nucleophile. Previously, Levitre et al. reported the catalytic and 
stoichiometric application of chiral non-C2-symmetric iodoarenes(III) for the asymmetric 
oxygenation of propiophenone. In this report, the enantioselective α-sulfonylation of  
ketones was achieved upon treatment with 1-naphthalenesulfonic acid (III-30) or methane 
sulfonic acid (III-31), mCPBA, and an hypervalent iodine compound.59 Therefore, we 
sought to apply these nucleophiles in conjunction with our iodoarene peptides to not only 
O O
OTs
mCPBA (3 eq)
pTSA•H2O (3 eq)
Peptide III-10 (0.1 eq)
Solvent (1 mL) 
RT, 24 hIII-7 III-8
Table 3.6: Non-Polar Mixed Solvent Screen
Entry Solvent  (Ratio) % ee of III-8a
1 MeCN/Hexanes (1:1) 22
2 MeCN/Toluene (1:1) 22
3 MeCN/Hexanes (9:1) 28
4 MeCN/Toluene (9:1) 27
5 MeCN/Hexanes (1:9) 15
6 MeCN/Toluene (1:9) 14
7 MeCN/Hexanes (3:1) 28
8 MeCN/Toluene (3:1) 26
9 MeCN/Hexanes (1:3) 22
10 MeCN/Toluene (1:3) 24
aDetermined by Chiral HPLC
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expand the utility of this method but also probe whether these nucleophiles would lead to 
higher levels of stereoinduction.  
 Hit peptide III-10 in addition to a handful of other peptides from the same peptide 
library were screened using the same reaction conditions as applied to the previous peptide 
screening reactions, except III-30 or III-31 were applied in 3 equiv rather than pTSA·H2O 
(Scheme 3.3). The structures for the screened peptides are depicted in Figure 3.8 along with 
their corresponding primary sequences. The success of the enantioinduction for each 
catalyst was determined by means of chiral stationary-phase HPLC analysis (Table 3.6). In 
general, the desired α-functionalized product, either III-32 or III-33, was detected; 
suggesting that our iodoarene peptides can serve as suitable catalysts for various other 
ketone α-sulfonylation reactions. The exception to this includes the lack of product detected 
when peptide III-34 was applied to the α-sulfonylation of 1-indanone with 1-napthelene 
sulfonic acid (Table 3.6, Entry 10). Moreover, no distinct trends were uncovered. For 
example, peptide III-28 gave moderate % ee for III-8, III-32, and III-33. On the other hand, 
peptide III-27 produced III-32 in 25% ee but generated in III-8 and III-33 in only 9 and 3 
% ee, respectively.  
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Scheme 3.3. The α-sulfonylation of 1-indanone, using III-30 and III-31 as the nucleophile.  
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Figure 3.8. Peptides screened in α-sulfonylation of 1-indanone reactions.  
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3.2.6. Catalyst Loading  
 In order to examine the limits of our hypervalent iodoarene peptide catalyzed 
system, we sought to perform a catalyst loading experiment. Using the optimized 
conditions, i.e.  3 equiv. mCPBA, 3 equiv pTSA•H2O, 4 Å molecular sieves, in dry MeCN 
at RT for 24 h,  0.05, 0.1, 0.2, 0.3, 0.4, 0.5, and 1 equiv of peptide III-10 were used in the 
a-oxytosylation of 1-indanone (Table 3.8). Typically, one would expect to observe a 
positive linear relationship between the catalyst loading and the observed enantioselectivity. 
60, 61 This was not the case, as the amount of peptide catalyst was increased, the % ee of 
product III-8 decreased.  
Table 3.7: Alternative Nucleophiles for the a- Functionalization of 1-Indanone 
Entry Peptide Catalyst % ee of III-32a % ee of III-33a % ee of III-8a
1 III-10 11 28 48
2 III-26 19 35 21
3 III-27 9 25 3
4 III-28 22 21 30
5 III-29 21 15 26
6 III-30 15 20 27
7 III-31 24 23 25
8 III-32 23 24 32
9 III-33 12 20 26
10 III-34 16 18 33
11 III-35 17 15 35
aDetermined by Chiral HPLC
 113 
 
 
Often, observed non-linear effects in asymmetric catalysis can be attributed to bi-
functional catalysis. 59, 60 Peptide III-10 may be promoting a side-reaction as well as the 
desired a-oxytosylation of 1-indanone. More specifically, the amine moiety on the ornithine  
amino acid residue in position i + 1 may be functioning as a nucleophile and promoting 
iminium or enamine formation via the condensation of the peptide and the 1-indanone 
substrate, and thus a potential and undesired side reaction. 
O O
OTs
III-7 III-8
Peptide III-10 (X eq)
mCPBA (3 eq)
pTSA·H2O (3 eq)
4Å Mol Sieves
Dry MeCN, RT, 24 h
*
Entry Peptide III-10 (equiv) % ee of III-8a
1 0.05 64
2 0.1 66
3 0.2 43
4 0.3 34
5 0.4 32
6 0.5 31
7 1 27
aDetermined by Chiral HPLC 
Table 3.8: Catalyst III-10 Loading Experiment  
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In order to evaluate this possibility, 1-indanone and a stoichiometric amount of III-
8 were allowed to react in deuterated MeCN for 24 h at RT. This reaction mixture was 
monitored via 1H NMR in order to follow the a-proton of 1-indanone. Throughout the 
reaction no indication of iminium or enamine formation was observed as no shifts or 
changes in splitting were observed in NMR spectrum for the a-proton of 1-indanone. An 
additional experiment was conducted, wherein equimolar amounts 1-indanone, peptide III-
10, and trifluoroacetic acid-d were allowed to stir in deuterated MeCN for 24 h at RT. The 
addition of acid to the mixture was thought appropriate due to the acidic nature of the a-
oxytosylation reaction of ketones. After 12h and 24 h, a slight shift in the a-proton of 1-
indanone resonance peaks of 1-indanone as well as the emergence of a slight shoulder to 
the right of the peak. Further, when comparing a pure sample of peptide III-10 to the 
mixture of peptide, acid, and 1-indanone, it is observed that the peak associated with the 𝛿 
protons of ornithine (~3 ppm) is altered (Figure 3.9). This observance possibly suggests bi-
functional catalysis between the amine side chain of ornithine and the 1-indanone substrate.  
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 Figure 3.9. 1H NMR overlays of 1-indanone, peptide III-10, and a mixture of them 
with TFA-d at 12 and 24 h.  
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3.3. Conclusions  
 These data further support the ability of our iodoarene-containing peptides to create 
a chiral environment that can impart moderate enantiocontrol onto hypervalent iodine-
mediated organic transformations in a mild, straightforward, and environmentally friendly 
manner. Switching ketone substrates from propiophenone to the cyclic congener, 1-
indanone, proved fortuitous as “hit” peptide III-10 was realized following an initial screen 
of only 50 peptides. Further, following the 
iterative optimization of this scaffold, an 
additional eight “hit” peptides emerged 
that generated the a-oxytosylated ketone 
product III-8 in >30% ee ( >65:35 er).  
It was also realized, after the  optimization of various reaction conditions such as, 
oxidant, time, temperature, solvent, etc., that the treatment of 1-indanone (III-7), with 
mCPBA (3 equiv),  pTSA•H2O (3 equiv), 10 mol% III-10 peptide, 4 Å molecular sieves, in 
dry MeCN for 24 h gave the desired ⍺-oxytosylated product III-8 in 65% ee and 23 % yield 
(Scheme 3.4). Further, upon application of these optimized conditions to propiophenone, 
only 24% ee of III-8 was observed in 27 % 
yield (Scheme 3.5). This in combination 
with the success of the peptide library 
formulated around the initial “hit” III-10 for 
the a-oxytosylation of 1-indanone suggests 
mCPBA (3 eq)
pTSA·H2O (3 eq)
HI Peptide (0.1 eq)
4Å Mol Sieves
Dry MeCN
RT, 24 h
O O
OTs
Scheme 3.5. The α-oxytosylation of 
propiophenone under optimized reaction 
conditions.   
24% ee  
Scheme 3.4. Optimized reaction conditions for 
the α-oxytosylation of 1-indanone.   
O O
OTs
mCPBA (3 eq)
pTSA•H2O (3 eq)
Peptide III-10 (0.1 eq)
Dry MeCN (1 mL)
4  Å MS
RT, 24 h
III-7 III-8
65% ee  
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that the (Z/E)-ratio of the key enol intermediate may profoundly influence the overall 
enantioselectivity of these reactions. Further experiments are required in order to verify this 
hypothesis, such as the treatment of pure samples of the (E)- and (Z)-enol of propiophenone 
with a stoichiometric amount of the oxidized III-10 peptide.  
 Ultimately, information gleaned from the research detailed in this thesis suggests 
that hypervalent aryl-iodo peptides can serve as versatile and mild precatalysts for HI-
mediated organic transformations. Nonetheless, this area of research is still in its infancy 
and many efforts are being put forth to realize highly reactive and enantioselective peptide 
catalysts. This is highlighted by the inability to realize synthetically useful levels of 
enantioselectivty following a reaction optimization campaign of over 100 different 
conditions. While this is an inherent difficulty in asymmetric catalysis, as there is a small 
energy difference (1 to 2 kcal/mol) that typically separates an inactive or nonreactive 
catalyst from a highly selective and reactive one, it also supports the need for further 
mechanistic studies. It is clear that additional research is needed in order to fully understand 
the intricacies behind the interactions of the peptide and substrate, the mode of 
enantioinduction, and the true mechanism of the hypervalent I(III)-mediated a-
oxytosylation of ketones.  
3.4. Future Directions  
 
 One of the clearest next steps is to screen precatalysts from the current iodoarene 
peptide library, consisting of over 800 different structures, in other HI enantioselective 
transformations. Theoretically, these peptides should prove useful in any I(III)-mediated 
transformation, given the correct in situ oxidation conditions. The literature is rich with 
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catalytic and asymmetric I(III)-promoted organic reactions. For example, given the success 
of our previously screened ⍺-functionalization reactions, other nucleophiles should prove 
accessible , such as, acetic acid or diphenylphosphate, for the asymmetric α-oxygenation  
and α-phosphorylation of propiophenone and 1-indanone, respectively (Scheme 3.6 A and 
B).59, 62 Additionally, Wang and co-workers have recently published the use of chiral HI 
reagents for the enantioselective oxidative fluorination of β-keto esters with 
trihydrofluoride-triethylamine (3HF•Et3N), as a nucleophilic fluoride source.63 There is 
potential for our iodoarene peptides to serve as successful chiral catalysts in this fluorination 
reaction, as well (Scheme 3.6 C).  
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Scheme 3.6. Potential future enantioselective HI-mediated transformations.  
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3.5. Experimental  
 
3.5.1. General Materials and Methods 
 Enantiomeric excess (% ee) of product III-8 was determined via chiral stationary-
phase high performance liquid chromatography (HPLC).  Chiral samples were run on an 
Agilent 1260 Infinity system equipped with a diode array detector (G4212-60008), and an 
Agilent 1260 Infinity auto sampler. The chiral stationary column used was a Chiralpak-AD 
(250mm X 4.6 mm). The mobile phase consisted of iso-propyl alcohol/hexanes mixture 
(80:20). The flow rate was set at 1 mL/min and the elution of analytes was monitored at 254 
nm, with enantiomeric retention times = 10.4 and 12.9 min.  
3.5.2. Screening Reaction Protocols 
 Chiral stationary-phase HPLC analyses of the crude reaction mixtures were 
completed to determine % ee for the a-oxytosylation of 1-indanone. A pure racemic sample 
of 1-indanone was prepared following the procedure detailed in section 3.5.3. of this chapter 
and used as HPLC standards to determine the retention times of product enantiomers.  
General Procedure for the a-Oxytosylation of 1-Indanone 
 Iodoarene peptide precatalysts were evaluated in the asymmetric α-oxytosylation of 
1-indanone using the following representative procedure: A 3 mL screw-capped vial was 
charged with 1-indanone (3.97 mg, 0.3 mmol, 1.0 equiv), pTSA•H2O (17.1 mg, 0.09 mmol, 
3 equiv), mCPBA (77%) (20.2 mg, 0.03 mmol, 3 equiv), the appropriate iodoarene peptide 
precatayst (0.01 mmol, 0.1 equiv) and a small stir bar. The reagents were dissolved in 1 mL 
of acetonitrile and the reaction was stirred for 24 h at RT. Following the allotted reaction 
time, the crude solution was concentrated by rotary evaporation and prepared for  
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HPLC analysis. Samples were prepared for HPLC analysis by dissolving the samples in 0.2 
mL of the HPLC solvent system of IPA/Hexanes (80/20) followed by filtration through 
micro-syringe filters into HPLC analysis vials.  
3.5.3. Synthesis of Racemic Products  
 The racemic product III-8 expected from the α-oxytosylation of 1-indanone was 
synthesized and purified to serve as a chiral HPLC standard for the determination of each 
enantiomeric peak retention time.  
General procedure for the Synthesis of Racemic 1-oxo-2,3-dihydro-1H-inden-2-yl 4-
methylbenzenesulfonate, III-8. 
  A flame dried, 100 mL round-bottom flask was charged with 1-indanone  II-7 (1 g, 
7.58 mmol, 1.0 equiv), para-toluenesulfonic acid monohydrate (4.32 g, 22.7 mmol, 3 
equiv), 77% meta-chloroperoxybenzoic acid  (5.1 g, 22.7 mmol, 3 equiv), and 4-iodotoluene 
(5 g, 22.7 mmol, 1.5 equiv). The reagents were dissolved in 20 mL of acetonitrile and the 
resulting solution was allowed to stir under N2 at 50 ˚C for 24 h.  The reaction mixture was 
concentrated by rotary evaporation, followed by dilution in DCM, and the organics were 
washed three times with an aqueous saturated sodium bicarbonate solution.  The combined 
organic layers were dried over sodium sulfate, filtered, and concentrated by rotary 
evaporation. The crude product was purified by column chromatography on silica gel (20:80 
EtOAc:hexanes) to give a beige solid III-8 (2.1 g, 92%). Rf = 0.21 (20:80 EtOAc:hexanes) 
1H NMR (500 MHz, CDCl3): δ 7.95 (2H, d, J = 8.3), 7.75 (1H, d, J = 7.6 Hz), 7.67 (1H, td, 
J = 7.5, 1.2 Hz), 7.46-7.40 (4H, m), 5.15 (1H, dd, J = 7.9, 4.8 Hz), 3.68 (1H, dd, J = 17.1, 
7.9), 3.30 (1H, dd, J = 17.2, 4.7), 2.49 (3H, s) ppm. 13C NMR (125 MHz, CDCl3): δ 197.6, 
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150.0, 145.2, 136.4, 133.6, 133.2, 129.9, 128.5, 128.3, 126.7, 124.7, 33.9, 21.8 ppm.  
3.5.4. Synthesis of Racemic Products for Alternative Nucleophiles  
General procedure for the Synthesis of Racemic, 1-oxo-2,3-dihydro-1H-inden-2-yl 
naphthalene-1-sulfonate,  III-32. 
The substrate 1-indanone II-7 (0.132 g, 1 mmol, 1.0 equiv), Oxone (0.46 g, 3 mmol, 
3 equiv), and 4-iodotoluene (0.65 g, 3 mmol, 3 equiv) were all added to a dry 100 mL round-
bottom flask. A separate solution of 1-napthelene sulfonic acid (0.62 g, 3 mmol, 3 equiv) 
was prepared by slowly adding 20 mL MeCN to the reagent under N2. This solution was 
then added dropwise to the contents of the round-bottom flask. The reaction was allowed to 
stir under N2 at 50 ˚C for 48 h. Following concentration of the reaction mixture by rotary 
evaporation and dilution in DCM, the crude mixture was washed three times with an 
aqueous saturated sodium bicarbonate solution. The combined organic layers were dried 
over sodium sulfate, filtered, and concentrated by rotary evaporation. The crude product 
was purified by column chromatography on silica gel (20:80 EtOAc:hexanes) to give a light 
brown solid III-32 (0.301 g, 89%). Rf = 0.18 (20:80 EtOAc:hexanes) 1H NMR (500 MHz, 
CDCl3): δ 8.75 (1H, dd, J = 8.7, 0.75 Hz), 8.40 (1H, d, 1.2 Hz), 8.20 (1H,  d, 8.3 Hz), 8.00 
(1H, d, 8.2 Hz), 7.72 -7.67 (2H, m), 7.66-7.60 (2H, m),  7.40 (2H, d, J = 7.5 Hz), 5.19 (1H, 
dd, J = 7.9, 4.8 Hz), 3.57 (1H, dd, J = 17.2, 8.0 Hz), 3.22 (1H, dd, J = 17.2, 8.0 Hz) ppm. 
13C NMR (125 MHz, CDCl3): δ 197.2, 149.8, 136.3, 135.7, 134.2, 133.6, 131.6, 130.3, 
128.8, 128.6, 128.4, 127.4, 126.6, 125.4, 124.9, 124.7, 123.9, 78.5, 33.7 ppm. 
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General procedure for the Synthesis of Racemic 1-oxo-2,3-dihydro-1H-inden-2-yl 
methanesulfonate, III-33. 
Racemic compound III-33 was prepared on the same scale and following the same 
synthetic protocol as described for compound III-32 except methane sulfonic acid (0.288 g, 
3 mmol, 3 equiv) was used as the nucleophile. The reaction mixture was also washed with 
an aqueous solution of sodium bicarbonate and extracted with DCM. The crude product was 
purified by column chromatography on silica gel (20:80 EtOAc:hexanes) to give brown 
solid III-33: (0.194 g, 86%). Rf = 0.24 (20:80 EtOAc:hexanes) 1H NMR (500 MHz, CDCl3): 
δ 7.81 (1H, d, J = 7.7 Hz), 7.72 (1H, t, J = 7.5 Hz), 7.51-7.46 (2H, m), 5.39 (1H, dd, J = 8.1, 
4.8), 3.74 (1H, dd, J = 17.1, 8.2), 3.35 (1H, s), 3.34-3.30 (1H, m) ppm. 13C NMR (125 MHz, 
CDCl3): δ 198.9, 150.1, 136.6, 133.5, 128.6, 126.8, 124.8, 79.1, 39.6, 33.7 ppm.  
General Procedure for the a-Functionalization of 1-Indanone Screening  
 In order to evaluate iodoarene peptide catalysts in the α-sulfonylation of  1-
indanone, a similar protocol as detailed in section 3.5.2 of this thesis was applied. Briefly, 
a 3 mL screw-capped vial was charged with 1-indanone (3.97 mg, 0.3 mmol, 1.0 equiv), 
mCPBA (19.1 mg, 0.03 mmol, 3 equiv), the iodoarene peptide precatalyst (0.01 mmol, 0.1 
equiv) and a small stir bar. The sulfonic acid, either 1-naphthalenesulfonic acid III-30 
(18.72 mg, 0.09 mmol, 3 equiv) or methane sulfonic acid III-31 (8.64 mg, 0.09 mmol, 3 
equiv), was added to a separate 3 mL vial and dissolved in 1 mL of MeCN. This solution 
was then added dropwise to the vial containing the substrate, peptide precatalyst and 
mCPBA. And the reaction was stirred for 24 h at RT. Following the allotted reaction time, 
the crude solution was concentrated by rotary evaporation and prepared for chiral HPLC 
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analysis. Samples were prepared for HPLC analysis by dissolving the samples in 0.2 mL of 
the HPLC solvent system followed by filtration through micro-syringe filters into HPLC 
analysis vials.  
 Both reactions, employing 1-naphthalenesulfonic acid III-30 and methane sulfonic 
acid III-31 were analyzed using a IPA/Hexanes (50/50) HPLC solvent system on a Chiral 
Pak OJ column with enantiomeric RT = 26.2 and 28.8 min and RT = 23.4 and 33.6 for chiral 
products III-32 and III-33, respectively.  
3.6. Supplementary Information  
Appendix B contains this chapter’s corresponding chiral HPLC chromatograms, 1H 
and 13C NMR spectra as well as all a catalog of the libraries of synthesized peptides and 
their corresponding MALDI-TOF characterization data.  
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Chapter Four  
 
INVESTIGATIONS OF THE SOLUTION PHASE STRUCTURE OF 
IODOARENE PEPTIDES AND ITS RELATIONSHIP TO 
ENANTIOSELECTIVITY  
 
4.1. Introduction 
4.1.1. Structure/Enantoselectivity Relationship of Aryl-Iodo Peptides 
 Despite the prevalence of short peptide sequences in nature as toxins, hormones, 
and neurotransmitters in addition to their application in medicinal chemistry, 
nanosciences, and asymmetric catalysis, there is still much to learn about their structures. 
Thus far, the research detailed in this thesis has demonstrated the utility of iodoarene 
peptides to catalyze I(III)-mediated organic transformations, such as the α-
functionalization of ketones and the oxylactonization of keto-carboxylic acids. 
Additionally, a few peptide structures have generated the desired chiral product with 
moderate enantioselectivities (>30% ee). Intriguingly, all of our “hit” peptides have 
exclusively emerged from peptide Scaffolds A and B. These scaffolds both possess the 
same Pro-D-Ala amino acid residue sequence that putatively nucleates a b-turn secondary 
structure. During the design of these peptide scaffolds, it was hypothesized that the 
inclusion of this type of secondary structure would impart some rigidity into the peptide 
scaffold in solution, thus enhancing the stereoselectivity of the catalytic process. In fact, 
it was quickly realized that the linear peptides from Scaffold C were not generating the 
desired products with even slight degrees of enantioselectivity; therefore, the focus 
quickly shifted to the synthesis of peptides only from Scaffold A and B (Figure 4.1).  
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This shift clearly increased the likelihood of “hit” peptides emerging solely from these 
scaffolds; nonetheless, it is interesting to delve deeper into the structural features of our 
iodoarene peptide catalysts and their ability to impart enantiocontrol onto a given 
reaction.  
In order to quickly probe the influence of the Pro-D-Ala amino acid residue 
sequence, the linear counterpart to “hit” peptide III-10, was prepared and screened under 
standard conditions in the α-oxytosylation of 1-indanone (Scheme 4.1). Precatalyst 
peptide IV-1, generated the desired product III-8 in only 7% ee. This suggests that the 
inclusion of the Pro-D-Ala sequence in the peptide sequence does influence the 
enantioselectivity of the reaction.  
 
 
Figure 4.1. Peptide pre-catalyst scaffolds A-C.  
N NH
HN
NH
H2N
O
O
CH3
O
O
NH
O
R3
O
I
R1
R2
N NH
HN
NH
H2N
O
O
CH3
O
O
NH
O
O
R1
R2
I
HN
R3
H3C
O
I
N
H
H
N
N
H
O R3
O R2
O
NH2
O
R1
Scaffold A Scaffold B Scaffold C
Proline-D-Alanine
 137 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.2. The β -Turn  
 Proteins contain a wide array of secondary and tertiary structure elements on their 
surface as well as buried in protein–protein interfaces. Reverse turns, such as β-, γ-, and α-
turns, represent one such class of protein secondary structure, wherein, following a chain 
reversal, a globular portion of the protein is created. These chain reversals are local 
features in proteins, and thus, have been extensively studied and mimicked using 
peptides.1-4  
 In folded proteins, the β-turn is the most commonly observed nonrepetitive 
reverse turn motif, and thus, amino acid sequences have been identified as being 
predisposed to adopt this secondary structure in peptide sequences. As previously 
discussed, it has been suggested that the incorporation of secondary structure into a short 
peptide sequence can impart rigidity into the peptide structure.103 Simply, a b-turn is a 
O O
OTs
HI Peptide (0.1 eq)
mCPBA (3 eq)
pTSA·H2O (3 eq)
MeCN, RT, 24 h
O OHH+
III-7 III-8
Scheme 4.1. The α-oxytosylation of 1-indanone, comparison of bent 
and linear peptides III-10 and IV-1.  
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portion of the protein consisting of four consecutive 
residues where the peptide chain folds back on itself by 
nearly 180 degrees. Also, stabilization of this turn is 
provided by intraturn hydrogen bond interactions 
between the backbone CO(i) and the backbone NH(i+3) 
(Figure 4.2). In addition to the added conformational 
support, the incorporation of a β-turn into a short peptide sequence can also facilitate 
advantageous interactions between the catalytic site and other amino acid residue side 
chains and backbone amides.  While, the most commonly observed β-turns display the 
aforementioned H-bond interactions between the i and i + 3 residues, they can further be 
classified as Type I/I’ or II/II’ based on the ϕ and ψ dihedral angles associated with  
amino acids i + 1 and  i + 2.  More simply stated, the main difference between Type I and 
II turns in the orientation of the amino acid residues in 
positions i+1 and i+2 (Figure 4.3).  
In proteins, the most commonly observed β-
hairpin turns are of type  Type I’ and II’ that contain 
proline and glycine amino acid residues in the i + 1 
and i + 2 positions, respectively. Nonetheless,  a variety 
of other α- amino acid residues have been found to provide the necessary conformational 
restraints to promote the turn when located in the i + 2 position. For example, synthetic 
models that mimic type I’ and II’ turns typically incorporate a Gly, L-Ala, D-Ala, Aib, 1-
Amino-1-cyclohexane carboxylic acid (Ac6c), or 1-aminocyclooctane-1-carboxylic acid 
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(Ac8c0) residue in the i + 2 position.1-5 Nonetheless, proline’s pyrrolidine ring provides 
the necessary conformational restraint, and thus is the most commonly observed turn 
inducing amino acid in the i + 1 position in peptides and proteins.5 
4.1.3. Previous Reports 
 Many have sought to take advantage of this β-turn secondary structure when 
designing asymmetric peptide catalysts. There are numerous reports by Miller et al., 
wherein the presence of a turn-inducing element greatly impacted the success of 
stereoinduction displayed by the peptide catalysts.6-13 Examples of these β-turn-peptide 
catalyzed transformations include: the kinetic resolution of alcohols, the dynamic kinetic 
resolution of oxazol-5(4H)-ones, and the addition of allenoates to N-acyl imines (Figure 
4.4). These peptides take advantage of a Pro-Xaa amino acid residue sequence, wherein 
Pro is D- or L-proline and Xaa is an achiral α-α-disubstituted amino acid.20 In particular, 
Miller and coworkers incorporated a loop region, of either D-Pro-Aib or D-Pro-Aic, 
known to promote the desired β-turn secondary structure within short peptide sequences. 
They later verified the presence of the β-turn in an additional 35 peptide structures via 
solid-state characterization using X-ray crystallographic analysis. Additionally, select 
solid-state structures were also compared to their solution-phase conformations using 1D 
and 2D NMR experiments. Following the analysis of proton chemical shifts and 1H-1H 
NOESY interactions, they propose that sophisticated peptide confirmations in short 
peptide sequences may be vastly more accessible than previously suggested.  
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Figure 4.4. β-turn peptide-mediated asymmetric reactions reported by 
Miller et al., including: A) The KR of alcohols, B) the DKR oxazol-5(4H)-
ones, and C) the addition of allenoates to imines.  
 
 
A 
B 
C 
 141 
4.2. Results and Discussion 
4.2.1. Solution-Phase Characterization  
 Following the screening of nearly 850 peptide catalyst structures for the 
asymmetric a-oxytosylation of propiophenone and 1-indanone as well as the 
oxylactonization of 5-oxo-5-phenylvaleric acid, it became clear that a better 
understanding of the structure-function relationship of the iodoarene peptide precatalysts 
and their ability to impart enantiocontrol was needed.  Specifically, we thought that a 
thorough understanding of the solution phase orientation of the pre-catalyst iodoarene 
peptide would prove critical for further catalyst optimization. Thus, solution-phase 
characterization of the secondary structure of our most selective peptide catalyst was 
completed by means of NMR spectroscopy. While the successful synthesis of peptides 
with the Pro-D-Ala sequence was confirmed by MALDI-TOF mass spectrometry, it was 
unclear as to whether or not they maintain the proposed b-turn secondary structure in the 
reaction solution. Briefly, solution-phase characterization was achieved by one and two 
dimensional NMR spectroscopy. One dimensional 1H NMR and 2D-COSY (correlated 
spectroscopy) was implemented to assign resonance peaks for individual protons.15,16 
Further, through space interactions of hit peptide III-10 was examined with 2D-NOESY 
(2-D Nuclear Overhauser and Exchange Spectroscopy) in order to confirm the presence 
of the  b-turn in solution. Finally, DMSO-d6 titration 1H NMR experiments were 
conducted in order to probe how well the peptide catalysts adopted and maintained the b-
turn.17-21 
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4.2.2. 1H NMR Characterization of Aryl-Iodo Peptides General Peptide Structure 
Characterization 
 Solution-phase characterization of peptide III-10 was achieved by 1H NMR and 
2D-COSY (correlation spectroscopy). This combination of techniques has been used 
previously to assign proton chemical shifts and identify through-bond interactions in 
short peptide structures.15,16,23,24 Further, these NMR experiments were conducted in 
CD3CN at room temperature to mimic our acetonitrile solvent reaction conditions used 
for the α-oxytosylation of ketones. Figure 4.5 depicts the assigned amino acid residue 
proton chemical shifts for peptide III-10. In general, the aromatic protons on the 
iodoarene as well as all free amines and amide protons appear downfield between 9 and 6 
ppm. Amino acid residue α-protons appear between 5 and 3.5 ppm. The 𝛿 protons of 
proline are observed as split resonances around 3.9 and 3.8 ppm, while the 𝛿 protons of 
Orn are observed slightly upfield around 3 ppm as a broad peak. The remaining  β- and  
γ-protons appear between 3 and 0 ppm. The methyl group of D-Ala is easily identified as 
a doublet around 1.3 ppm and the t-butyl group of Tle is observed as a strong singlet at 
0.9 ppm.14,15  
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Further, a 2D-COSY experiment aided in the assignment of these proton 
resonances. A COSY displays cross-peaks associated with [1H,1H]-correlations due to 
scalar (through-bond) couplings. For example, the amide proton on D-Ala will exhibit a 
cross-peak with its α-proton, which will then display a cross-peak with the Ala methyl 
group peak at 1.3 ppm. Since the primary structure of the peptide is known, the COSY 
was used to identify individual amino acid residue spin systems by identifying 
characteristic cross peaks in the spectrum (See SI for spectrum).  
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Verification of the b-Turn in Solution  
 Next, in order to verify the presence of the β-turn in our reaction solvent, MeCN, 
a NOESY experiment was performed. A NOESY 
spectrum contains information related to the spatial 
proximity of protons in the structure of interest. 
More specifically, cross peaks arise due to dipolar 
couplings from interactions of spins close in space 
and hence only depend on the distance and not on 
the number of intervening bonds. As previously mentioned, it is suggested that the b-turn 
motif is nucleated by the D-Ala-Pro sequence and stabilized via the hydrogen bonding of 
a carbonyl oxygen of one residue with the amide proton of an amino acid three residues 
down the chain. If the peptide catalyst is maintaining the β-turn secondary structure in 
solution, diagnostic through-space NOE interactions will be observed (Figure 4.6). 
Interactions 1-3 are suggestive of a folded turn structure, while interaction 3 is indicative 
of Type II turns. Observation of  NOE interaction 4 confirms that the proline amide has 
adopted the anticipated s-trans conformation. Lastly, if the amino acid residues in 
positions i+1 and i+4 are substituted with side-chain β-protons, as is the case with Orn 
and Ile in peptide III-10, the NOE interaction highlighted by 5 may be observed. Upon 
analysis of the NOESY spectrum for peptide III-10, all five NOE cross-peaks were 
observed (Figure 4.7). The presence of these diagnostic interactions in this solution phase 
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Figure 4.6. Expected NOE 
interactions for peptide III-10. 
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NMR study suggests that peptide III-10 does exhibit a bent orientation, possibly a Type 
II β-turn, in the Orn-Pro-D-Ala-Ile region.  
There is extensive literature describing the presence of a β-turn as the result of the 
D-Ala-Pro sequence. Therefore, it was not surprising that these initial solution-phase 
characterization efforts confirm the presence of the expected β-turn in our peptide 
scaffolds. Further experiments are necessary in order to determine whether or not this 
peptide maintains its bent structure in its oxidized hypervalent I(III)-state. 
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Figure 4.7. Identified NOE interactions characteristic of a turn secondary 
structure in peptide III-10. 
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Probing the stability of the b-Turn: DMSO Titration Experiments  
Peptide scaffolds A and B were designed so that they would be predisposed to 
adopt a b-turn secondary structure. The aforementioned 2D-NOESY data confirms that 
our best peptide for the α-oxytosylation of 1-indanone (III-10), maintains its secondary 
structure in MeCN. Next, in order to further elucidate the role that the peptide structure 
plays in the observed enantioselectivity, DMSO-d6 titration experiments on peptide 
catalysts showing high, moderate, and low levels of selectivity were performed by means 
of NMR spectroscopy.  Briefly, when a peptide is dissolved in benzene-d6 solution and 
then titrated with a strong H-bond accepting solvent, such as DMSO-d6, the solvent 
exposed amide protons will exhibit a diagnostic 
downfield shift in the 1H NMR spectrum. However, in a 
typical β-turn, the i+1 and i+3 amide N-H protons are 
engaged in H-bonds with the i+4 and i+1 amide 
carbonyls, respectively, and are thus shielded from this 
shift. Figure 4.8 highlights the expected solvent-shielded 
N-H amide protons that would be engaged in hydrogen 
bonding interactions in the predicted b-turn,  i.e. positions i and i+3.26-28  
Iodoarene peptides III-10, IV-10, and IV-11 were chosen as representative 
peptides as they displayed the highest (48% ee), moderate (28% ee), and low levels (0% 
ee) of enantioselectivity in the initial screenings for the α-oxytosylation of 1-indanone, 
respectively (Figure 4.9). Solutions containing 0.025 mmol of each peptide and 0.2 mL of 
benzene-d6 were prepared in NMR tubes. A baseline 1H NMR spectrum for each was 
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taken. Then following the sequential addition of 5 µL aliquots of DMSO-d6, the chemical 
shifts of the amide protons were recorded. The observed amide protons shifts (ppm) were 
then plotted against the amount of DMSO-d6 solvent added (µL) in order to observe the 
extent of the engagement of amide protons in hydrogen bonding either intramolecularly 
within the peptide or intermolecularly with the protic solvent. 
 
 The resulting DMSO-d6 dilution curves for peptides III-10, IV-10, and IV-11 are 
depicted in Figure 4.10. Table 4.1 contains the calculated slopes as well as the overall 
change in chemical shift (Δ ppm) for curves corresponding to the amide protons in 
positions i, i +2, i +3, and i +4.  
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Figure 4.9. Peptides displaying high, moderate, and low levels of enantioselectivity for the α-
oxytosylation of 1-indanone.  
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If involved in the expected intramolecular hydrogen bonding network predicted 
for the β-turn, i and i +3 amide protons should display little to no change in chemical 
shift upon the addition of increasing amounts of DMSO-d6. Further, observation of a 
large change in chemical shift (~1 ppm) is characteristic of an amide proton that is not 
engaged in intramolecular H-bonding.26-28 Upon analysis of the dilution curves, it can be 
suggested that  peptides III-10 and IV-11 display strong intramolecular H-bonding in the 
expected positions. Both peptides contain an Orn residue in position i and an Ile or Abu 
amino acid residue in position i+3, respectively. It can be suggested that the H-bond 
network is slightly stronger in peptide III-10, due to the smaller slope and Δ ppm 
observed for the amides of interest (Table 4.1). On the other hand, the amide proton in 
position i of  peptide IV-10, experiences a noticeable shift (~0.6 ppm), suggesting that it 
is involved in a weaker intramolecular H-bond as compared to the other two peptides. It 
is interesting to note, that the Tle amide proton (i+4) in peptide IV-10, is not sensitive 
toward the addition of DMSO, possibly suggesting an alternative strong H-bonding 
network in this peptide. Lastly, the amide protons in position i+4 (Tle) in peptides III-10 
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and IV-11 both display a slight up-field shift. This observation may be suggestive of an 
intermolecular H-bond association of these amides with benzene-d6.28   
 
4. 3. Conclusion 
A majority of all “hit” peptides have stemmed from peptide scaffolds A and B, 
which all possess the same D-Ala-Pro nucleated b-turn secondary structure (Figure 4.1). 
This observation suggested that the structural rigidity imparted by this secondary 
structure could be an important factor in the overall enantioselectivity of the reaction. 
Therefore, in an attempt to further our understanding of the relationship between catalyst 
structure and observed product enantioselectivity, a series of solution phase 
characterization experiments were conducted. First, noted NOESY interactions indicated 
that “hit” peptide III-10 adopts the ß-turn secondary structure in the reaction solvent 
(MeCN). Further, 1H NMR DMSO-d6
 
titration experiments suggest that the extent of the 
ß-turn may play a factor in enantioselectivity. For example, the ability to design a peptide 
scaffold that would position the catalytically active iodoarene site in close proximity to 
other functional groups, such as backbone amides, may play a significant role in 
achieving high levels of enantioselectivity. Lastly, there are other factors that need to be 
considered, such as, electronic and steric influences around the active I(III)-site, 
mechanism, and enol geometry. The influence of the proximity of the iodine center with 
respect to the peptide backbone is highlighted by screening peptide structures IV-12 and 
IV-13 in the α-oxytosylation of 1-indanone. These peptides have identical primary 
sequences to peptide III-10 except for the location of the iodine moiety, with respect to 
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the peptide amide, on the arene ring (Figure 4.11). Reactions were performed under 
optimized conditions. Namely 1-indanone (III-7) was treated with mCPBA (3 equiv),  
pTSAH2O (3 equiv), 10 mol% peptide IV-12 or IV-13, 4 Å molecular sieves, in dry 
MeCN for 24 h to generate the ⍺-oxytosylated product III-8 in 0 and 25% ee, 
respectively. The observed drastic decreases in the enantioselectivty of these reactions 
clearly demonstrates the significance of the proximity of the active I(III)-center with 
regards to the peptide.  
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4. 4. Future Directions 
 
 Ultimately, there are numerous experiments that can be performed in order to 
truly understand the structure-function continuum for catalytic reactions. In order to fully 
understand the structural characteristics that promote highly enantioselective peptides, 
one must consider the orientation of the peptide backbone with respect to the iodoarene 
active site. This can be accomplished by examining the solution-phase and solid-state 
structure of the peptide catalysts in their oxidized I(III)-state. Presumably, this can be 
accomplished by conducting similar 1D and 2D NMR experiments as well as 
complementary solid-state X-ray crystallographic analysis of oxidized peptides. The I(I) 
peptides can be oxidized to their corresponding hydroxytosyloxy I(III) reagent upon 
treatment with 5 equiv mCPBA and 1 equiv pTSAH2O in DCM for 48 h at elevated 
temperatures (Scheme 4.2).29,30 Following reverse phase column purification, pure 
samples of the I(I) and I(III) peptides can be obtained. In order to obtain X-ray quality 
crystals, a systematic crystallizing solvent screen will be conducted. Ultimately, NMR 
solution state experiments and X-Ray analysis of these peptides will shed light on how 
the aryl-iodo active site interacts with the peptide backbone and if this interaction 
changes upon oxidation to the active I(III) state.  
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Scheme 4.2. Oxidation of I(I) peptide to its active I(III) congener.  
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Completion of the proposed solution-phase and solid-state characterization 
experiment will offer valuable information as to how the peptide sequence and its 
secondary structure influences the selectivity and reactivity of the I(III) catalyst. It will be 
especially interesting if trends can be gleaned upon comparison of peptide catalysts 
displaying high, moderate, and low levels of enantioselectivity.  
 
4. 5. Experimental 
 
General Remarks 
 
 All NMR experiments were carried out on a Bruker Avance NEO NMR (500 
MHz) spectrometer equipped with a broadband Prodigy N2 cooled cryoprobe. Proton 
chemical shifts are reported in ppm (δ) relative to the residual NMR solvent: CD3CN (δ 
1.94 ppm) or C6D6 (δ 7.16 ppm) NMR data are reported as follows: chemical shift 
(integration, multiplicity [singlet (s), doublet (d), doublet of doublets (dd), triplet (t), 
triplet of triplets (tt),  quartet (q), multiplet (m)], coupling constants [Hz]). 13C resonances 
are reported in ppm relative to residual solvent peaks for CD3CN (118.3 ppm) or C6D6 
(128.1 ppm).NMR solvents, acetonitrile-d3, benzene-d6, and dimethylsulfoxide-d6 were 
purchased from Cambridge Isotope Laboratories and used without further purification. 
DMSO- d6 Titration Experiments 
 
NMR peptide samples were prepared by dissolving 0.025 mmol of the peptide of 
interest in 0.2 mL of  benzene-d6 in an NMR sample tube. 1H NMR titration experiments 
were ran after the addition of 0, 5, 10, 15, 20, 25, 30, 25, 40, and 45 µL of DMSO-d6. The 
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5 µL aliquots of DMSO-d6 were added via micropipette to the NMR tube. In order to 
ensure homogeneity, the sample tube was equipped with a glass stopper and inverted. 
The sample tube was sealed with an NMR cap and the 1H NMR spectrum was recorded.  
4. 6. Supplemental Information 
Peptide 2-IBA-Orn-Pro-D-Ala-Ile-Tle, III-10: 1H NMR (500 MHz, CDCl3): δ 7.92 
(1H, m), 7.57-7.53 (3H, m), 7.47-7.44 (1H, m), 7.38 (1H, dd, J = 7.6, 1.7 Hz), 7.25 (1H, 
d, J =  7.8 Hz), 7.23-7.2 (3H, m), 6.72 (1H, s), 6.23 (1H, s), 4.91-4.87 (1H, m), 4.41-4.39 
(1H, m), 4.32-4.27 (1H, m), 4.04 (1H, d, J = 8.3 Hz), 4.00 (1H, t, J = 8.2 Hz), 3.91-3.84 
(1H, m), 3.72-3.67 (1H, m), 3.00 (1H, br), 2.16-2.00 (5H, m), 1.87-1.81 (4H, m), 1.52-
1.44 (1H, m), 1.35 (3H, d, J = 7.13 Hz), 1.20-1.15 (1H, m), 1.00 (9H, s), 0.89-0.85 (6H, 
m)  ppm.  
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COSY spectrum for peptide III-10 
 
   
DMSO-d6 Titration Experiments 
1H NMR spectra of the aromatic and amide regions of each DMSO-d6 titration are 
included for peptides III-10, IV-10, and IV-11. Each spectrum, starting from the bottom, 
represents 0, 5, 10, 15, 20, 25, 30, 35, 40, and 45 µL additions of  DMSO-d6 to the 
peptide sample that was prepared in benzene-d6.  
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DMSO-d6 Titration Experiment Overlay for Peptide III-10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PAX
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DM SO-d6 Titration Experiment Overlay for Peptide IV-10 
 
 
 
PAH
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DMSO-d6 Titration Experiment Overlay for Peptide IV-11 
 
 
 
 
PJX
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CHAPTER 5 
 
MODIFIED KAOLINITE CLAY FOR THE CAPTURE OF VOLATILE ORGANIC 
COMPOUNDS 
 
5.1. Introduction 
 
5.1.1. Volatile Organic Compounds 
  
 In the late 1950s Haagen–Smit recognized the significance of anthropogenic 
organic compounds as they pertain to atmospheric chemistry through his pioneering studies 
on Los Angeles smog. This study highlighted how various volatile organic compounds 
(VOCs) and nitrogen oxides (NOx) react to generate tropospheric ozone via a 
photochemical process.1-3 Since then, interest in emissions of VOCs into the atmosphere 
and their effects has amplified. VOCs can be defined as chemicals with low vapor pressures 
that are emitted into the atmosphere from either biogenic or anthropogenic sources. This 
class of compounds 
encompasses a wide 
range of reactive 
moieties, such as 
aldehydes, carboxylic 
acids, alcohols, amines, 
amides, and aromatic 
compounds (Figure 5.1).4-6  
While biogenic VOC emissions dominate world-wide, it is anthropogenic sources 
that result in the vast majority of volatile emissions and air pollution in urban areas.4,5 
VOCs from degreasers, lubricants, solvent thinners, fuels, and other heavily used 
H
O
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O
Acetone Benzene
C
Cl
ClCl
Cl
Carbon tetrachloride
O
O
Ethyl acetate
HO
Ethylene glycol
OH
H
O
Formaldehyde Heptane Hexane
OH
Isopropyl alcohol
O
Methyl ethyl ketone
O
Monomethyl ether
OH
Napthalene Styrene Toluene Xylene
CH3
Figure 5.1. A selection of common volatile organic compounds. 
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petrochemical and chemical industrial products constitute the majority of detected 
emissions.7,8,10,11 For example, in population dense cities such as Boston and Los Angeles, 
non-methane VOCs are detected in the following ratios: alkanes, 40 – 45%; aromatic 
hydrocarbons, 20%; and oxygenates, 10 – 15%. The remaining 20 – 30% consists of 
alkenes and other unidentified VOCs.3  
Among the different anthropogenic pollutants emitted into the troposphere, VOCs 
are particularly important because they represent the major contributors to two of the most 
serious air quality problems: photochemical smog and ground-level ozone.2 Photochemical 
smog is composed of light-scattering liquid and solid particulates that result in the 
characteristic brown tinge associated with smog. Furthermore, chemicals such as ozone, 
NOx, and peroxyacetyl nitrate (PAN) are known to halt plant growth by delaying 
photosynthesis as well as play a negative role in climate change.2,7,12  
In addition, several VOCs pose a threat to the health and well-being of humanity. 
For example, some VOCs detected in urban air such as 1,3-butadiene, benzene, 
acetaldehyde, and formaldehyde are known carcinogens.7-9,12 Short term exposure to high 
concentrations of VOCs can cause many to experience eye-irritation, dizziness, and asthma 
attacks. Long-term exposure and the consequent accumulation of toxic VOCs can lead to 
liver and kidney damage and failure as well as cancer.7 Furthermore, many volatile 
carbonyl compounds are notorious for their low, often unpleasant, odor thresholds (i.e. 
sometimes below 1 parts per billion).8 It is evident that these daily VOC emissions are of 
great importance due to their potential toxicity and malodorous characteristics.  
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5.1.2. Traditional Remediation Techniques  
 The mounting concern surrounding environmental pollution has propelled the 
implementation of legislation and regulations pertaining to the control of organic aerosol 
pollutants worldwide. As a result, numerous chemical technologies have been developed 
and used to treat organic and toxic pollutants, including biological oxidation, chemical 
oxidation/incineration, and adsorption.7-9  
 Numerable reports of successful biological oxidation and degradation of VOCs 
using biofilters, bioscrubbers, biotrickling filters, and other bioreactors can be found in the 
literature. The main mechanism of remediation for these systems involves the conversion 
of pollutants to less-harmful compounds such as carbon dioxide and water upon treatment 
with microorganisms.13 For example, biofiltration involves the flow of VOC-polluted air 
through a filter bed followed by diffusion into a biofilm where microorganism-assisted 
biological oxidation can occur.14 Singh et al. disclosed the successful remediation of 
toluene-contaminated air upon treatment with a Pseudomonas putida (MTCC 102) 
inoculated polyurethane foam biofilter resulting in removal efficiencies of 68.2 to 99.9%.15  
Biofiltration can also be applied to hydrophilic and hydrophobic VOC mixtures. 
Specifically, Mohseni and Allen applied biofilters packed with wood chips and compost to 
treat methanol and a-pinene contaminated air. Notably, no microorganism inoculation was 
necessary. Rather, in this instance the microorganisms indigenous to the compost and wood 
chips were sufficient, resulting in 90 – 95% removal of the VOCs.16 
 Thermal oxidation/incineration is one of the more recognizable and commonly used 
methods for industrial gas waste treatment because it represents a universal method for the 
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disposal of gaseous organic effluent resulting in the breakdown of VOCs into less harmful 
by-products. Briefly, thermal oxidation involves an apparatus consisting of a single 
combustion chamber unit containing ceramic refractory blanket-lined oxidizers, which is 
connected to a propane or natural gas burner and a stack. Incineration is an attractive 
method because combustion of industrial gas effluent containing only carbon, hydrogen, 
and nitrogen-based VOCs will result in CO2 and H2O as the main by-products. Conversely, 
if chlorinated and/or sulfur-containing compounds are in the mixture, the combustion 
products will consist of CO2 and H2O as well as HCl and SO2, respectively. These 
additional acidic by-products thus require removal by an added acid scrubber unit, resulting 
in increased costs.17 In some cases, the addition of a catalyst to the thermal oxidant is 
required.  Adsorption and subsequent reaction of VOCs onto the catalyst surface 
accelerates the oxidation as well as allows for lower operation temperatures between 320 
and 540 ˚C compared to the 760 – 870 ˚C range required for traditional thermal oxidation. 
Commonly used catalysts contain chromium/nickel oxides and palladium and platinum 
metal.18  
Lastly, adsorption, in the context of VOC remediation, refers to the ability of a solid 
sorbent to adsorb certain compounds selectively under mild conditions as well as to 
facilitate the recovery of the adsorbed organic compounds. Therefore, this approach has 
been widely applied in clean energy and environmental research. For instance, functional 
sorbents have been effectively used in the desulfurization and denitrogenation of ultra-
clean transportation fuels, water purification, and air quality control.19-26 For example, 
zeolites have been employed as sorbents for a variety of air remediation applications due 
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to their favorable pore size, surface area, and negatively charged framework. This charged 
framework makes zeolites an excellent platform for the addition of transition metal ions 
that are known to aid in the adsorption of sulfur from fossil fuels.19 Yang et al. reported 
the use of Cu+ and Ag+ loaded zeolite Y for the adsorptive desulfurization of commercial 
diesel. Upon treatment with this material, the detectable sulfur content declined from 430 
ppmw to below 1 ppmw. Furthermore, the metal-anion doped zeolite was successfully 
regenerated by washing in dimethylformamide or carbon tetrachloride solvent to retain 
100% of its remediation capacity upon reuse.21 Mesoporous silica has also been widely 
implemented as an efficient desulfurization material for jet fuel.22 Silica frameworks 
possess inherently high surface areas as well as pore sizes ranging from 2 – 4 nm and 4.5 
– 30 nm in diameter for MCM-41 and SBA-15 mesoporous silica materials, respectively. 
These frameworks can be loaded with various metal ions or metal oxides, such as, Ag+, 
Pd2+, and cuprous oxide. Two such materials, specifically a Pd2+ loaded SBA-15 and a Ag+ 
loaded MCM-41 were reported by Wang and co-workers for the successful desulfurization 
of JP-5 jet fuel, demonstrating a sulfur saturation capacity of 16.0 mg S g-1 and 32.1 mg S 
g-1, respectively. Each material could also be regenerated by washing with solvent to 
maintain 50% of their adsorption capacity upon reuse.24-26 
 Metal-organic frameworks (MOFs) have also proven to be advantageous for the 
capture of VOCs and other airborne pollutants. MOFs are inherently amenable to chemical 
structure modifications that typically result in increased adsorption capacities. Numerable 
MOF structures have been investigated, under standard temperature pressure (STP) 
conditions, for their ability to adsorb, store, and remove CO2.27 Specifically, MOF 
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materials such as Cu-BTTri, CPO-27, HKUST-1,  MIL-53, MOF-5, MIL-100, and YO-
MOF, have all been evaluated based on their performance as it pertains to number of open 
metal sites, adaptable chemical structure, and ease of functionalization.27-31 A magnesium 
doped MOF (Mg-MOF-74) was evaluated by Britt et al. for the capture of CO2.32 This 
material displayed an adsorption capacity of 8.9 wt% as well as CO2 release at 80 ˚C. MOF 
adsorption capacities can be enhanced following a simple ethylene diamine modification. 
Following diamine-functionalization of a Mg(DOBDC) MOF, an improved CO2 
adsorption performance was noticed, namely 400 ppm CO2 adsorption at 1 bar pressure. 
This same modification resulted in an en-Mg2(dobpdc) MOF that displayed excellent 
sorption capacities of 16.7 wt % of CO2 in respect to the mass of the material. It was noted 
that the adsorption of CO2 onto the free amines of the MOF produced carbamic acid, 
ultimately increasing the CO2 adsorption capacity. Overall, while MOFs represent a 
promising material for air quality management they are not without their drawbacks. MOF-
based formulations often exhibit poor selectivity, rather low capacities, high fabrication 
costs and difficulties with effective regeneration.28,29  
Nanomaterials have also emerged as excellent sorbents for the mitigation of 
gaseous emissions due to their large surface-to-volume ratios, high chemical reactivity, and 
unique functionalities.33-37  Carbon nanotubes (CNTs) have been applied as sorbents for the 
remediation of toxic gas pollutants from ambient air. CNTs are simply graphene sheets of 
hexagonally-oriented carbon atoms surrounding a tube axis and can be categorized as 
single wall carbon nanotubes (SWCNTs) or multiwall carbon nanotubes (MWCNTs).38 
There are numerous reports of CNTs successfully capturing environmental pollutants such 
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as dioxin. The two arene rings on dioxin display a strong attraction to the surface of CNTs 
as well as the porous wall, resulting in an increased and bifunctional adsorption. Long and 
Yang also disclosed the use of CNTs for the mitigation of NOx emissions from fossil fuel 
combustion. The uptake efficiency of NOx was reported as 78 mg g-1 CNTs at room 
temperature.39  A manganese oxide material with gold NPs grown into the pores has also 
proved highly efficient for the removal of VOCs and oxides of nitrogen and sulfur from air 
at room temperature. This catalytic material was able to remove and degrade common 
indoor air pollutants such as acetaldehyde, toluene, and hexane. They report a free radical 
promoted VOC degradation mechanism. Specifically, the presence of the gold NPs lowers 
the barrier of radical formation, in turn allowing VOC degradation to occur on the surface 
of the material.40  
Previously, our group has demonstrated successful VOC remediation using 
biodegradable functionalized nanoparticles (NPs).41,42 This initial interest in nanomaterials 
was motivated by the ease of functionalization via coating techniques or chemical 
modification in order to improve surface and prevent aggregation. The first generation NPs 
studied in our group were comprised of poly(D, L-lactic acid)-poly(ethylene glycol)-
poly(ethyleneimine) (i.e. PDLLA-PEG-PEI) block copolymers that facilitated capture of 
aldehyde and carboxylic acid VOCs from gaseous mixtures. These NP materials showed 
reduction of aldehyde and carboxylic acid vapors greater than 80% and 76%, respectively, 
with reductions of up to 98% in some cases. Additionally, the NPs were effective in 
selectively capturing target aldehyde and carboxylic acid contaminants even when 
challenged by comparable or more volatile non-targeted vapors. While NPs are an effective 
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platform, these first generation materials proved to be relatively expensive, somewhat 
unstable, and potentially difficult to scale-up. Consequently, we pivoted our focus to 
poly(amine) functionalization of cheaper and easier to  manipulate natural materials such 
as micro- and nano-crystalline cellulose and clay materials.43   
5.1.3. Natural Clay Materials as a Viable Alternative  
Just as nanoparticles are known for their high surface areas, clays and modified 
clays have been used as materials for numerous industrial applications due to their 
abundant availability, inexpensive cost, and large degree of surface area available for 
sorption. Furthermore, the sorption of polar and non-polar gases using phyllosilicate clay 
minerals has been explored by numerous groups.44-53 Previous studies have employed clay 
minerals for the removal of H2S from systems that mimic environmental conditions.46,47 
For example, activated carbon-sepiolite pellets were used for the adsorption of ammonia 
and H2S. Bentonite clay can also be treated with either aqueous iron chloride or copper 
chloride solutions to prepare modified bentonite materials as adsorbents for H2S gas.47 This 
study showed that the iron and copper ions improved the natural adsorption capabilities of 
the bentonite clay by increasing its surface area. Lastly, clay minerals were assessed for 
the adsorption of chlorobenzene and trichloroethylene, wherein the successful 
hexadecyltrimethylammonium modification of montmorillonite clay led to increased 
adsorption. 
Considering the underscored issues displayed by the nanoparticle materials as well 
as the established literature, inexpensive and naturally abundant kaolinite (Kao) clay was 
identified as a desirable alternative. More specifically, one can take advantage of the 
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mesoporous channels  that aid in the electrostatic capture of contaminants along with their 
potential for surface-functionalization with amine groups suitable for chemical capture.48 
Polymeric modifications to Kao clay have proved effective for CO2 capture. Simple acid 
and base Kao pore modifications followed by PEI (polyethylenimine) immobilization onto 
the clay resulted in new materials exhibiting CO2 sorption capacities approaching 112 mg 
CO2 g-1 sorbent at 75 ˚C under dry conditions.53  
Based on the promising results of our previous reports on PDDLA-PEG-PEI NPs 
as efficient sorbents for the selective capture of aldehyde and carboxylic acid vapors, we 
knew that the free amines of PEI were necessary to promote covalent or ionic capture of 
the respective VOCs. Applying this information, we set out to combine the efficient and 
selective reactivity of PEI with the attractive adsorption properties and thermal stability 
intrinsic to clay minerals. The presented work details the successful modification of a 
natural clay platform (i.e. kaolinite) that yielded a considerably less expensive yet highly 
effective material for VOC capture. 
5.2. Results and Discussion 
 
5.2.1. Preparation and Characterization of Kao-PEI 
 
 In order to investigate the comparatively inexpensive clays as a platform for 
polyamine functionalization, we first sought to successfully prepare and characterize 
polyethylenimine (PEI) functionalized kaolinite clay (i.e. Kao-PEI). The kaolinite clay was 
easily functionalized with PEI following a well-established wet impregnation technique, 
wherein the PEI is immobilized onto the porous clay substrate.53 Briefly, the clay substrate 
was suspended in a solution of PEI and methanol and allowed to stir for 3 h. The wet 
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poly(amine)-functionalized clay was then dried in vacuo at 75 ˚C for 12 h. For evidence of 
successful modification, FT-IR spectroscopy, thermogravimetric analysis (TGA) and 
energy-dispersive X-ray spectroscopy (EDX) analyses were performed.  
 FTIR spectroscopy was used to qualitatively confirm PEI-functionalization of the 
kaolinite clay. Figure 5.2 depicts the overlay FT-IR spectra of unmodified Kao, Kao-PEI, 
and PEI. At approximately 3650 cm-1, the three intense bands are attributed to the kaolinite 
hydroxyl stretching vibrations and are present in both the kaolinite and Kao-PEI spectra. 
Strong overlapping bands around 1000 cm-1 include vibrations arising from the silicon-
oxygen bonds and the bending vibration of the hydroxyl groups present in kaolinite. The 
appearance of new bands in the Kao-PEI spectra corresponding to the immobilized PEI are 
diagnostic of successful modification. Specifically, the bending vibrations of NH2 resulting 
in bands at 1600 cm-1 and at 1470 cm-1 are evident. The broad N-H stretching bands at 3280 
cm-1 and bending bands at 1650 cm-1, the stretching vibrations for CH2 at 2871 cm-1 and 
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Figure 5.2. FTIR spectrum of PEI-functionalized kaolinite clay (Kao-PEI, dotted purple 
line, unmodified Kao (dashed black line), and PEI (solid orange line).   
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2943 cm-1 and the bending mode of the carbon-nitrogen bond at 1330 cm-1 are all 
qualitative matches for PEI’s experimental vibrational bands.  
 TGA profiles for the Kao-PEI also support the effective modification of the 
substrate (Figure 5.3).  Unmodified Kao shows little thermal degradation (i.e. < 20%) up 
to 1000 ˚C. Kao-PEI presents an altered temperature degradation profile. The thermal 
degradation of Kao-PEI is observed at approximately 300 ˚C showing a 25% mass loss 
until the poly(amine) is fully desorbed from the clay surface by around 400 ˚C, which 
ultimately results in a total mass loss of 63% over the temperature gradient.  Kao-PEI clay 
materials were also characterized by energy-dispersive X-ray spectroscopy (EDX), and 
transmission electron microscopy TEM analyses.  EDX analysis of Kao-PEI revealed the 
presence of nitrogen as compared to unmodified kaolinite.  
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Figure 5.3. TGA analysis of PEI-functionalized kaolinite clay (Kao-PEI, dotted purple 
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5.2.2. VOC Capture Assay with Kaolinite and Kao-PEI    
Next, initial investigations into the application of Kao-PEI for the remediation 
VOCs were conducted. A representative 
compound from three functional group 
classes (i.e. aldehydes, carboxylic acids, 
and organodisulfides) were employed: 
butyraldehyde/hexanal, butyric acid, and 
dimethyl disulfide, respectively (Figure 
5.4). Treatment of each VOC with Kao-
PEI was completed in sextuplicate, and vapor reduction percentages were calculated by 
means of a previously established GC headspace analysis protocol (See section 5.7.2 for 
details).41-43 Briefly, untreated sample vials were prepared by creating a small sample well 
using a glass stir rod and a small swatch of tissue paper. The vial was then capped and a 1 
µL injection of the volatile liquid substrate was introduced into the vial by passing the 
needle through the tissue paper barrier. After a 30-minute vaporization equilibrium time, 
the vial was subjected to GC analysis to collect baseline vapor levels.  A similar assay was 
also conducted in the presence of unmodified Kao and Kao-PEI. Thus, 10 mg of kaolinite 
or Kao-PEI was added into the tissue paper sample well and then secured with a vial cap. 
Once again, a 1 µL injection of the designated volatile substrate was introduced into the 
vial by passing the needle through the tissue paper barrier and allowed to vaporize and 
subsequently react with the kaolinite or Kao-PEI sorbent for 30 min. Upon completion of 
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Figure 5.4. Representative VOCs of interest and 
their respective vapor pressures (20 °C) used in 
GC vapor capture assays.  
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the 30 min treatment period, the vial was subjected to GC analysis. Unmodified kaolinite 
was employed as control.   
Figure 5.5 highlights the percent reduction for each VOC after a 30 minute 
exposure to either kaolinite or Kao-PEI. Butyraldehyde vapors were partially remediated 
in the presence of kaolinite with 33% (P < 0.0005) vapor reduction observed (Figure 5.5A). 
When treated with the Kao-PEI, butyraldehyde was completely reduced with 100% (P < 
0.0005) vapor capture (Figure 5.5A).  We surmise that the highly effective capture of 
aldehydes with PEI-Kao is driven by the rapid condensation of the aldehyde analyte with 
the poly(amine) to form imines, an observation that we confirmed spectroscopically with 
our 1st generation polymeric nanoparticles (Scheme 5.1A).41-43 
Unmodified kaolinite in the presence of butyric acid vapors was somewhat effective 
at sequestering the carboxylic acid (18% capture (P < 0.0005), Figure 5.5B). We attribute 
this minor VOC reduction to vapor diffusion into the clay pores. Favorably, the Kao-PEI 
was successful in reducing 90% (P < 0.0005) of the butyric acid vapors (Figure 5.5B), 
presumably through the formation of ammonium carboxylates via acid-base reaction 
between the carboxylic acid vapor and the poly(amine) resident on the modified clay 
(Scheme 5.1B).41-43  
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Lastly, we probed the potential capture of dimethyl disulfide (DMDS). Sulfur 
compounds are exceptionally pungent to the human olfactory senses and thus are often 
targeted for remediation. DMDS vapor was treated with kaolinite and Kao-PEI, with both 
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materials performing as promising adsorbents. Treatment of DMDS with kaolinite resulted 
in 79% (P < 0.0005) reduction of DMDS vapors while Kao-PEI was 99% (P < 0.0005) 
effective (Figure 5.5C). Since we have no evidence for the covalent capture of disulfides 
with amine nucleophiles, 
it was concluded that 
possible electrostatic or 
ionic capture is feasible 
due to the large surface 
area and pores available 
within the clay materials 
for capture.43 While the unmodified kaolinite clay was poorly/moderately effective at 
remediating VOCs, the amine functionalized kaolinite was especially successful at 
capturing organics in the vapor phase. These data clearly indicate that Kao-PEI can serve 
as an effective sorbent for the mitigation of a selection of representative VOCs.  
5.2.3. Kao-PEI Hexanal Capture Time Study 
Upon successful remediation of butyraldehyde, butyric acid, and dimethyl disulfide 
VOCs, we sought to glean further information pertaining to the sorption kinetics as well as 
the ability of Kao-PEI to retain the captured VOCs following the initial 30 min analysis 
period. Thus, the vapor capture efficiency of Kao-PEI was followed over a period of 6 h. 
Hexanal was chosen as a representative aldehyde for GC vapor capture analysis at 10 min, 
20 min, 30 min, 1 h, 2 h, 3 h, 4 h, and 6 h time points. At 10 min a 49% reduction is seen, 
NH2 N
OH
O
H
O
NH3 O
O
NH2
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Scheme 5.1. Proposed Kao-PEI capture mechanism of  
A. butyraldehyde and B. butyric acid. 
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followed by a 65% reduction at 20 min, with complete hexanal vapor capture noted at 30 
min (Figure 5.6). 
Furthermore, there is no evidence of hexanal vapor release from the modified clay 
at 1 h, as no hexanal vapor is detected via GC analysis. The Kao-PEI is able to retain the 
captured VOCs for at least 6 h with no hexanal vapor being detected at the remaining time 
points. However, we do note a decrease in hexanal vapor in the untreated controls, with a 
significant loss of detectable VOC starting at 2 h. This is likely due to vapor leakage 
through the lid of the GC chamber.  
5.3. On-Site Rendering Plant Pilot Study  
VOC emissions stem from a myriad of sources with global industries representing 
one of the leading producers of high VOC loads. Rendering is one such industry that 
involves the processing and recycling of major by-products, such as, skins, hides, feet, 
hooves, bones, toenails, whole carcasses and other muscle and fat tissues resulting from 
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meat-packing and butchering operations. This widespread industry serves a vital role in 
processing tremendous amounts of by-product material that must be sterilized and 
preferably repurposed into new products such as meat and bone meal, poultry meal, and 
rendered animal fats. This becomes more significant when considering that humans 
consume only one-third to one-half of animals produced for meat, milk, eggs, and fiber.  
This results in an annual processing load of over 22.7 million metric tons of animal by-
products in the United States annually. Ultimately, rendering operations play a vital role in 
the sustainability of animal agriculture and food industries by handling massive quantities 
of material in a safe, environmentally responsible, and efficient manner facilitating the 
recovery of value-added resources.54,55 However, it is not without undesirable side-effects. 
As a global industry, rendering operations handles and processes substantial quantities of 
raw material. The process of cooking, processing, and recycling this material emits a 
significant amount of VOCs, many of which are malodorous compounds. Rendering 
operations represent a reasonable case-study to assess the performance of PEI-Kao 
materials for the remediation of industrial VOC emissions and nuisance odors.  
When considering viable control and remediation technologies for VOCs one must 
first consider the necessity for a comprehensive emission inventory or VOC load 
assessment. This inventory can provide the basis for planning and identifying applicable 
regulations, the selection of practical control options, and the industry’s overall 
contribution to global VOC emissions. A limited number of VOC load emission studies for 
rendering operations have been reported. The groups of Van Langenhove et al. Defour et 
al., and Bhatti et al. have conducted assessments of rendering operations VOC emissions 
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only pertaining to odor nuisance compounds.56-59 Furthermore, only one other study, 
reported in 2014 by Bhatti et al. took on the task of completing a complete VOC load 
emission inventory of an enclosed rendering plant.59 Therefore, we previously pursued an 
all-encompassing assessment of VOC emissions at two open-air rendering plants located 
in the Central Valley of California, USA.60 Via this study, a detailed analysis of the 
emission inventory resulting from said rendering plants was compiled resulting in 43 
detectable compounds whose presence and concentration seasonally vary. Volatile organic 
compounds including ammonia, fatty acids such as acetic acid, aldehyde/ketones such as 
acetone, and ethanol constitute the bulk of these emissions. They also significantly 
contribute to the malodorous atmosphere surrounding rendering operations. These data 
along with previous results from aforementioned groups emphasize the need for 
appropriate techniques and technologies for VOC abatement and control.  
In order to probe the usefulness of the Kao-PEI for rendering operation VOC 
emission capture, we sought to conduct on-site sampling experiments. Sample cartridge 
tubes packed with Kao-PEI clay were prepared in the hopes of screening their ability to 
reduce the VOC load at an open-air rendering facility in California. While at the rendering 
facility, ambient air was passed through the Kao-PEI packed tubes and into a sampling 
cartridge that assayed for volatile fatty acids (VFAs). We were interested in volatile fatty 
acids because they are major constituents of nuisance rendering odors. Untreated air 
samples, that is air that was not passed through a Kao-PEI clay packed tube, was also 
sampled in order to assess the percent reduction of the detectable VFAs after exposure to 
the Kao-PEI clay (see Figure 5.7 for sampling set-up). Air samples were collected as 
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follows: plant air was pumped through a commercially available sodium hydroxide-coated 
silica gel cartridge (700 mL min-1 flow rate) for an allotted time of 100 min. All field air 
samples, untreated and treated, were collected in triplicate and analyzed via GC/MS 
following standardized methods by a contracted environmental analysis laboratory in 
California, USA.  
 
The results of this analysis show that the Kao-PEI material significantly reduces 
the VOC load of all detectable volatile fatty acids in comparison to the untreated plant air 
samples. Heptanoic acid, octanoic acid, and nonanoic acid were all reduced by at least 60% 
(Table 5.1, Entries 10-12). Most notably, the three constituents that make up the bulk of 
this VOC load, acetic acid, propanoic acid, and butanoic acid, were all reduced by greater 
than 97% (Table 5.1, Entries 1, 2, and 4). The remaining constituents such as 2-
methylpropanoic acid, 2-methylbutanoic acid, pentanoic acid etc. all experienced a 
reduction of at least 90% (Table 5.1). Ultimately, this study represents an important step in 
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Figure 5.7. Rendering plant air VFA sampling experimental set-up for A) Kao-PEI treated air and B) 
untreated air.  
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demonstrating the applicability of PEI-modified kaolinite clay and other functionalized 
naturally-occurring clays in VOC mitigation in an industrial setting.  
 
 
 
5.4. Conclusions  
  
 This work highlights the ability of PEI-functionalized kaolinite to serve as an 
abatement material for several small molecule VOCs. The remediation of these small 
molecules was first explored in a laboratory setting via a gas chromatography (GC) 
headspace technique that assesses the removal of target VOCs from the gas phase. 
Specifically, this functionalized clay has shown a significant effect in capturing aldehydes, 
carboxylic acids, and alkyl disulfides with most of these assays showing 100% reduction 
of these vapors. Furthermore, upon successful scale-up of the Kao-PEI, this material was 
Table 5.1. Pilot-scale study for the Kao-PEI  capture of detectable volatile fatty acids from a rendering 
facility. 
Entry Volatile Fatty Acids Unreated (ppb) Treated (ppb)
1 acetic acid 233.3  ±  5.8 < 8
2 propanoic acid 163.3 ± 5.8 1.9 ± 1.1
3 2-methylpropanoic acid 17.0 ± 1.0 0.9 ± 0.4
4 butanoic acid 180.0 ± 10.0 2.0 ± 1.7
5 2-methylbutanoic acid 11.7 ± 0.6 < 0.6
6 3-methylbutanoic acid 11.3 ± 0.6 < 0.6
7 pentanoic acid 19.7 ± 1.2 < 0.6
8 4-methylpentanoic acid 6.9 ± 0.5 < 0.5
9 hexanoic acid 10.0 ± 0.9 < 0.5
10 heptanoic acid 1.6 ± 0.2 < 0.5
11 octanoic acid 1.7 ± 0.2 < 0.5
12 nonanoic acid 1.0 ± 0.1 < 0.4
% Reduction
> 97%
99%
95%
99%
> 95%
> 95%
> 97%
> 93%
> 95%
> 69%
> 71%
> 60%
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prepped into cartridges used for on-site small-scale VOC abatement study at an open-air 
rendering plant in order to probe their ability to reduce volatile fatty acid emissions directly 
produced by rendering operations, demonstrating removal efficiencies between 60 and 
99%.61  
5.5. Future Directions 
 
Ultimately, the ability to recycle or reuse the Kao-PEI clay would greatly improve 
its function and utility in an industrial setting. We have attempted to drive-off captured 
VOCs by heating previously used Kao-PEI clay at 65, 75, 85, and 100 ˚C for 24 h. This 
proved ineffective upon retreatment of the Kao-PEI with hexanal; no additional capture of 
vapor was observed. VOC capture was observed, however, when previously used Kao-PEI 
clay was subsequently reused in the hexanal vapor capture GC assay. As expected, when 
hexanal vapor was treated with fresh Kao-PEI a 100% reduction was noted. Upon reuse of 
the Kao-PEI to treat a second aliquot of hexanal vapor 82% reduction was still seen  (Figure 
5.8). Further experiments are necessary in order to determine the regeneration potential of 
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this material. Thermal regeneration of the materials may still be possible at higher 
temperatures and longer treatment periods. Solvent regeneration, in this case, is not viable 
due to the non-covalent PEI-modification of the Kao clay. Attempts to wash the clay with 
EtOH or H2O result in loss of PEI functionalization and VOC capture efficiency as 
confirmed by TGA analyses of washed samples..  
In order to apply our poly(amine)-functionalized clay material to other 
environmental remediation applications a covalent modification must be realized. Covalent 
grafting represents one potential functionalization route for Kao and other similar 
aluminum silicate clay minerals. Rubino and co-workers utilized this method to prepare an 
ampicillin (AMP) grafted montmorillonite (MMT)  clay.62 Upon successful 
functionalization, the MMT-AMP clay was embedded into a UV curable acrylate coating 
and applied onto a 
polypropylene film 
for the preparation 
of antimicrobial 
materials. 
Presumably, 
modifications to 
their reported 
method would 
yield a PEI 
covalently grafted 
O
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OCH3
OCH3
(3-Glycidyloxypropyl)trimethoxysilane 
3GTS
N
NH2
N
H
N
H
N N
H
N NH2
N
H
NH2
N NH2H2N
Poly(ethylenimine), PEI
PEI (2.5 equiv)
H2O, pH=4
40 °C
O Si OH
OH
OH
R =
R
OH
O Si OH
OH
OHR
OH
HO-Si/Al (1.5 equiv)
H2O:MeOH (2:1)
40 °C
O Si O
OH
OHR
OH
Si/Al
Scheme 5.2. Proposed two-step synthetic route for PEI covalent grafting 
of an aluminum silicate clay such as Kao.  
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clay that could be used in aqueous applications such as wastewater treatment as well as 
withstand solvent regeneration protocols.  
In order to covalently graft PEI onto a clay mineral, a tether moiety such as 3-
glycidyloxypropyl trimethoxysilane (3GTS) must be used, wherein PEI would be linked to 
the epoxy-terminated side chain under slightly acidic conditions. Subsequently, the silanol 
groups on the clay surface would be linked to the 3GTS-amine resulting in the desired 
functionalized clay (Scheme 5.2).  
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5.7. Experimental Methods 
 
5.7.1. Preparation and Characterization of Kaolinite-poly(amine) Clay  
 A solution of polyethylenimine (3 g equiv. per 1 g Kao clay) and 40 mL of methanol 
(MeOH) were allowed to stir in a 100 mL round bottom flask at room temperature for 30 
min. Kaolinite clay is then added and the suspension is stirred for an additional 3 h. Upon 
removal of the stir bar, the clay was allowed to settle to the bottom of the flask. The top 
layer of MeOH was then decanted and the wet clay was dried in vacuo in a vacuum oven 
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at 75 ˚C for 12 h.  Larger scale batches (>1 gram clay) required a drying period of up to 48 
h.  
5.7.2. Gas Chromatographic Vapor Capture Assay Methods 
GC analyses were carried out on a Shimadzu GC-2014 Gas Chromatograph, 
equipped with a Shimadzu AOC-20i Auto-Injector and a Flame Ionization Detector (FID), 
within the following parameters: inlet temperature: 250.0 ˚C; splitless injection at 30.9 mL 
min-1; injector sampling depth: 10 mm; column flow: 1.33 mL min-1, constant pressure; 
carrier gas: helium; FID temperature: 225 ˚C; temperature program: 40 ˚C for 5 min, 50 ˚C 
min-1 ramp to 200 ˚C, hold for 5 min. The GC was equipped with a 30 m x 0.25 mm x 0.25 
µm Zebron ZB-WAX Plus capillary GC column. Agilent Technologies Gas 
Chromatography 1.5 mL volume vials with septum screw-caps were used in the analysis 
assays.  
Our previously disclosed method for vapor capture assay was used to determine the 
standard vapor areas for each substrate of interest followed by their percent reduction upon 
interaction with kaolinite and Kao-PEI. Briefly, the opening of a 1.5 mL GC vial was 
covered with a 5 x 5 cm piece of Kimwipe tissue paper. Using a glass stir rod, a small 
sample well was made with the Kimwipe by gently applying pressure with the tip of the 
glass stir rod. A vial cap was secured on the vial and a 1 µL injection of the volatile liquid 
substrate was introduced into the vial by passing the needle through the Kimwipe barrier. 
After a 30 min vaporization equilibrium time, the vial was subjected to GC analysis as 
described above to collect baseline vapor levels.  A similar assay is also conducted in order 
to probe the effectiveness of the kaolinite and Kao-PEI material. Using the previously 
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described process for formation of a well within the GC vial, 10 mg of the kaolinite or Kao-
PEI was added into the Kimwipe sample well and then secured with a vial cap. A 1 µL 
injection of the designated volatile substrate was introduced into the vial by passing the 
needle carefully through the Kimwipe barrier and allowed to vaporize and subsequently 
react with the kaolinite or Kao-PEI sorbent for 30 min. Upon completion of the 30 min 
reaction time, the vial was subjected to GC analysis. 
5.7.3. Kao-PEI Hexanal Capture Time Study  
 
Screw-top GC vials were prepared following the above described protocol for the 
GC vapor capture assay. Each vial was then charged with 10 mg of Kao-PEI sorbent 
material followed by a 1 µL injection of hexanal that was allowed to vaporize and 
subsequently react with the Kao-PEI sorbent. Upon completion of the prescribed reaction 
time, the vial was subjected to GC analysis. 
Experiments were conducted in triplicate for analysis at 10 min, 20 min, 30 min, 1 h, 2 h, 
3 h, 4 h, and 6 h.  Hexanal analyte standards were also prepared in the same manner, i.e. 
pre-prepared vials were charged with only 1 µL of hexanal and no sorbent material. The 
standards were allowed to vaporize for the same amount of time as their respective treated 
counterparts i.e. 10 min, 20 min, 30 min, etc. prior to GC analysis.  
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5.7.4. Kaolinite-poly(amine) Cartridge Preparation for In-Plant Sampling Experiment  
Sample cartridges were prepared by packing 0.75 grams of Kao-PEI clay into a 
glass tube (7mm inner diameter) between two cotton plugs, consistently achieving a clay 
path length of ca. 3 cm. The cartridges were then sealed by heating the tips of the glass 
over a Bunsen burner until the glass became malleable enough to seal off each end of the 
cartridge with gentle twisting (Figure 5.9).  
The Kao-PEI packed cartridges were assessed for volatile fatty acid (VFA) 
abatement in an open-air rendering facility in the Central Valley region of California, USA. 
The sampling equipment was positioned in plant near the raw material pile and the cookers. 
Untreated plant air was sampled in triplicate using an SKC universal air sampling pump 
that was plumbed to a commercially available KOH-impregnated silica gel VFA sampling 
cartridge by a short length of Tygon tubing.  The VFA samples were collected at a 700 
mL/min flow rate for 100 min.  Plant air treated with Kao-PEI cartridges for VFA 
Kao-PEI  
Cotton 
Figure 5.9. Kao-PEI packed cartridges for pilot-scale VOC capture test at 
a rendering facility.     
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abatement was sampled in triplicate using an SKC universal air sampling pump that was 
plumbed in sequence to a commercially available KOH-impregnated silica gel VFA 
sampling cartridge followed by a Kao-PEI packed cartridge using short lengths of Tygon 
tubing.  Treated VFA samples were collect at a 700 mL/min flow rate for 100 min.  After 
the 100 min sampling period, the VFA sampling cartridges were sealed with plastic caps 
and stored in zip-top bags at 0 ˚C during transport to a commercial atmospheric sampling 
laboratory, where they were processed using GC/MS analysis following the laboratory’s 
standard operation procedures. 
5.7.5. Kao-PEI Reuse Experiments 
Screw-top GC vials were prepared following the GC vapor capture assay described 
above. Hexanal analyte standards were first prepared, in triplicate, in order to establish a 
baseline for untreated hexanal vapor, i.e. pre-prepared vials were charged with only 1 µL 
of hexanal and no sorbent material. The standards were allowed to vaporize for 30 min 
prior to GC analysis. Next, the treated vials were prepped in triplicate; each treated vial 
was charged with 10 mg of Kao-PEI followed by a 1 µL addition of hexanal. The hexanal 
was also allowed to vaporize and react with the Kao-PEI sorbent for 30 min. Following the 
30 min time period, the vial was subjected to GC analysis. These same treated vials were 
immediately reused by injecting an additional 1 µL of hexanal into the chamber. The 
hexanal was once again allowed to vaporize for 30 min prior to GC analysis.  
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5.8. Supplementary Information 
Kao and Kao-PEI SEM and EDX Imaging 
The surface morphologies of kaolinite and kaolinite-PEI samples were imaged by 
scanning electron microscopy (Hitachi SU-6600, SEM-EDX analysis) with an accelerating 
voltage of approximate 0.5 ~ 30kV with advanced variable pressure 10 ~300 Pa. For 
imaging, two different excitation voltages (7 and 10 kV) and a small sample detector 
distance (10.5 mm) were used. Under these experimental conditions, charging effects were 
minimal, and hence, it was not necessary to metalize the samples and no special grounding 
techniques were needed, so that true sample features were not masked. 
The SEM images in Figure 5.S1 are of the pristine Kaolinite with different scale 
bars (A and B) and PEI-modified Kaolinite (C and D).  These images indicate that there is 
no real change in crystallinity, homogeneity, and size distribution of the substrate upon PEI 
modification aside from some observable particle agglomeration after modification.   
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Figure 5.S1. SEM Images A. Kaolinite (100 µm) B. Kaolinite (50 µm)  C. Kao-PEI (300 µm)  D. 
Kao-PEI (100µm) 
 
EDX analysis, depicted in Figure 5.S2, was also used to provide elemental identification 
and quantitative compositional information. It has been found that kaolinite constituted of 
100 wt% of oxygen, silicon, and aluminum as expect, and no EDX signal for nitrogen was 
noted. In contrast, after its modification by PEI, Figure 5.S2 revealed a decrease in O, Si, 
Al metals to 98 wt% at expense of the nitrogen (2 wt%). Overall, EDX proves the absence 
of nitrogen in parent kaolinite and showed a 2 wt% nitrogen content on kaolinite surface.  
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Figure 5.S2. EDX Images A. Kaolinite B. Kao-PEI  
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CHAPTER SIX 
 
AMINE-GRAFTED CELLULOSE NANOCRYSTALS FOR PESTICIDE 
REMEDIATION  
 
 
6.1. Introduction 
 
6.1.1. Pesticides   
 
 The use of pesticides in agriculture has undeniably played a significant role in 
improving crop yields as well as protecting against aggressive pests and invasive weeds. 
The application of synthetic pesticides has become an integral component of modern 
agriculture, so much so, that upwards of 2.4 million metric tons of pesticide active 
ingredients are applied globally every year. The rapidly increasing world population and 
subsequent food demands have considerably increased the global use of pesticides. Further, 
pesticides are often applied to maintain urban plantations, to control weed and forage 
growth below and around infrastructure such as power lines and railways, and for mosquito 
control. The pervasive application of pesticides has led to universal contamination, 
detectable in all aspects of the ecosystem.1,2 This contamination poses several health 
hazards toward the public and non-target ecological species due to their potentially  toxic, 
stable, and less soluble active ingredients of pesticide formulations.3,4 These active 
ingredients have aptly been classified based on their LD50 values as extremely hazardous 
class 1A, highly hazardous class 1B, moderately hazardous class 2, and slightly hazardous 
class 3 active ingredients by the World Health Organization.5  
 Due to the amplified use of pesticides and the subsequent resistance developed in 
insects and invasive plants, the required dosage to counteract the target organism has 
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increased. Unsurprisingly, this increased pesticide application along with the sometimes 
slow environmental degradation of residual pesticides has resulted in an accumulation of 
active ingredients and their degradants in the environment, resulting in many instances of 
water source contamination, soil quality degradation, biomagnification, and reduced 
biodiversity. Many reports concerning the negative effects on humans and ecosystems 
underscore the necessity to remediate pesticides and their residues, especially from 
aqueous sources.6,7 
6.1.2. Pesticides of Interest  
Pesticides are either classified based on their target (fungicide, insecticide, 
herbicide, bactericides, etc.) or, more commonly, on their chemical composition.3, 5	The 
most commonly used pesticides belong to one of four compound classes: organochlorines 
(OC), organophosphates, substituted ureas, or carbamates. Figure 6.1 depicts common 
pesticide structures from each class.  
 For over three decades, OC pesticides were the most widely utilized pesticides in 
the agricultural industry. It was eventually realized that they are very stable in the 
environment, displayed significant toxicity to plants and animals, and were easily absorbed 
by organisms and food.8 Classified, as persistent organic pollutants, OC pesticides such as 
aldrin and dichlorodiphenyltrichloroethane (i.e. DDT) were eventually phased out of 
production and subsequently banned.9-11	
Organophosphate (OP) pesticides eventually took over as the slightly safer, yet still 
effective, alternative. They function by inhibiting the enzyme cholinesterase (AChe) 
following phosphorylation of serine amino acid residues.11 One of the first OP pesticides 
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to be widely used, malathion,  (i.e. diethyl 2-
[(dimethoxyphosphorothioyl)sufanyl]butanediolate), is described as a nonsystemic 
insecticide with highly selective toxicity.7 Other examples include chlorpyrifos, diazinon, 
glyphosate, and parathion.11 There are several reports detailing the negative effects that 
OPs have on  aquatic fauna as well as over 200,000 deaths reported annually from OP 
poisoning.12, 13 
Many developing countries are limited to the use of cheaper broad-spectrum 
carbamate pesticides, such as, carbofuran, carbaryl, thiram, and mancozeb. First introduced 
in 1956, carbamates are typically applied as insecticides and display the same mechanism 
of toxicity as OP pesticides by inhibiting the AChE enzyme.14 Reports detailing the 
negative effects of carbaryl and carbofuran on the reproductive systems of non-target 
species have been reported, as well, as significant toxicological concerns for the 
metabolites of carbamates.15, 16  
The least-toxic alternatives arise from the substituted urea class of pesticides. 
Commonly used as herbicides, they exhibit lower environmental persistence and high 
selectivity via a free imino hydrogen which forms hydrogen bonds to inhibit the 
acetolactate synthase enzyme.17 For example, diuron has been reported to decease 
photosynthesis efficiency in target plants at concentrations as low as 1.5 µg L-1. The major 
health concern surrounding this class involves the formation of pesticide residues that are 
more stable and toxic in comparison to their parent pesticide.19	
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Figure 6.1. Examples of organochlorine, organophosphorus, carbamate, and 
substituted urea pesticides.    
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6.1.3. Traditional Remediation Techniques  
 One of the biggest hurdles surrounding pesticide remediation is that it is particularly 
difficult to develop a single, universal method for pesticide effluent remediation.20-22 This 
is highlighted by the plethora of physical, chemical, and biological methods that have been 
explored to mitigate pesticide pollution such as, coagulation/flocculation, photocatalytic 
degradation, electrochemical or aerobic degradation, oxidation, membrane filtration, 
nanofiltration, and adsorption.1,2, 20-23 In terms of detectable pesticides in surface waters, 
microbial, photochemical, and/or chemical treatments are the primary degradative 
decontamination processes. There are numerous examples of microorganism-assisted 
methodologies, i. e. the application of fungi, bacteria, and viruses for pesticide 
remediation.24, 25 Initially, bacteria already present in the ecosystem were studied for their 
ability to degrade pesticide residues. Theoretically, the use of naturally abundant bacteria 
would serve as a cost-effective and environmentally friendly technique, since the method 
would not cause any secondary pollution. It was quickly realized, however, that the time 
frame required for native bacteria to degrade pesticide contaminants was impractically 
long, and many uncontrollable environmental influences, such as temperature and pH, 
drastically affected the course of the microbial degradation. This prompted studies to 
closely evaluate naturally occurring bacteria from soil and water sources in order to 
understand their mechanism for organic pesticide degradation.  From these findings, 
bacteria capable of degrading pesticides to lower molecular weight products have been 
isolated and their degradation pathways have been described.26-33  Table 6.1 details a 
number of microorganisms that can effect the biodegradation of pesticides.  
 211 
  
Table 6.1. Overview of microorganisms successfully applied to the biodegradation of pesticides.   
Pesticide Microorganisms Involved in Biodegradation 
DDT in soil 
 
Escherichia coli, Enterobacter aerogenes, Enterobacter 
cloacae, Klebsiella pneumonia, Pseudomonas putida, 
Bacillus species and Hydrogenomonas 
Endosulfan Pseudomonas spp., Bacillus spp., and Flavobacterium spp. 
Iprodione Pseudomonas spp. 
Lindane Bacillus thiooxidans and Basea thiooxidans, Sphingomonas paucimobilis, Streptomyces spp., and Pleurotus ostreatus 
Nitrobenzene 
Pseudomonas pseudoalcaligenes and Pseudomonas putida HS12, Comamonas spp.  
Pseudomonas mendocina KR-1, Pseudomonas pickettii PKO1, Cyanobacterium spp., 
Microcystis aeruginosa, Arthrobacter spp.,  Serratia spp., , and Stenotrophomonas spp.  
Comamonadaceae and Clostridium spp., and Rhodotorula mucilaginosa  
 
Cypermethrin E. coli, S. aureus, P. aeruginosa, B. subtilis, Enterobacter asuburiae and Pseudomonas stutzeri 
Carbofuran Pseudomonas spp., Flavobacterium spp., Achromobacterium spp., Sphingomonas spp. and Arthrobacter spp. 
 
Carbendazin Pseudomonas 
 
Aldrin Trichoderma viridae, Pseudomonas spp., Micrococcus spp., and Bacillus spp. 
 
Endrin Trichoderma viridae, Pseudomonas spp., Micrococcus spp., Arthrobacter spp., and Bacillus spp. 
 
Dieldrin Pseudomonas spp. 
 
Further studies have focused on the identification of microbial enzymes, such as, 
oxidoreductases, dioxygenases, and hydrolases that have the potential to activate pesticides 
in situ and potentially serve as an additional tool for bioremediation.34 While effective, 
biodegradation approaches are time consuming, often requiring days to months for 
complete metabolism to occur, leading to increased expenses that are incompatible with 
industrial-scale applications.35  
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Various photochemical methods, such as direct photolysis and photocatalysis, have 
also emerged as viable pesticide degradation strategies. Photolysis can occur either directly 
or indirectly, with the former occurring when the pesticide of interest adsorbs light energy, 
enters an excited state, and undergoes a chemical transformation, contingent on there being 
enough energy to overcome the activation barrier.36 The latter occurs when pesticides react 
with other photochemically produced species such as hydroxyl radicals and ions.36-39 Direct 
photochemical degradation is limited to gas phase interactions in the atmosphere, shallow 
layers of soil, and in surface water due the need for direct contact of the appropriate 
wavelength of light with the pesticide matrix.40 Light sources with greater intensities than 
sunlight have also been employed. For example, xenon or krypton lamps are able to 
produce light pulses over a range of wavelengths (i.e. 200–1000 nm) in very short and 
intense intervals (50–3000 μs). This approach has been applied effectively to pesticide 
contaminated water, degrading atrazine, simazine, chlorpyrifos-methyl, pirimiphos-
methyl, phosmet, and azinphos-ethyl.41 
Alternatively, photocatalysis relies on the use of a semiconductor metal oxide 
catalyst such as, TiO2, WO3, or ZnO to accelerate the 
photoreaction.42-44 Briefly, the semiconductor catalyst (C) absorbs 
an energy quantum to produce energetic species (e- and h+) 
followed by subsequent transfer of excited electrons to the oxidant 
(Ox1). Simultaneously, the catalyst accepts electrons from the 
reductant (Red2) to fill the holes left in the semiconductor valance band (Equation 6.1). 
Further, in the presence of H2O and/or hydroxyl ions, hydroxyl radicals (·OH) are formed 
C C (e- + h+)hv
h+ + Red2             Ox2
e- + Ox1             Red1
Equation 6.1. 
Photocatalysis with a 
semiconductor  
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and may form other reactive radicals such as superoxide radical anion (O2·−)  that can 
react with pesticides. When the solid conductor is used in aqueous sources, a colloidal 
suspension is formed that is stable upon irradiation. This method has been successfully 
applied to the degradation of a carbamic, chlorinate, triazine, and urea pesticides.43-45 For 
instance, Higarashi and Jardim studied the remediation of diuron in contaminated soil 
using a TiO2 photocatalyst. When irradiated with sunlight, they observed that the 
pesticide and its intermediates were completely degraded in the topsoil, up to a depth of 
4 cm.43 Photocatalysts are an attractive method because they are generally cost-effective, 
chemically inert, non-toxic, and easily attainable.45 The disadvantages of this method is 
the difficulty associated with identifying an appropriate light source to facilitate practical 
remediation efforts. Often, a compatible light source that was identified in the laboratory 
becomes unsuitable when applied in the field, due to either undesired photon absorption by 
the pesticide formulating agents or the increased opaqueness of environmentally relevant 
solutions. 46-48 
In aqueous systems, such as wastewater, the most common pathways applied to 
promote chemical degradation are hydrolysis and oxidation. Hydrolysis is an attractive 
method because it has been proven to be economical and effective. Hydrolysis occurs via 
a water substitution or elimination reaction pathway. Whether the degradation occurs more 
rapidly at a high pH (alkaline hydrolysis) or a low pH (acid hydrolysis) varies among 
pesticides. The rate of hydrolysis also depends on the temperature, where increased 
temperatures (~100 ˚C) are typically required for degradation to occur within 24 h.49 
Oxidation processes, specifically advanced oxidation processes (AOPs), require the 
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addition of oxidants such as hydrogen peroxide/ferrous salts, TiO2 photocatalysts, and 
ozone, as well as formulating agents and surfactants to quench and remove the oxidative 
species.50-52 Currently, the limiting factor surrounding AOPs is the high cost of many of the 
necessary oxidants.20  
6.1.4. Nanomaterials for Pesticide Remediation 
 A variety of nanomaterials and nanocomposites have also been established as useful 
technologies for water pollutant remediation. Numerous reports can be found in the 
literature detailing the adsorption of pollutants, mitigation of pathogens, and degradation 
of toxins into less-toxic derivatives.35, 54-61 Some examples include the use of TiO2, ZnO, 
metal oxide and sulfide nanomaterial photocatalysts that possess attractive characteristics, 
such as optimal morphology, size, and higher adsorption capacity. Additionally, they do 
not require mass transfer allowing the process to be applicable with atmospheric oxygen 
under ambient conditions. On exposure to the appropriate light source, these materials 
generate electron–hole pairs which migrate to the surface of the semiconductor material, 
promoting pesticide degradation via photooxidation or photoreduction.62-64 Degradation 
efficiency can be amplified by decreasing the particle size or by doping the photocatalyst, 
with both manipulations leading to changes in the band gap, making photooxidation or 
photoreduction more facile.63, 64  
 Metal oxide	 nanomaterials can also function as reactive sorbents, promoting 
hydrolytic reactions in aqueous solutions.  Sastny et al. reported the reactive adsorption of 
parathion methyl upon treatment with mesoporous MnO2 via the nucleophilic attack on the 
phosphorus atom, followed by  release of 4-nitrophenol.65 OC pesticides are also 
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susceptible to degradative nanoadsorbants such as TiO2 (via photocatalysis) and Fe
0 
nanoparticles (via redox reaction). Bandala and coworkers reported that the treatment of 
pesticide contaminated water with TiO2 NPs and UV lamps resulted in oxidation of aldrin 
into dieldrin, chlordane, and 1,2-hydroxy-dieldrin.66 Further, doping of the TiO2 
photocatalyst with species such as nitrogen, IO3 , or other metal ions has been reported to 
increase degradation efficieny. For instance, malathion degradation increased by over 
170% when treated with an Au and Pd doped TiO2 nanotube film in comparison to the 
undoped version.67 It is suggested that increased adsorption is a result of the metal ions 
present in the semiconductor lattice promoting the formation of Ti3+ ions, causing more 
surface defects and increasing adsorption of oxygen onto the titania surface. Moreover, the 
quantum yield of the photoreaction is bolstered as a result of the metal ions increasing the 
charge separation of the electrons and holes in the conduction and valance bands.67 
 Zero valent iron based NP catalysts, such as nZVI, have been very effective at 
degrading nearly all halogenated hydrocarbons, in under 24 h,  to their less toxic 
hydrocarbon derivatives by means of a dichlorination mechanism.68-73 Thus numerous 
studies have been conducted to determine the optimized nanoparticle formulations. Elliot 
et al. disclosed the significance of nZVI particle size on degradation efficiency. More 
specifically, a greater percent degradation of lindane was observed for 60 nm nZVI in 
comparison to 10 µm commercial iron, 95 and 60% degradation, respectively.74  
Cellulose nanocrystal (CNC) represents one class of nanomaterial that is an ideal 
platform for further functionalization due to the large surface area of the substrate as well 
as the presence of the C6 carbinol functionality that can serve as a handle for covalent bond 
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formation. Cellulose-based materials are also abundant in nature, renewable, 
biodegradable, and biocompatible. Our group has explored poly(ethylenimine) (i.e. PEI) 
functionalized nanoparticles, microparticles, cellulose nanocrystals, and kaolinite clay 
materials for VOC remediation.75-78 We have also explored the use of PEI-modified 
cellulose microcrystals for the removal of poly- and perfluorinated surfactants from 
water.79 In continuation of our efforts in this area, we sought to evaluate the preparation of 
a series amine-functionalized cellulose nanocrystals (CNCs) to serve as a new material for 
the remediation of pesticide residues from water.  
6.2. Results and Discussion 
6.2.1. Preparation and Characterization of Amine-Modified CNC 
 Samples of cellulose nanocrystals grafted with ethylenediamine (EDA), tris(2-
aminoethyl)amine (TRIS), and poly(ethylenimine) (PEI) were prepared following a 
protocol previously described by our group.77 Briefly, commercially available CNC was 
oxidized via an aqueous TEMPO-mediated process wherein the primary, C6-alcohols of 
Scheme 6.1. TEMPO-mediated oxidation of CNC followed by ion exchange to effect the 
neutralization of the C-6 sodium carboxylates. EDC assisted amine-functionalization of oxidized 
CNC with TRIS, EDA, or PEI.  
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the CNC material were selectively oxidized to their corresponding sodium carboxylates. 
Following successful oxidation, the material was treated with an ion-exchange solution in 
order to convert the C6 sodium carboxylates to their neutral counterparts. Finally, CNC-
EDA, CNC-TRIS, and CNC-PEI were obtained after carbodiimide coupling with EDA, 
TRIS, or PEI, respectively (Scheme 6.1).  
 The amine-modified CNC materials were characterized by Fourier-transform 
infrared spectroscopy (FTIR) and thermogravimetric analysis (TGA). Changes to a 
diagnostic carbonyl stretching frequency were easily followed throughout the chemical 
modification process by FTIR (Figure 6.2 A). Following TEMPO oxidation, the new C-6 
carbonyl produces an identifiable C=O stretch at 1712 cm-1 that is not present in the 
unmodified CNC starting material. Furthermore, upon amine (EDA, TRIS, or PEI) 
functionalization this carbonyl stretch experiences a shift to smaller wavenumbers, around 
1585 cm-1, suggesting successful amide bond formation following EDC coupling of the C6 
carbonyl of the oxidized CNC and the prescribed amine. This shift is likely due to the larger 
electron donation of the more electropositive amide bond into the carbonyl as compared to 
its carboxylic acid predecessor. It is important to note the absence of characteristic amine 
N-H sp3 stretches in the oxidized CNC materials which are coincident with the OH 
stretches from the CNC core of the material. Thermogravimetric analysis of the amine-
modified materials resulted in similar degradation profiles that each differ in comparison 
to the oxidized CNC precursor prior to amine coupling, lending further support of 
successful amine-modification  (Figure 6.2 B).  
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Figure 6.2.  A)  Infrared spectra of amine-modified CNC. CNC-COOH 
(purple line), CNC-TRIS (black line), CNC-EDA (yellow line) and CNC-
PEI (blue line). B) TGA analysis of CNC (red line), CNC-COOH (purple 
line), CNC-TRIS (black line), CNC-EDA (yellow line) and CNC-PEI 
(blue line). 
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6.2.2. Pesticide Remediation in Organic Solvent  
As previously discussed, organophosphorus pesticides are currently the most 
commonly utilized pesticide class of agrochemicals. Malathion is one such OP pesticide 
that is primarily used as an insecticide to control mosquito and fruit fly populations. 
Malathion also serves as a viable alternative to the traditionally-used organochlorine (OC) 
compounds, such as DDT, lindane, and endosulfan.80 These OC pesticides are notorious 
for their persistent and biocumulative nature, which resulted in the release of highly toxic 
pesticide residues into natural water supplies. While OP pesticides do serve as a less 
harmful alternative to chlorinated pesticides they still represent a major environmental 
concern, especially in the context of water source contamination.7, 81-83  
 In the context of pesticide remediation from aqueous environments, we sought to 
implement amine-modified CNCs as a material to facilitate pesticide degradation.  In order 
to easily assess and 
compare the 
remediation efficiency 
of each amine-CNC 
material, a GC analysis 
protocol was first 
optimized using 
solutions of DCM 
spiked with malathion. 
OP pesticides tend to be 
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Figure 6.3. CNC-PEI loading experiment: Malathion pesticide 
samples treated with increasing  amounts of CNC-PEI.  
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poorly water soluble, therefore, these initial analyses allowed for a higher degree of OP 
pesticide solubility as well as clean chromatograms for analysis. The loading of CNC-PEI 
was first optimized. Briefly, 1.5 mL glass screw top GC vials were charged with 10, 20, 
30, 40, 50, 60, and 70 mg of the CNC-PEI material followed by a 1 mL aliquot of a solution 
of 165 ppm malathion in DCM. The vials were then capped and sealed with Teflon tape 
followed by Parafilm to avoid evaporation of the DCM solvent. Control vials were also 
prepared consisting only of the 1 mL 165 ppm solution of pesticide in DCM and analyzed 
at time 0 h as well as 24 h. The vials were then placed on an orbital shaker for 24 h. 
Following treatment with amine modified CNCs for 24 h, the vials were subjected to GC 
analysis.  All experiments were conducted in triplicate and pesticide degradation 
percentages were calculated. Following the CNC-PEI loading experiments, it was 
determined that 50 mg of the material was sufficient to completely degrade a 165 ppm 
solution of malathion in DCM. An increase in remediation apparent when increasing the  
CNC-PEI loading from 10 mg to 50 mg with 75.6 ± 0.8% and 100% remediation of 
malathion, 
respectively (Figure 
6.3). Using the 
optimized 50 mg 
CNC-PEI loading, it 
was also concluded 
that agitation was 
necessary for Figure 6.4. Agitation experiment that demonstrates the 
necessity of agitation of the amine-modified material and the 
pesticide solution.  
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complete degradation to occur with only 74% reduction reported with no agitation 
compared to 100% with agitation of the CNC-PEI and malathion solution (Figure 6.4).  
Lastly, all three amine-modified materials were assessed for their pesticide 
degradation effectiveness. A 50 mg loading of EDA-, TRIS-, and PEI-modified CNC 
resulted in 59 ± 2%, 50 ± 5%, and 100% remediation of malathion, respectively (Figure 
6.5). The superior performance of the CNC-PEI material is likely due to the additional 
reactive sites available as compared to the mono- and di-functional EDA and TRIS caps, 
respectively. Lastly, a sample of unmodified CNC was tested as a control in order to 
demonstrate the necessity of the amine functionalization step for effective remediation. 
Upon subjecting a DCM solution of malathion to unmodified CNCs, the chromatogram 
revealed only malathion, suggesting no appreciable degradation by the unmodified CNC.  
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6.2.3. Pesticide Remediation in Aqueous Systems  
Following the successful remediation of malathion in organic solvent, we sought to 
investigate the efficiency of the CNC-PEI material in an aqueous environment. Many 
insecticides are typically utilized as a liquid or spray that employ water as the carrier.84 
Therefore, commercially available pesticide formulations of malathion, permethrin, and 
deltamethrin were employed (Figure 6.6). These commercial formulations are widely 
available at local hardware stores or from internet vendors. It is important to note that many 
commercial pesticide solutions are formulated as a mixture of the active ingredient and 
other components. The active ingredient is the pesticide, therefore, pure standards of each 
pesticide were used to identify the peaks of interest in the GC chromatograms of the 
P
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O
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Br OO
O
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Cl
VI.1; Malathion VI.2; Deltamethrin VI.3; Permethrin
Figure 6.6. Commercially available pesticides treated with treatment with CNC-PEI.  
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complex commercially available 
solutions. Each commercially available 
pesticide solution was prepared as 
instructed on the packaging prior to 
treatment with the amine-CNC materials 
and analysis. As previously described, 
control GC vials containing only 
pesticide solution as well as treated vials 
containing the prescribed pesticide and 50 
mg CNC-PEI were prepared. All 
experiments were conducted in triplicate 
with agitation for 24 h. Treatment of the 
commercially available malathion 
solution with 50 mg CNC-PEI, resulted in 
100 % degradation of the OP pesticide at 
ambient temperature (Figure 6.7 A). 
Similarly, treatment of the deltamethrin 
solution with CNC-PEI resulted in a 95 ± 
0.9 % reduction at ambient temperature 
(Figure 6.7 B). The analysis of the 
commercial permethrin preparation was 
complicated by the fact that the active 
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ingredient is present as a pair of detectable cis/trans stereoisomers about the central 
cyclopropane ring.  Nevertheless, upon treatment with CNC-PEI samples at a slightly 
elevated temperature of 35 ˚C, the two peaks exhibited an average of 84.3 ± 0.7% and 78 
± 2% reduction, respectively (Figure 6.7 C).   
6.2.4. Pesticide Degradation Mechanism 
Next, in order to 
probe the mechanism of 
degradation, we sought to 
identify the by-products 
resulting from the 
interaction of malathion 
and CNC-PEI. Thus, a 165 
ppm solution of malathion was prepared in deionized water, and treated with 50 mg of 
CNC-PEI followed by agitation for 24 h. The CNC-PEI material was then removed from 
the reaction mixture by filtration, and the filtrate was then analyzed via GC-MS in order 
to identify the degradation products resulting from CNC-PEI treatment. Two main 
degradation products, O,O-dimethyl phosphorodithioic acid (VI-4’, DMTP) and diethyl 
fumarate (VI-5), were identified by GC-MS analysis. These compounds have previously 
been reported as commonly observed hydrolysis degradation by-products of malathion.85-
87   We believe that, in our system, these products arise from a facile CNC-PEI induced 
elimination of one of the ester α-protons from malathion to generate DMTP and diethyl 
fumarate (Scheme 6.2).  The diethyl fumarate degradation product returned a mass 
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Scheme 6.2. Suggested malathion degradation by-products.  
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spectrum that was consistent with data published in the National Institute of Standards 
and Technology (NIST) library; while the DMTP (m/z = 158) mass spectrum exhibits a 
fragmentation pattern that is easily assigned to by-product VI-4’.88 In a previous study, 
Bavcon et. al. monitored the degradation of malathion in untreated water, where only 
30% of an initial 10.3 ppm malathion concentration was degraded over 14 days.89 
Consistent with this previous observation of slow degradation of malathion in untreated 
water, control GC-MS experiments with untreated aqueous malathion samples revealed 
no detectable degradation over 24 h. Additionally, maloxon, a commonly observed toxic 
oxidation by-product which is the P=O congener of malathion, was not detected via GC-
MS.89, 90 
Next, we also investigated the degradation products of deltamethrin after 
treatment with CNC-PEI. Upon GC-MS analysis, three lower molecular weight by-
products were identified (Scheme 6.3). Deltamethrin by-product VI-6 (m/z = 429) is 
presumably the result of cleavage of the diaryl ether moiety, while compounds VI-7’ 
(m/z = 281) and VI-8’ (m/z = 209) are likely by-products of ester cleavage. More 
Scheme 6.3. Proposed deltamethrin degradation by-products.  
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specifically, compound VI-7’ is the acylium ion of deltamethrinic acid (VI-7) while VI-
8’ is the counterpart to a-hydroxy-3-phenoxy-benzeneacetonitrile (VI-8). Deltamethrinic 
acid, VI-7, and a-hydroxy-3-phenoxy-benzeneacetonitrile, VI-8, have previously been 
reported in the literature as a major hydrolysis degradation by-products in aquatic 
environments.91-93 Further, the mass spectrum of VI-8 aligns well with that of the neutral 
3-phenoxyphenylacetonitrile on the NIST database.94 An additional by-product was 
detected via GC-MS; however, its identity is as yet unclear; further investigations are 
being conducted in order to elucidate the structure and clarify the degradation pathway of 
deltamethrin in the presence of CNC-PEI.  
6.2.5. CNC-PEI Reuse Experiment  
 
Next, we explored 
the reusability of the 
material for pesticide 
remediation by re-
subjecting used CNC-PEI 
samples to further 
treatment with additional 
aliquots of pesticide-
contaminated water 
(Figure 6.9).  Thus, spent CNC-PEI samples were filtered from the pesticide solution and 
washed with 10 mL aliquots of deionized water until no pesticide contaminants or 
degradation products were detected upon GC analysis. The washed material was then 
Figure 6.9. CNC-PEI reuse experiments. Complete loss of function is 
observed at reuse cycle 3.  
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allowed to air dry for 24 h. The dried CNC-PEI was then subjected to FTIR and TGA 
analyses to monitor any potential changes to the used material. No signs of drastic PEI loss 
were detected following the first wash cycle (Figure 6.10). The CNC-PEI was then re-
subjected to fresh samples of malathion contaminated water and the degree of malathion 
degradation was analyzed by GC. A previously used and washed sample of CNC-PEI 
resulted in 98 ± 4% degradation following the first reuse cycle (Figure 6.9). Following a  
subsequent reuse cycle, however, only 50 ± 13% malathion degradation was achieved. It 
is clear that the effectiveness of the CNC-PEI material does decrease as the number of wash 
and reuse cycles increases. For example, the 3rd reuse experiment resulted in no detectable 
malathion degradation.   
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6.3. Conclusions and Future Directions  
This research has demonstrated the successful preparation and characterization of 
amine-functionalized CNC-materials. Further, these nanomaterials were successfully 
applied as effective tools for the degradation of various pesticides into their respective 
lower molecular weight by-products in both organic and aqueous media. Namely, 
ethylenediamine (EDA), tris(2-aminoethyl)amine (TRIS), or poly(ethylenimine) (PEI) 
grafted CNC materials were evaluated for their ability to remediate pesticide solutions. 
These formulations represent an economical, non-toxic, and viable new nanocellulose 
functionalized material for pesticide remediation. 
  Self-decontaminating materials (SDM) are the product of a surface modification 
that renders the material resistant or reactive to various threats such as pesticides, 
hazardous chemicals, and chemical warfare agents.95  Polymeric coatings, heterogeneous 
catalysts, metal-organic frameworks, quaternary ammonium salts, peroxide solutions, and 
nucleophiles all represent possible options for incorporation into a SDM.95-97 There are 
examples in the literature detailing the successful application of SDM materials for the 
degradation of organophosphate esters via a hydrolysis mechanism.98, 99 It can be 
imagined that our CNC-PEI materials could potentially serve as inspiration for new 
SDMs targeted toward the hydrolysis of organophosphate ester pesticides and chemical 
warfare agents. For example, cellulose nanofibers, presumably, would possess the desired 
adsorbent properties as well the ability to be functionalized with the PEI reactive 
functionality.   
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 Cellulose nanofibers (CNFs) can be liberated from wood biomass following a 
commonly utilized pretreatment and mechanical disintegration protocol.100 Typically, 
TEMPO-assisted catalytic oxidation serves as an effective pretreatment strategy. The 
prescribed method, closely resembles the TEMPO-mediated oxidation that is applied to 
our CNC slurries prior to amine coupling. Briefly, the wood biomass is subjected to a 
TEMPO/NaBr/NaClO oxidation in basified water, wherein the primary hydroxyl groups 
are converted to their sodium carboxylate derivatives. This is followed by gentle 
mechanical disintegration of the solution to obtain individual cellulose nanofibers. These 
fibers could then be functionalized with PEI using an EDC coupling protocol. The amine-
functionalized CNFs could then be prepared into films by casting and drying the aqueous 
solution or into a non-woven fabric via electrospinning. A practical SDM should be non-
toxic, have a rapid response to the threat, produce by-products of a lower toxicity compared 
to the parent threat, and function in all weather conditions. Therefore, these materials 
would be characterized and then tested for their response to organophosphate pesticides 
and other OP containing pollutants. 
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6. 5. Experimental Methods 
6. 5. 1. General Materials and Methods 
 Cellulose nanocrystal (CNC) slurry (12.2 wt.% in H2O) was purchased from 
Cellulose Lab. Ethylendiamine (EDA), tris(2-aminoethyl)amine (Tris), 
Poly(ethyleneimine) solution (PEI) (1200-1300 Da, 50 wt.% in H2O), 10-15% sodium 
hypochlorite solution (NaClO), sodium hydroxide, 2,2,6,6-Tetramethylpiperidine 1-oxyl 
free radical (TEMPO), N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride 
(EDC),  and sodium bromide were purchased from Sigma-Aldrich and used without any 
further purification. Gas Chromatography (GC) analyses were conducted using an Agilent 
7890A Gas Chromatograph equipped with an Agilent G4513A and a Flame Ionization 
Detector (FID). A Zebron ZB-MultiResidue-1 capillary GC column (30 m x 0.25 mm x 
0.25 µm) was installed for pesticide detection.  Agilent Technologies Gas Chromatography 
1.5 mL volume vials with septum screw-caps were used in the analysis assays. Thermal 
gravimetric analysis (TGA) was performed on a TA Instrument Hi-Res TGA 2950 
analyzer. Analysis was conducted under nitrogen from 25 to 1000 ˚C using a 10 ˚C min-1 
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gradient. Fourier Transform Infrared (FTIR) analysis was performed with a Nicolet Magna 
500 with NicPlan FT-IR Microscope and Mapping Stage.  
 
6. 5. 2. Synthesis and Characterization of Polyamine-Grafted Cellulose Nanocrystals  
TEMPO-mediated Oxidation and Ion Exchange 
 A 20 g sample of a CNC slurry (12.2 wt.% in H2O) was suspended in a water 
solution containing 0.20 g of TEMPO and 0.025 g of sodium bromide. A 4.77 g portion of 
a 12% aq. NaClO solution was added to the cellulose suspension in order to initiate the 
TEMPO-mediated oxidation. The reaction was performed at room temperature and stirred 
for 5 h. Additionally, a pH of 10 was maintained by adding of a 0.5M NaOH solution. After 
5 h, the solution was thoroughly washed with water by means of dialysis to remove any 
unreacted reagents. The pH of this purified suspension was then adjusted to a pH of 2.5 in 
order to neutralize the C-6 sodium carboxylates that resulted from the oxidation. The 
aqueous suspension was then washed thoroughly via dialysis, freeze-dried, and stored at 
−20 ˚C.  
Amine-Functionalization  
 In order to achieve successful amine-functionalization, a 100 mg sample of the 
oxidized CNC was re-suspended in water (1% cellulose/water) in a 50 mL beaker. Next, 
110 mg of EDC and the prescribed amine was added to the suspension. Specifically, 
ethylenediamine (40 µL, 0.590 mmol), tris(2-aminoethyl)amine (89 µL, 0.590 mmol), or 
poly(ethylenimine) (40 µL, 0.590 mmol) were added and allowed to stir for 6 h at room 
temperature. The modified cellulose nanocrystals were thoroughly washed with water by 
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dialysis followed by freeze-drying and storage at −20 ˚C prior to full characterization and 
testing for pesticide remediation. 
6. 5. 3. Gas Chromatographic Pesticide Remediation Assay Methods 
 GC analyses were carried out within the following parameters: inlet temperature: 
170.0 ˚C; splitless injection at 15 mL min-1; column flow: 2.0143 mL min-1, constant 
pressure; carrier gas: helium; FID temperature: 340 ˚C; temperature program: 100 ˚C for 
0.5 min, ramp to 180 ˚C at 20 ˚C min-1, hold for 4.5 min., final ramp to 240 ˚C at 6 ˚C min-
1, hold for 14.5 min.  
 In order to assess the effectiveness of the amine-modified CNC materials we opted 
to determine the standard pesticide area followed by the percent reduction of that area upon 
interaction with the material. In other words, the area of an untreated pesticide sample was 
compared to the area of treated pesticide samples. Control experiments were also necessary 
in order to ensure that pesticide remediation was not a result of solvent, agitation, or time. 
In order to determine the standard pesticide area, before treatment with CNC-material, a 
165 ppm solution of malathion pesticide in DCM was prepared. This solution was then 
added in 1 mL aliquots to 1.5 mL glass screw top GC vials. The vials were immediately 
subjected to GC analysis to determine the untreated pesticide peak area at t = 0 h. An 
additional set of vials were prepared, this time with 50 mg of the prescribed amine-
functionalized CNC and the 165 ppm malathion pesticide solution. The vials were then 
capped and sealed with Teflon tape followed by Parafilm to avoid evaporation of the DCM 
solvent. These treated vials were then placed on an agitator plate for 24 h prior to GC 
analysis. A final set of control vials were also analyzed that contained only a 165 ppm 
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pesticide solution aged for 24 h. All experiments were conducted in triplicate. Pesticide 
remediation percentages could then be calculated by comparing the untreated pesticide 
peak area to the treated pesticide peak area.  
6. 5. 4. CNC-PEI Material Loading Experiment 
 To determine the optimal material loading for effective pesticide remediation, a 
series of GC vials were prepared containing a 165 ppm malathion solution in DCM as well 
as increasing amounts of CNC-PEI material. Thus, 1.5 mL glass screw-top GC vials were 
prepped with 10, 20, 30, 40, 50 ,60, and 70 mg of the CNC-PEI material followed by 1 mL 
of a 165 ppm malathion solution in DCM. The vials were then capped and sealed with 
Teflon tape followed by Parafilm to avoid evaporation of the DCM solvent. Control vials 
were also prepared consisting only of the 1 mL 165 ppm solution of pesticide in DCM and 
analyzed at time 0 h as well as 24 h. Vials were then placed on an agitator plate for 24 h. 
Upon completion of the 24 h reaction time, the vial was subjected to GC analysis. All 
experiments were conducted in triplicate and pesticide degradation percentages were 
calculated. 
6. 5. 5. Agitation Experiment 
 In order to determine whether or not agitation was required for pesticide 
remediation to occur, two experiments were conducted under otherwise identical 
conditions where one sample set was set on the agitator plate for the treatment period while 
the other sample set was allowed to stand on the benchtop. Untreated control samples were 
also prepared for analysis at time 0 h and 24 h. All trials were completed in triplicate. Upon 
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GC analysis, it was concluded that agitation was necessary for optimal pesticide 
degradation to occur.  
6. 5. 6. Evaluation of CNC-PEI in Aqueous Systems 
 All commercially available pesticides were purchased from a local hardware store 
or over the internet. Pesticide solutions were prepared following the directions indicated 
on the respective packaging or used directly from the bottle as directed. More specifically, 
the Southern AGÒ  malathion commercial pesticide was purchased over the internet in its 
50% emulsifiable concentrate formulation. Therefore, this pesticide was prepared as a 2 
tsp/gal aqueous solution as described on the label. While, the deltamethrin (EliminatorÒ 
Ant, Flea, and Tick Killer) and permethrin (EliminatorÒ Home Insect Killer) were both 
purchased from a local hardware store as their ready-to-use formulations, with 2.5% and 
0.02% active pesticide ingredient, respectively.  
 Pure samples of each pesticide sample were so prepared by making a solution of 10 
mg of pesticide per 1 mL of water. Due to the poor aqueous solubility of most pesticides, 
these solutions were allowed to sonicate for approximately 20 min and then analyzed by 
means of GC. These analytical pesticide standards were prepared to facilitate comparison 
to the commercial pesticide formulation that contain a number of additives along with the 
active pesticide ingredient. Once the retention times of each pesticide was determined, the 
remediation experiments could be completed. GC vials were prepared following the 
previously described method: control untreated vials (t =0 h and t = 24 h) contained only 1 
mL of the pesticide solution while treated samples contained 1 mL of the pesticide solution 
and 50 mg CNC-PEI. All experiments were conducted in triplicate.  
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6. 5. 7. GC-MS Methods for Pesticide Degradation By-Product Detection 
 Pesticide samples containing degradation by-products were evaluated using a 
Shimadzu GC-2010 Plus, equipped with a AOC-20i auto injector, coupled to a QP2010 SE 
mass spectrometer. A Shimadzu GC SH-Rxi-5ms capillary column (15 m x 0.25 mm x 
0.25 µm) and a Shimadzu SH-RXI-5SIL MS column (30 m x 0.25 mm x 0.25 µm) were 
installed for product detection. GC analyses were carried out within the following 
parameters: inlet temperature: 50.0 ˚C; split injection (4 µL) at 14.1 mL min-1; column 
flow: 1.0 mL min-1, constant pressure; carrier gas: helium; temperature program: 40 ˚C for 
3 min.; ramp to 320 ˚C at 20 ˚C min-1, hold for 10 min. MS analyses were conducted as 
follows: ion source temperature: 200 ˚C; interface temperature: 100 ˚C; solvent cut time: 3 
min. 
6. 5. 8. Malathion and Deltamethrin Degradation Studies 
 A 165 ppm solution of malathion was prepared in deionized water, 50 mg of CNC-
PEI was added and the suspension was allowed to stir for 24 h at room temperature. Next, 
the solvent and any soluble compounds were filtered from the solid CNC-PEI materials 
and washed with deionized H2O. The filtrate was then analyzed via GC-MS in order to 
identify the mass of all present compounds.  
 Similarly, a 165 ppm solution of deltamethrin was prepared in deionized water, 50 
mg of CNC-PEI was added and the suspension was allowed to stir for 24 h at room 
temperature. Next, the water and any soluble compounds were filtered from the solid CNC-
PEI materials, and the collected nanocrystals were washed with deionized H2O. The 
aqueous filtrates were then analyzed via GC-MS in order to identify the mass of all 
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detectable by-products of deltamethrin degradation. Upon GC-MS analysis, three lower 
molecular weight by-products were identified.  
6.6. Supplementary Information 
 
6.6.1. GC-MS Data for Malathion Degradation  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. 11. GC trace of malathion solution following 24 h treatment with 
CNC-PEI. A) Full GC analysis chromatogram B) Zoomed in to highlight 
peaks at RT = 8.70 and 8.75 min. Note: Peaks seen before RT = 3 min can 
be attributed to solvent oversaturation and impurities. 
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Figure 6.13. Identification of malathion hydrolysis by-products by GC-MS. Mass 
spectrum of diethyl fumarate (m/z=172), RT = 8.75 min.     
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Figure 6.12. Identification of malathion hydrolysis by-products by GC-MS. Mass 
spectrum of O,O-dimethyl phosphorodithioic acid (DMTP) (m/z=158), RT = 8.70 
min.  
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6.6.2. GC-MS Data for Deltamethrin Degradation 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.14. GC trace of deltamethrin solution following 24 h treatment with CNC-PEI.  GC 
analysis chromatogram. Peaks attributed to degradation by-products were found at RT = 
8.3, 9.6, 10.73, and 11.77 min. 
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Figure 6.16. Identification of deltamethrin degradation by-products by GC-MS. 
Mass spectrum of  (m/z=281) the acylium ion of deltamethrinic acid, RT = 
10.73 min.  
Figure 6.15. Identification of deltamethrin by-product by GC-MS. Mass 
spectrum of suggested compound (m/z=429), RT = 9.6 min.  
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Figure 6.18. Identification of deltamethrin degradation by-products by GC-MS. 
Mass spectrum of unidentified compound (m/z=355), RT = 8.3 min.  
Figure 6.17. Identification of deltamethrin degradation by-products by GC-MS. 
Mass spectrum of 3-phenoxyphenyl-acetonitrile (m/z=209), RT = 11.765 min.  
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Appendix A 
Supplementary Information for Chapter 2 
 
FUNCTIONAL PEPTIDES FOR ENANTIOSELECTIVE HYPERVALENT 
IODINE(III)-MEDIATED CHEMISTRY 
 
1H NMR Spectra of Racemic II-2, 1-oxo-1-phenylpropan-2-yl-4-methylbenzenesulfonate 
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A2 
13C NMR Spectra of Racemic II-2, 1-oxo-1-phenylpropan-2-yl-4-
methylbenzenesulfonate 
 
 
 
 
 
1H NMR Spectra of Racemic II-4, Lactone Product 
 
 
 
13C NMR Spectra of Racemic II-4, Lactone Product 
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HPLC Chromatogram of Racemic II-2, 1-oxo-1-phenylpropan-2-yl-4-
methylbenzenesulfonate 
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A4 
 
 
“Hit” Peptides and the corresponding HPLC Chromatograms for the a-Oxytosylation of 
Propiophenone Product II-2, Enantiomer RT = ~7.1 and ~7.6.  
 
 
 
 
 
 
HPLC Trace for Peptide II-13, 48% ee 
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2-IBA-Ile-Pro-D-Ala-Asp-Gln
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2-IBA-hPhe-Pro-D-Ala-Phg-Asp
23% ee
 
 
 
 
A5 
HPLC Trace for Peptide II-14, 23% ee  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A6 
1H NMR Spectra of Racemic II-4, 5-benzoyldihydrofuran-2(3H)-one 
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A7 
13C NMR Spectra of Racemic II-4, 5-benzoyldihydrofuran-2(3H)-one 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
200 180 160 140 120 100 80 60 40 20 0 ppm
24
.9
8
26
.8
3
78
.2
6
12
8.
82
12
9.
04
13
3.
63
13
4.
33
17
6.
23
19
4.
32
 
 
 
 
A8 
Chiral HPLC Spectra of Racemic II-4, 5-benzoyldihydrofuran-2(3H)-one 
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A9 
“Hit” Peptides for the Oxidative Cyclization of 5-oxo-5-Phenylvaleric Acid 
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A10 
HPLC Trace for Peptide II-15, 10% ee  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A11 
HPLC Trace for Peptide II-16, 18% ee  
 
 
 
 
 
 
 
 
 
 
A12 
HPLC Trace for Peptide II-17, 16% ee  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A13 
 
HPLC Trace for Peptide II-18, 22% ee  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A14 
HPLC Trace for Peptide II-19, 20% ee  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A15 
HPLC Trace for Peptide II-20, 24% ee  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A16 
1st Generation Aryl-Iodo Peptides Screened in the a-Oxytosylation of Propiophenone 
 
Table A1: Scaffold A Peptides 
Sequence 
Exact 
Mass 
Calc. 
[M+H]+ 
Calc. 
[M+Na]+ 
 
Observed 
[M+H]+ or 
[M+Na]+  
% ee of 
II-2 
      
Ac-Asn-4-I-Phe-Pro-D-Ala-Trp-Glu 929.2569 930.2649 952.2461 930.10 9.7 
Ac-Ile-4-I-Phe-Pro-D-Ala-Ala-Ala 755.2503 756.2583 778.2395 756.10 0 
Ac-Nva-4-I-Phe-Pro-D-Ala-Asp-Tyr 877.2507 878.2587 900.2399 878.10 8.6 
Ac-Phe-4-I-Phe-Pro-D-Ala-hPhe-Dap 894.2925 895.3005 917.2817 895.14 14.3 
Ac-Nle-4-I-Phe-Pro-D-Ala-Thr-Ala 785.2609 786.2689 808.2501 808.40 0 
Ac-Leu-4-I-Phe-Pro-D-Ala-Lys-Val 840.3395 841.3475 863.3287 841.19 NP 
Ac-Tle-4-I-Phe-Pro-D-Ala-Ile-Dap 812.3082 813.3162 835.2974 813.16 12.4 
Ac-Trp-4-I-Phe-Pro-D-Ala-Ala-Glu 886.2511 887.2591 909.2403 887.10 4.6 
Ac-Nle-4-I-Phe-Pro-D-Ala-Ile-Tle 839.3442 840.3522 862.3334 862.48 8.8 
Ac-Tyr-4-I-Phe-Pro-D-Ala-Ile-hPhe 937.3235 938.3315 960.3127 960.46 NP 
Ac-Tle-4-I-Phe-Pro-D-Ala-Bip-Leu 949.3599 950.3679 972.3491 972.59 0 
Ac-Tyr-4-I-Phe-Pro-D-Ala-Thr-Ser 851.2351 852.2431 874.2243 852.08 3.6 
Ac-Asp-4-I-Phe-Pro-D-Ala-Ala-Gln 814.2147 815.2227 837.2039 837.46 8.6 
Ac-Dap-4-I-Phe-Pro-D-Ala-Ile-dPhe 922.3238 923.3318 945.313 923.17 3.6 
Ac-Nva-4-I-Phe-Pro-D-Ala-Thr-hPhe 861.2922 862.3002 884.2814 862.14 7.3 
Ac-Bip-4-I-Phe-Pro-D-Ala-Tle-Ile 949.3599 950.3679 972.3491 950.21 8.6 
Ac-Asn-4-I-Phe-Pro-D-Ala-Ser-Dap 787.215 788.223 810.2042 788.06 6.6 
Ac-Nva-4-I-Phe-Pro-D-Ala-Nle-His 849.3034 850.3114 872.2926 850.15 3.8 
Ac-Ile-4-I-Phe-Pro-D-Ala-Phe-Lys 888.3395 889.3475 911.3287 889.51 16 
Ac-Lys-4-I-Phe-Pro-D-Ala-Tyr-Nva 890.3188 891.3268 913.308 891.17 12.4 
Ac-Tle-4-I-Phe-Pro-D-Ala-hPhe-Val 873.8345 874.8425 896.8237 896.97 9.6 
Ac-Phg-4-I-Phe-Pro-D-Ala-hPhe-Leu 907.3129 908.3209 930.3021 930.54 NP 
Ac-Ser-4-I-Phe-Pro-D-Ala-Nle-Abu 785.2609 786.2689 808.2501 808.49 0 
Ac-Leu-4-I-Phe-Pro-D-Ala-Lys-Val 840.3395 841.3475 863.3287 863.57 4.6 
Ac-Ala-4-I-Phe-Pro-D-Ala-Ile-Glu 813.2558 814.2638 836.245 836.49 8.7 
Ac-Nva-4-I-Phe-Pro-D-Ala-4-Pya-2-Nap 895.2878 896.2958 918.277 918.52 NP 
Ac-Phe-4-I-Phe-Pro-D-Ala-dPhe-Nle 983.3442 984.3522 1006.3334 984.19 3.8 
Ac-dPhe-4-I-Phe-Pro-D-Ala-Tle-Thr 937.3235 938.3315 960.3127 938.17 9.4 
Ac-Thr-4-I-Phe-Pro-D-Ala-Bip-1-Nap 1021.3235 1022.3315 1044.3127 1022.17 1.2 
Ac-Phg-4-I-Phe-Pro-D-Ala-Nva-Phe 879.2816 880.2896 902.2708 880.13 7.6 
Ac-2-Pya-4-I-Phe-Pro-D-Ala-Glu-Phe 924.2667 925.2747 947.2559 925.11 NP 
Ac-1-Nap-4-I-Phe-Pro-D-Ala-Orn-Tle 924.3395 925.3475 947.3287 925.20 2.3 
 
 
 
 
A17 
Ac-1-Nap-4-I-Phe-Pro-D-Ala-Asp-Ile 925.2871 926.2951 948.2763 926.14 13.2 
Ac-Leu-4-I-Phe-Pro-D-Ala-hPhe-Leu 887.3442 888.3522 910.3334 888.19 6.5 
Ac-1-Nap-4-I-Phe-Pro-D-Ala-Nle-Phg 943.3129 944.3209 966.3021 944.16 3.4 
Ac-Nva-4-I-Phe-Pro-D-Ala-Ser-Tyr 849.2558 850.2638 872.245 850.10 2.7 
Ac-Bip-4-I-Phe-Pro-D-Ala-Nva-Ala 893.2973 894.3053 916.2865 916.55 NP 
Ac-Ile-4-I-Phe-Pro-D-Ala-dPhe-Ser 923.3079 924.3159 946.2971 946.56 6.5 
Ac-Ile-4-I-Phe-Pro-D-Ala-Asn-Ser 814.2511 815.2591 837.2403 837.50 10 
Ac-Glu-4-I-Phe-Pro-D-Ala-Abu-Glu 843.23 844.238 866.2192 866.48 3.4 
Ac-Trp-4-I-Phe-Pro-D-Ala-Orn-Thr 901.2984 902.3064 924.2876 924.55 5.4 
Ac-Asn-4-I-Phe-Pro-D-Ala-hPhe-Val 874.2875 875.2955 897.2767 897.54 3.7 
Ac-Gln-4-I-Phe-Pro-D-Ala-2-Nap-dPhe 1048.9805 1049.9885 1071.9697 1072.23 11.6 
Ac-Dap-4-I-Phe-Pro-D-Ala-Glu-Ser 802.2147 803.2227 825.2039 825.46 9.6 
Ac-dPhe-4-I-Phe-Pro-D-Ala-Orn-3-Pya 985.3347 986.3427 1008.3239 1008.58 14.8 
Ac-Gln-4-I-Phe-Pro-D-Ala-Nle-tPhe 873.3286 874.3366 896.3178 896.58 2.8 
Ac-4-Pya-4-I-Phe-Pro-D-Ala-Ala-3-Pya 867.2565 868.2645 890.2457 890.51 17.3 
Ac-Val-4-I-Phe-Pro-D-Ala-hPhe-Trp 946.3238 947.3318 969.313 969.57 12.2 
Ac-Dap-4-I-Phe-Pro-D-Ala-Nva-Phe 818.2612 819.2692 841.2504 841.09 6.8 
Ac-Gln-4-I-Phe-Pro-D-Ala-Ser-Ala 786.2198 787.2278 809.209 809.05 2.9 
Ac-Orn-4-I-Phe-Pro-D-Ala-Tyr-tPhe 980.3657 981.3737 1003.3549 1003.19 7.4 
Ac-Leu-4-I-Phe-Pro-D-Ala-Dap-Orn 813.3034 814.3114 836.2926 836.13 4.6 
Ac-Val-4-I-Phe-Pro-D-Ala-Phg-hPhe 893.2973 894.3053 916.2865 894.15 12.4 
Ac-Phe-4-I-Phe-Pro-D-Ala-Phg-hPhe 941.2973 942.3053 964.2865 942.15 2.6 
Ac-Dap-4-I-Phe-Pro-D-Ala-Phg-hPhe 880.2769 881.2849 903.2661 881.12 3.8 
Ac-Asp-4-I-Phe-Pro-D-Ala-Phg-hPhe 909.2558 910.2638 932.245 910.10 11.6 
Ac-Abu-4-I-Phe-Pro-D-Ala-Phg-hPhe 879.2816 880.2896 902.2708 880.13 8.9 
Ac-tPhe-4-I-Phe-Pro-D-Ala-Phg-hPhe 997.3599 998.3679 1020.3491 998.21 6.4 
Ac-Gln-4-I-Phe-Pro-D-Ala-Phg-hPhe 922.2875 923.2955 945.2767 923.14 6.3 
Ac-Ser-4-I-Phe-Pro-D-Ala-Phg-hPhe 881.2609 882.2689 904.2501 882.11 11.2 
Ac-Ala-4-I-Phe-Pro-D-Ala-Phg-hPhe 865.266 866.274 888.2552 888.44 2.5 
Ac-Trp-4-I-Phe-Pro-D-Ala-Phg-hPhe 980.3082 981.3162 1003.2974 1003.48 9.4 
Ac-Glu-4-I-Phe-Pro-D-Ala-Phg-hPhe 923.2715 924.2795 946.2607 946.44 3.5 
Ac-Nva-4-I-Phe-Pro-D-Ala-Phg-hPhe 893.2973 894.3053 916.2865 916.47 11.3 
Ac-Leu-4-I-Phe-Pro-D-Ala-Phg-hPhe 907.3129 908.3209 930.3021 930.48 7.4 
Ac-Bip-4-I-Phe-Pro-D-Ala-Phg-hPhe 1017.3286 1018.3366 1040.3178 1040.50 0 
Ac-Tle-4-I-Phe-Pro-D-Ala-Phg-hPhe 907.3129 908.3209 930.3021 930.48 9.2 
Ac-His-4-I-Phe-Pro-D-Ala-Phg-hPhe 931.2878 932.2958 954.277 954.46 5.4 
Ac-Asn-4-I-Phe-Pro-D-Ala-Phg-hPhe 908.2718 909.2798 931.261 931.44 7.1 
Ac-Tyr-4-I-Phe-Pro-D-Ala-Phg-hPhe 957.2922 958.3002 980.2814 980.46 10.5 
 
 
 
 
A18 
Ac-Phg-4-I-Phe-Pro-D-Ala-Phg-hPhe 927.2816 928.2896 950.2708 950.45 NP 
Ac-Thr-4-I-Phe-Pro-D-Ala-Phg-hPhe 895.2766 896.2846 918.2658 918.45 2.6 
Ac-Lys-4-I-Phe-Pro-D-Ala-Phg-hPhe 922.3238 923.3318 945.313 945.49 14.7 
Ac-Nle-4-I-Phe-Pro-D-Ala-Phg-hPhe 907.3129 908.3209 930.3021 930.48 3.8 
Ac-Orn-4-I-Phe-Pro-D-Ala-Phg-hPhe 908.3082 909.3162 931.2974 931.48 4.3 
Ac-hPhe-4-I-Phe-Pro-D-Ala-Phg-hPhe 955.3129 956.3209 978.3021 978.48 0 
Ac-dPhe-4-I-Phe-Pro-D-Ala-Phg-hPhe 1017.3286 1018.3366 1040.3178 1040.50 12.9 
Ac-1-Nap-4-I-Phe-Pro-D-Ala-Phg-hPhe 991.3129 992.3209 1014.3021 1014.12 6.7 
Ac-4-Pya-4-I-Phe-Pro-D-Ala-Phg-hPhe 942.2925 943.3005 965.2817 965.10 0 
Ac-2-Nap-4-I-Phe-Pro-D-Ala-Phg-hPhe 991.3129 992.3209 1014.3021 1014.12 NP 
Ac-3-Pya-4-I-Phe-Pro-D-Ala-Phg-hPhe 942.2925 943.3005 965.2817 965.10 8.6 
Ac-2-Pya-4-I-Phe-Pro-D-Ala-Phg-hPhe 942.2925 943.3005 965.2817 943.14 4.8 
Ac-Bip-4-I-Phe-Pro-D-Ala-Tle-hPhe 949.3599 950.3679 972.3491 950.21 12.4 
Ac-Nle-4-I-Phe-Pro-D-Ala-Bip-Asp 951.3028 952.3108 974.292 952.15 8.4 
Ac-Thr-4-I-Phe-Pro-D-Ala-Ser-Asp 803.1987 804.2067 826.1879 804.05 2.4 
Ac-Thr-4-I-Phe-Pro-D-Ala-Ala-Nle 785.2609 786.2689 808.2501 786.11 0 
Ac-Ala-4-I-Phe-Pro-D-Ala-Ser-Ile 771.2453 772.2533 794.2345 772.09 2.8 
Ac-hPhe-4-I-Phe-Pro-D-Ala-Bip-Tle 997.3599 998.3679 1020.3491 998.21 5.4 
Ac-hPhe-4-I-Phe-Pro-D-Ala-Bip-Ala 955.3129 956.3209 978.3021 956.16 7.8 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A19 
 
Table A2: Scaffold B Peptides 
 
Sequence Exact Mass 
Calc. 
[M+H]+ 
Calc. 
[M+Na]+ 
Observed 
[M+H]+ or 
[M+Na]+  
% ee of II-
2 
2-IBA-tPhe-Pro-D-Ala-Phg-Phg 884.2758 885.2838 907.265 885.05 8.4 
2-IBA-Tyr-Pro-D-Ala-Tle-Thr 792.2344 793.2424 815.2236 815.04 7.5 
2-IBA-Val-Pro-D-Ala-Orn-Bip 865.3024 866.3104 888.2916 888.11 NP 
2-IBA-tPhe-Pro-D-Ala-Phg-Nle 864.3071 865.3151 887.2963 887.12 9.4 
2-IBA-Trp-Pro-D-Ala-tPhe-Nle 917.3337 918.3417 940.3229 918.11 NP 
2-IBA-3-Pya-Pro-D-Ala-1-Nap-Abu 845.2398 846.2478 868.229 846.41 2.4 
2-IBA-2-Nap-Pro-D-Ala-1-Nap-Val 908.2758 909.2838 931.265 909.44 6.4 
2-IBA-Orn-Pro-D-Ala-Bip-Thr 839.2503 840.2583 862.2395 840.42 7.9 
2-IBA-Gln-Pro-D-Ala-Lys-Val 770.2612 771.2692 793.2504 792.45 1.2 
2-IBA-Thr-Pro-D-Ala-Tle-Leu 742.2551 743.2631 765.2443 765.62 2.2 
2-IBA-dPhe-Pro-D-Ala-Lys-2-Pya 914.2976 915.3056 937.2868 915.07 0 
2-IBA-Val-Pro-D-Ala-Orn-Bip 865.3024 866.3104 888.2916 888.45 17.1 
2-IBA-Nle-Pro-D-Ala-Nle-Ile 754.2915 755.2995 777.2807 777.10 12.8 
2-IBA-Val-Pro-D-Ala-Abu-Dap 699.2241 700.2321 722.2133 722.03 4.7 
2-IBA-Ile-Pro-D-Ala-Tle-Ile 788.2758 789.2838 811.265 811.09 7.8 
2-IBA-Ile-Pro-D-Ala-Phg-Asp 776.2031 777.2111 799.1923 799.01 3.2 
2-IBA-2-Nap-Pro-D-Ala-2-Nap-Leu 922.2915 923.2995 945.2807 945.44 9.6 
2-IBA-Gln-Pro-D-Ala-Bip-Bip 975.2816 976.2896 998.2708 997.47 4.8 
2-IBA-Tle-Pro-D-Ala-Nva-Ser 714.2238 715.2318 737.213 737.37 6.7 
2-IBA-tPhe-Pro-D-Ala-Asp-Ser 820.2293 821.2373 843.2185 821.78 NP 
2-IBA-Thr-Pro-D-Ala-Asp-3-Pya 779.1776 780.1856 802.1668 802.51 7.5 
2-IBA-Glu-Pro-D-Ala-His-Phe 828.2092 829.2172 851.1984 829.38 11.3 
2-IBA-Phe-Pro-D-Ala-2-Pya-Leu 823.2554 824.2634 846.2446 824.42 6.8 
2-IBA-Lys-Pro-D-Ala-Lys-Gln 799.2878 800.2958 822.277 822.66 9.4 
2-IBA-Thr-Pro-D-Ala-hPhe-2-Pya 825.2347 826.2427 848.2239 847.42 14.2 
2-IBA-Trp-Pro-D-Ala-2-Pya-1-Nap 946.2663 947.2743 969.2555 968.46 NP 
2-IBA-1-Nap-Pro-D-Ala-2-Pya-Trp 946.2663 947.2743 969.2555 969.42 8.6 
2-IBA-Phe-Pro-D-Ala-2-Nap-Glu 888.2344 889.2424 911.2236 911.56 4.6 
2-IBA-Val-Pro-D-Ala-Phg-hPhe 822.2602 823.2682 845.2494 823.03 8.6 
2-IBA-Val-Pro-D-Ala-hPhe-Phg 822.2602 823.2682 845.2494 845.41 3.4 
2-IBA-hPhe-Pro-D-Ala-Lys-Leu 817.3024 818.3104 840.2916 818.47 12.2 
2-IBA-Leu-Pro-D-Ala-Nva-Glu 756.2344 757.2424 779.2236 757.40 5.9 
2-IBA-Tyr-Pro-D-Ala-Asn-Nva 791.214 792.222 814.2032 792.38 4.7 
 
 
 
 
A20 
2-IBA-Nva-Pro-D-Ala-Tyr-Asn 791.214 792.222 814.2032 792.38 8.7 
2-IBA-Phg-Pro-D-Ala-Tyr-Asn 825.1983 826.2063 848.1875 848.35 5.0 
2-IBA-Tyr-Pro-D-Ala-Asn-Phg 825.1983 826.2063 848.1875 847.39 2.0 
2-IBA-Trp-Pro-D-Ala-Ile-hPhe 875.2867 876.2947 898.2759 898.62 12.4 
2-IBA-Trp-Pro-D-Ala-hPhe-Trp 875.2867 876.2947 898.2759 898.66 14.2 
2-IBA-Tyr-Pro-D-Ala-Tyr-Asn 855.2089 856.2169 878.1981 878.58 7.6 
2-IBA-Tyr-Pro-D-Ala-Asn-Phg 825.1983 826.2063 848.1875 848.53 4.3 
2-IBA-Ile-Pro-D-Ala-Tle-Orn 755.2867 756.2947 778.2759 778.62 5.8 
2-IBA-hPhe-Pro-D-Ala-Phg-Asp 824.2031 825.2111 847.1923 847.35 23 
2-IBA-Asp-Pro-D-Ala-Phg-hPhe 824.2031 825.2111 847.1923 825.75 3.6 
2-IBA-Ile-Pro-D-Ala-Asp-Gln 771.2089 772.2169 794.1981 794.54 48 
2-IBA-Asp-Pro-D-Ala-Gln-Ile 771.2089 772.2169 794.1981 771.98 14.5 
2-IBA-Dap-Pro-D-Ala-Ile-2-Nap 811.2554 812.2634 834.2446 834.58 14.6 
2-IBA-2-Nap-Pro-D-Ala-1-Nap-Dap 811.2554 812.2634 834.2446 812.18 12.6 
2-IBA-Phg-Pro-D-Ala-hPhe-Val 808.2445 809.2525 831.2337 809.17 4.8 
2-IBA-Val-Pro-D-Ala-hPhe-Phg 808.2445 809.2525 831.2337 831.39 5.8 
2-IBA-Abu-Pro-D-Ala-Abu-Nva 684.2132 685.2212 707.2024 706.40 8.4 
2-IBA-Abu-Pro-D-AlaNva-Abu 684.2132 685.2212 707.2024 707.54 16.2 
2-IBA-Lys-Pro-D-Ala-Ser-Dap 716.2143 717.2223 739.2035 739.02 12.6 
2-IBA-hPhe-Pro-D-Ala-Phg-hPhe 856.2445 857.2525 879.2337 879.05 13.7 
2-IBA-Phe-Pro-D-Ala-Phg-hPhe 856.2445 857.2525 879.2337 879.05 12.3 
2-IBA-Phe-Pro-D-Ala-Phg-Dap 781.2085 782.2165 804.1977 804.02 8.7 
2-IBA-Phe-Pro-D-Ala-Asn-hPhe 837.2347 838.2427 860.2239 860.04 NP 
2-IBA-Gln-Pro-D-Ala-Lys-2-Nap 868.2769 869.2849 891.2661 891.09 12.6 
2-IBA-Ala-Pro-D-Ala-1-Nap-Orn 797.2398 798.2478 820.229 820.05 6.7 
2-IBA-1-Nap-Pro-D-Ala-Orn-Ala 797.2398 798.2478 820.229 798.17 4.3 
2-IBA-Orn-Pro-D-Ala-Phg-Ile 761.2398 762.2478 784.229 762.17 7.8 
2-IBA-Thr-Pro-D-Ala-tPhe-Abu 804.2707 805.2787 827.2599 805.20 5.6 
3-IBA-His-Pro-D-Ala-Tyr-Leu 828.2456 829.2536 851.2348 829.79 16.2 
2-IBA-tPhe-Pro-D-Ala-Phg-Phg 791.3964419 792.4044419 814.3856419 792.17 6.6 
2-IBA-Tyr-Pro-D-Ala-Tle-Thr 790.4917993 791.4997993 813.4809993 813.30 5.7 
2-IBA-Val-Pro-D-Ala-Orn-Bip 789.5871567 790.5951567 812.5763567 812.40 NP 
2-IBA-tPhe-Pro-D-Ala-Phg-Nle 788.6825141 789.6905141 811.6717141 811.49 10.4 
2-IBA-Trp-Pro-D-Ala-tPhe-Nle 787.7778715 788.7858715 810.7670715 788.55 NP 
2-IBA-3-Pya-Pro-D-Ala-1-Nap-Abu 786.8732289 787.8812289 809.8624289 788.04 12.4 
2-IBA-2-Nap-Pro-D-Ala-1-Nap-Val 785.9685863 786.9765863 808.9577863 787.14 8.2 
2-IBA-Orn-Pro-D-Ala-Bip-Thr 785.0639437 786.0719437 808.0531437 786.23 2.4 
2-IBA-Gln-Pro-D-Ala-Lys-Val 784.1593011 785.1673011 807.1485011 806.35 9.5 
 
 
 
 
A21 
2-IBA-Thr-Pro-D-Ala-Tle-Leu 783.2546585 784.2626585 806.2438585 806.62 0 
2-IBA-dPhe-Pro-D-Ala-Lys-2-Pya 782.3500159 783.3580159 805.3392159 783.12 3.8 
2-IBA-Val-Pro-D-Ala-Orn-Bip 781.4453733 782.4533733 804.4345733 804.59 5.4 
2-IBA-Nle-Pro-D-Ala-Nle-Ile 780.5407306 781.5487306 803.5299306 803.35 9.2 
2-IBA-Val-Pro-D-Ala-Abu-Dap 779.636088 780.644088 802.625288 802.45 0 
2-IBA-Ile-Pro-D-Ala-Tle-Ile 778.7314454 779.7394454 801.7206454 801.54 8.7 
2-IBA-Ile-Pro-D-Ala-Phg-Asp 777.8268028 778.8348028 800.8160028 800.64 6.4 
2-IBA-2-Nap-Pro-D-Ala-2-Nap-Leu 776.9221602 777.9301602 799.9113602 800.07 4.7 
2-IBA-Gln-Pro-D-Ala-Bip-Bip 776.0175176 777.0255176 799.0067176 798.21 5.8 
2-IBA-Tle-Pro-D-Ala-Nva-Ser 775.112875 776.120875 798.102075 798.26 8.7 
2-IBA-tPhe-Pro-D-Ala-Asp-Ser 774.2082324 775.2162324 797.1974324 775.76 3.2 
2-IBA-Thr-Pro-D-Ala-Asp-3-Pya 773.3035898 774.3115898 796.2927898 796.63 0 
2-IBA-Glu-Pro-D-Ala-His-Phe 772.3989472 773.4069472 795.3881472 773.57 3.2 
2-IBA-Phe-Pro-D-Ala-2-Pya-Leu 771.4943046 772.5023046 794.4835046 772.66 5.4 
2-IBA-Lys-Pro-D-Ala-Lys-Gln 770.589662 771.597662 793.578862 793.96 7.6 
2-IBA-Thr-Pro-D-Ala-hPhe-2-Pya 769.6850194 770.6930194 792.6742194 791.87 8.2 
2-IBA-Trp-Pro-D-Ala-2-Pya-1-Nap 768.7803768 769.7883768 791.7695768 790.97 1.5 
2-IBA-1-Nap-Pro-D-Ala-2-Pya-Trp 767.8757342 768.8837342 790.8649342 791.02 8.2 
2-IBA-Phe-Pro-D-Ala-2-Nap-Glu 766.9710916 767.9790916 789.9602916 790.30 5.2 
2-IBA-Val-Pro-D-Ala-Phg-hPhe 766.066449 767.074449 789.055649 766.84 7.6 
2-IBA-Val-Pro-D-Ala-hPhe-Phg 765.1618064 766.1698064 788.1510064 788.31 4.3 
2-IBA-hPhe-Pro-D-Ala-Lys-Leu 764.2571638 765.2651638 787.2463638 765.43 8.7 
2-IBA-Leu-Pro-D-Ala-Nva-Glu 763.3525212 764.3605212 786.3417212 764.52 9.6 
2-IBA-Tyr-Pro-D-Ala-Asn-Nva 762.4478786 763.4558786 785.4370786 763.62 3.6 
2-IBA-Nva-Pro-D-Ala-Tyr-Asn 761.543236 762.551236 784.532436 762.71 3.7 
2-IBA-Phg-Pro-D-Ala-Tyr-Asn 760.6385934 761.6465934 783.6277934 783.79 5.5 
2-IBA-Tyr-Pro-D-Ala-Asn-Phg 759.7339508 760.7419508 782.7231508 781.92 1,4 
2-IBA-Trp-Pro-D-Ala-Ile-hPhe 758.8293082 759.8373082 781.8185082 782.16 4.8 
2-IBA-Trp-Pro-D-Ala-hPhe-Trp 757.9246656 758.9326656 780.9138656 781.29 16.2 
2-IBA-Tyr-Pro-D-Ala-Tyr-Asn 757.020023 758.028023 780.009223 780.39 6.9 
2-IBA-Tyr-Pro-D-Ala-Asn-Phg 756.1153804 757.1233804 779.1045804 779.44 4.8 
2-IBA-Ile-Pro-D-Ala-Tle-Orn 755.2107378 756.2187378 778.1999378 778.54 1.3 
2-IBA-hPhe-Pro-D-Ala-Phg-Asp 754.3060952 755.3140952 777.2952952 777.46 7.2 
2-IBA-Asp-Pro-D-Ala-Phg-hPhe 753.4014526 754.4094526 776.3906526 754.95 NP 
2-IBA-Ile-Pro-D-Ala-Asp-Gln 752.49681 753.50481 775.48601 775.83 5.8 
2-IBA-Asp-Pro-D-Ala-Gln-Ile 751.5921674 752.6001674 774.5813674 752.37 1.6 
2-IBA-Dap-Pro-D-Ala-Ile-2-Nap 750.6875248 751.6955248 773.6767248 774.02 4.7 
2-IBA-2-Nap-Pro-D-Ala-1-Nap-Dap 749.7828822 750.7908822 772.7720822 750.71 0 
 
 
 
 
A22 
2-IBA-Phg-Pro-D-Ala-hPhe-Val 748.8782396 749.8862396 771.8674396 749.81 8.3 
2-IBA-Val-Pro-D-Ala-hPhe-Phg 747.9735969 748.9815969 770.9627969 771.12 1.9 
2-IBA-Abu-Pro-D-Ala-Abu-Nva 747.0689543 748.0769543 770.0581543 769.26 NP 
2-IBA-Abu-Pro-D-AlaNva-Abu 746.1643117 747.1723117 769.1535117 769.49 2.5 
2-IBA-Lys-Pro-D-Ala-Ser-Dap 745.2596691 746.2676691 768.2488691 768.07 2.5 
2-IBA-hPhe-Pro-D-Ala-Phg-hPhe 744.3550265 745.3630265 767.3442265 767.16 0 
2-IBA-Phe-Pro-D-Ala-Phg-hPhe 743.4503839 744.4583839 766.4395839 766.26 2.6 
2-IBA-tPhe-Pro-D-Ala-Phg-Phg 742.5457413 743.5537413 765.5349413 743.32 1.5 
2-IBA-Tyr-Pro-D-Ala-Tle-Thr 741.6410987 742.6490987 764.6302987 764.45 6 
2-IBA-Val-Pro-D-Ala-Orn-Bip 740.7364561 741.7444561 763.7256561 763.55 0 
2-IBA-tPhe-Pro-D-Ala-Phg-Nle 739.8318135 740.8398135 762.8210135 762.64 0 
2-IBA-Trp-Pro-D-Ala-tPhe-Nle 738.9271709 739.9351709 761.9163709 739.70 2.1 
2-IBA-3-Pya-Pro-D-Ala-1-Nap-Abu 738.0225283 739.0305283 761.0117283 739.19 7 
2-IBA-2-Nap-Pro-D-Ala-1-Nap-Val 737.1178857 738.1258857 760.1070857 738.29 3.6 
2-IBA-Orn-Pro-D-Ala-Bip-Thr 736.2132431 737.2212431 759.2024431 737.38 2.7 
2-IBA-Gln-Pro-D-Ala-Lys-Val 735.3086005 736.3166005 758.2978005 757.50 2.2 
2-IBA-Thr-Pro-D-Ala-Tle-Leu 734.4039579 735.4119579 757.3931579 757.77 4.7 
2-IBA-dPhe-Pro-D-Ala-Lys-2-Pya 733.4993153 734.5073153 756.4885153 734.27 0 
2-IBA-Val-Pro-D-Ala-Orn-Bip 732.5946727 733.6026727 755.5838727 755.74 14.1 
2-IBA-Nle-Pro-D-Ala-Nle-Ile 731.6900301 732.6980301 754.6792301 754.50 2.1 
2-IBA-Val-Pro-D-Ala-Abu-Dap 730.7853875 731.7933875 753.7745875 753.59 8.6 
2-IBA-Ile-Pro-D-Ala-Tle-Ile 729.8807449 730.8887449 752.8699449 752.69 3.4 
2-IBA-Ile-Pro-D-Ala-Phg-Asp 728.9761023 729.9841023 751.9653023 751.79 NP 
2-IBA-2-Nap-Pro-D-Ala-2-Nap-Leu 728.0714597 729.0794597 751.0606597 751.22 3.9 
2-IBA-Gln-Pro-D-Ala-Bip-Bip 727.1668171 728.1748171 750.1560171 749.36 7 
2-IBA-Tle-Pro-D-Ala-Nva-Ser 726.2621745 727.2701745 749.2513745 749.41 0 
2-IBA-tPhe-Pro-D-Ala-Asp-Ser 725.3575319 726.3655319 748.3467319 726.91 0 
2-IBA-Thr-Pro-D-Ala-Asp-3-Pya 724.4528893 725.4608893 747.4420893 747.78 14.8 
2-IBA-Glu-Pro-D-Ala-His-Phe 723.5482467 724.5562467 746.5374467 724.72 10.4 
2-IBA-Phe-Pro-D-Ala-2-Pya-Leu 722.6436041 723.6516041 745.6328041 723.81 12.4 
2-IBA-Lys-Pro-D-Ala-Lys-Gln 721.7389615 722.7469615 744.7281615 745.11 5.1 
2-IBA-Thr-Pro-D-Ala-hPhe-2-Pya 720.8343189 721.8423189 743.8235189 743.02 3.1 
2-IBA-Trp-Pro-D-Ala-2-Pya-1-Nap 719.9296763 720.9376763 742.9188763 742.12 4.6 
2-IBA-1-Nap-Pro-D-Ala-2-Pya-Trp 719.0250337 720.0330337 742.0142337 742.17 7.1 
2-IBA-Phe-Pro-D-Ala-2-Nap-Glu 718.1203911 719.1283911 741.1095911 741.45 1.3 
2-IBA-Val-Pro-D-Ala-Phg-hPhe 717.2157485 718.2237485 740.2049485 717.99 3.9 
2-IBA-Val-Pro-D-Ala-hPhe-Phg 716.3111058 717.3191058 739.3003058 739.46 1 
2-IBA-hPhe-Pro-D-Ala-Lys-Leu 715.4064632 716.4144632 738.3956632 716.57 NP 
 
 
 
 
A23 
2-IBA-Leu-Pro-D-Ala-Nva-Glu 714.5018206 715.5098206 737.4910206 715.67 4.5 
2-IBA-Tyr-Pro-D-Ala-Asn-Nva 713.597178 714.605178 736.586378 714.77 8.6 
2-IBA-Nva-Pro-D-Ala-Tyr-Asn 712.6925354 713.7005354 735.6817354 713.86 0 
2-IBA-Phg-Pro-D-Ala-Tyr-Asn 711.7878928 712.7958928 734.7770928 734.94 2.7 
2-IBA-Tyr-Pro-D-Ala-Asn-Phg 710.8832502 711.8912502 733.8724502 733.07 2.1 
2-IBA-Trp-Pro-D-Ala-Ile-hPhe 709.9786076 710.9866076 732.9678076 733.31 2.9 
2-IBA-tPhe-Pro-D-Ala-Phg-Phg 709.073965 710.081965 732.063165 709.85 3.7 
2-IBA-Tyr-Pro-D-Ala-Tle-Thr 708.1693224 709.1773224 731.1585224 730.98 2.4 
2-IBA-Val-Pro-D-Ala-Orn-Bip 707.2646798 708.2726798 730.2538798 730.07 0 
2-IBA-tPhe-Pro-D-Ala-Phg-Nle 706.3600372 707.3680372 729.3492372 729.17 6.3 
2-IBA-Trp-Pro-D-Ala-tPhe-Nle 705.4553946 706.4633946 728.4445946 706.23 7.7 
2-IBA-3-Pya-Pro-D-Ala-1-Nap-Abu 704.550752 705.558752 727.539952 705.72 5.1 
2-IBA-2-Nap-Pro-D-Ala-1-Nap-Val 703.6461094 704.6541094 726.6353094 704.81 0.0 
2-IBA-Orn-Pro-D-Ala-Bip-Thr 702.7414668 703.7494668 725.7306668 703.91 0.0 
2-IBA-Gln-Pro-D-Ala-Lys-Val 701.8368242 702.8448242 724.8260242 724.03 NP 
2-IBA-Thr-Pro-D-Ala-Tle-Leu 700.9321816 701.9401816 723.9213816 724.30 11.1 
2-IBA-dPhe-Pro-D-Ala-Lys-2-Pya 700.027539 701.035539 723.016739 700.80 5.3 
2-IBA-Val-Pro-D-Ala-Orn-Bip 699.1228964 700.1308964 722.1120964 722.27 15.0 
2-IBA-Nle-Pro-D-Ala-Nle-Ile 698.2182538 699.2262538 721.2074538 721.03 3.7 
2-IBA-Val-Pro-D-Ala-Abu-Dap 697.3136112 698.3216112 720.3028112 720.12 14.0 
2-IBA-Ile-Pro-D-Ala-Tle-Ile 696.4089686 697.4169686 719.3981686 719.22 17 
2-IBA-Ile-Pro-D-Ala-Phg-Asp 695.504326 696.512326 718.493526 718.31 5 
2-IBA-2-Nap-Pro-D-Ala-2-Nap-Leu 694.5996834 695.6076834 717.5888834 717.75 9 
2-IBA-Gln-Pro-D-Ala-Bip-Bip 693.6950408 694.7030408 716.6842408 715.88 NP 
2-IBA-Tle-Pro-D-Ala-Nva-Ser 692.7903982 693.7983982 715.7795982 715.94 NP 
2-IBA-tPhe-Pro-D-Ala-Asp-Ser 691.8857556 692.8937556 714.8749556 693.43 0 
2-IBA-Thr-Pro-D-Ala-Asp-3-Pya 690.981113 691.989113 713.970313 714.31 0 
2-IBA-Glu-Pro-D-Ala-His-Phe 690.0764704 691.0844704 713.0656704 691.24 9.1 
2-IBA-Phe-Pro-D-Ala-2-Pya-Leu 689.1718278 690.1798278 712.1610278 690.34 20.0 
2-IBA-Lys-Pro-D-Ala-Lys-Gln 688.2671852 689.2751852 711.2563852 711.64 6.1 
2-IBA-Thr-Pro-D-Ala-hPhe-2-Pya 687.3625426 688.3705426 710.3517426 709.55 13.2 
2-IBA-Trp-Pro-D-Ala-2-Pya-1-Nap 686.4579 687.4659 709.4471 708.65 19.4 
2-IBA-1-Nap-Pro-D-Ala-2-Pya-Trp 685.5532574 686.5612574 708.5424574 708.70 NP 
2-IBA-Phe-Pro-D-Ala-2-Nap-Glu 684.6486148 685.6566148 707.6378148 707.98 8.4 
2-IBA-Val-Pro-D-Ala-Phg-hPhe 683.7439721 684.7519721 706.7331721 684.52 8.0 
2-IBA-Val-Pro-D-Ala-hPhe-Phg 682.8393295 683.8473295 705.8285295 705.99 4.4 
2-IBA-hPhe-Pro-D-Ala-Lys-Leu 681.9346869 682.9426869 704.9238869 683.10 2.3 
2-IBA-Leu-Pro-D-Ala-Nva-Glu 681.0300443 682.0380443 704.0192443 682.20 2.8 
 
 
 
 
A24 
2-IBA-Tyr-Pro-D-Ala-Asn-Nva 680.1254017 681.1334017 703.1146017 681.29 6.7 
2-IBA-Nva-Pro-D-Ala-Tyr-Asn 679.2207591 680.2287591 702.2099591 680.39 0.0 
2-IBA-Phg-Pro-D-Ala-Tyr-Asn 678.3161165 679.3241165 701.3053165 701.47 4.2 
2-IBA-Tyr-Pro-D-Ala-Asn-Phg 677.4114739 678.4194739 700.4006739 699.60 17 
2-IBA-tPhe-Pro-D-Ala-Phg-Phg 676.5068313 677.5148313 699.4960313 677.28 6.6 
2-IBA-Tyr-Pro-D-Ala-Tle-Thr 675.6021887 676.6101887 698.5913887 698.41 5.7 
2-IBA-Val-Pro-D-Ala-Orn-Bip 674.6975461 675.7055461 697.6867461 697.51 NP 
2-IBA-tPhe-Pro-D-Ala-Phg-Nle 673.7929035 674.8009035 696.7821035 696.60 10.4 
2-IBA-Trp-Pro-D-Ala-tPhe-Nle 672.8882609 673.8962609 695.8774609 673.66 NP 
2-IBA-3-Pya-Pro-D-Ala-1-Nap-Abu 671.9836183 672.9916183 694.9728183 673.15 2.4 
2-IBA-2-Nap-Pro-D-Ala-1-Nap-Val 671.0789757 672.0869757 694.0681757 672.25 6.8 
2-IBA-Orn-Pro-D-Ala-Bip-Thr 670.1743331 671.1823331 693.1635331 671.34 3.6 
2-IBA-Gln-Pro-D-Ala-Lys-Val 669.2696905 670.2776905 692.2588905 691.46 2.8 
2-IBA-Thr-Pro-D-Ala-Tle-Leu 668.3650479 669.3730479 691.3542479 691.73 5.4 
2-IBA-dPhe-Pro-D-Ala-Lys-2-Pya 667.4604053 668.4684053 690.4496053 668.23 0 
2-IBA-Val-Pro-D-Ala-Orn-Bip 666.5557627 667.5637627 689.5449627 689.70 2.7 
2-IBA-Nle-Pro-D-Ala-Nle-Ile 665.6511201 666.6591201 688.6403201 688.46 6.4 
2-IBA-Val-Pro-D-Ala-Abu-Dap 664.7464775 665.7544775 687.7356775 687.56 8.3 
2-IBA-Ile-Pro-D-Ala-Tle-Ile 663.8418349 664.8498349 686.8310349 686.65 4.9 
2-IBA-Ile-Pro-D-Ala-Phg-Asp 662.9371923 663.9451923 685.9263923 685.75 3.2 
2-IBA-2-Nap-Pro-D-Ala-2-Nap-Leu 662.0325497 663.0405497 685.0217497 685.18 0 
2-IBA-Gln-Pro-D-Ala-Bip-Bip 661.1279071 662.1359071 684.1171071 683.32 8.4 
2-IBA-Tle-Pro-D-Ala-Nva-Ser 660.2232645 661.2312645 683.2124645 683.37 3.6 
2-IBA-tPhe-Pro-D-Ala-Asp-Ser 659.3186219 660.3266219 682.3078219 660.87 NP 
2-IBA-Thr-Pro-D-Ala-Asp-3-Pya 658.4139793 659.4219793 681.4031793 681.74 13.3 
2-IBA-Glu-Pro-D-Ala-His-Phe 657.5093367 658.5173367 680.4985367 658.68 14.4 
2-IBA-Phe-Pro-D-Ala-2-Pya-Leu 656.6046941 657.6126941 679.5938941 657.77 15.6 
2-IBA-Lys-Pro-D-Ala-Lys-Gln 655.7000515 656.7080515 678.6892515 679.07 16.7 
2-IBA-Thr-Pro-D-Ala-hPhe-2-Pya 654.7954089 655.8034089 677.7846089 676.98 17.9 
2-IBA-Trp-Pro-D-Ala-2-Pya-1-Nap 653.8907663 654.8987663 676.8799663 676.08 NP 
2-IBA-1-Nap-Pro-D-Ala-2-Pya-Trp 652.9861237 653.9941237 675.9753237 676.14 8.8 
2-IBA-Phe-Pro-D-Ala-2-Nap-Glu 652.0814811 653.0894811 675.0706811 675.41 3.2 
2-IBA-Val-Pro-D-Ala-Phg-hPhe 651.1768384 652.1848384 674.1660384 651.95 7.6 
2-IBA-Val-Pro-D-Ala-hPhe-Phg 650.2721958 651.2801958 673.2613958 673.42 4.5 
2-IBA-hPhe-Pro-D-Ala-Lys-Leu 649.3675532 650.3755532 672.3567532 650.54 8.6 
2-IBA-Leu-Pro-D-Ala-Nva-Glu 648.4629106 649.4709106 671.4521106 649.63 2.1 
2-IBA-Tyr-Pro-D-Ala-Asn-Nva 647.558268 648.566268 670.547468 648.73 0 
2-IBA-Nva-Pro-D-Ala-Tyr-Asn 646.6536254 647.6616254 669.6428254 647.82 8.6 
 
 
 
 
A25 
2-IBA-Phg-Pro-D-Ala-Tyr-Asn 645.7489828 646.7569828 668.7381828 668.90 4.3 
2-IBA-Tyr-Pro-D-Ala-Asn-Phg 644.8443402 645.8523402 667.8335402 667.03 9.2 
2-IBA-tPhe-Pro-D-Ala-Phg-Phg 643.9396976 644.9476976 666.9288976 644.71 6.6 
2-IBA-Tyr-Pro-D-Ala-Tle-Thr 643.035055 644.043055 666.024255 665.84 5.7 
2-IBA-Val-Pro-D-Ala-Orn-Bip 642.1304124 643.1384124 665.1196124 664.94 NP 
2-IBA-tPhe-Pro-D-Ala-Phg-Nle 641.2257698 642.2337698 664.2149698 664.03 10.4 
2-IBA-Trp-Pro-D-Ala-tPhe-Nle 640.3211272 641.3291272 663.3103272 641.10 NP 
2-IBA-3-Pya-Pro-D-Ala-1-Nap-Abu 639.4164846 640.4244846 662.4056846 640.58 2.0 
2-IBA-2-Nap-Pro-D-Ala-1-Nap-Val 638.511842 639.519842 661.501042 639.68 4.0 
2-IBA-Orn-Pro-D-Ala-Bip-Thr 637.6071994 638.6151994 660.5963994 638.78 7.4 
2-IBA-Gln-Pro-D-Ala-Lys-Val 636.7025568 637.7105568 659.6917568 658.89 1.2 
2-IBA-Thr-Pro-D-Ala-Tle-Leu 635.7979142 636.8059142 658.7871142 659.17 6.5 
2-IBA-dPhe-Pro-D-Ala-Lys-2-Pya 634.8932716 635.9012716 657.8824716 635.67 3.7 
2-IBA-Val-Pro-D-Ala-Orn-Bip 633.988629 634.996629 656.977829 657.14 4.5 
2-IBA-Nle-Pro-D-Ala-Nle-Ile 633.0839864 634.0919864 656.0731864 655.89 2.4 
2-IBA-Val-Pro-D-Ala-Abu-Dap 632.1793438 633.1873438 655.1685438 654.99 0.0 
2-IBA-Ile-Pro-D-Ala-Tle-Ile 631.2747012 632.2827012 654.2639012 654.08 6.8 
2-IBA-Ile-Pro-D-Ala-Phg-Asp 630.3700586 631.3780586 653.3592586 653.18 3.2 
2-IBA-2-Nap-Pro-D-Ala-2-Nap-Leu 629.465416 630.473416 652.454616 652.61 4.6 
2-IBA-Gln-Pro-D-Ala-Bip-Bip 628.5607734 629.5687734 651.5499734 650.75 3.6 
2-IBA-Tle-Pro-D-Ala-Nva-Ser 627.6561308 628.6641308 650.6453308 650.81 7.6 
2-IBA-tPhe-Pro-D-Ala-Asp-Ser 626.7514882 627.7594882 649.7406882 628.30 NP 
2-IBA-Thr-Pro-D-Ala-Asp-3-Pya 625.8468456 626.8548456 648.8360456 649.18 13.3 
2-IBA-Glu-Pro-D-Ala-His-Phe 624.942203 625.950203 647.931403 626.11 14.4 
2-IBA-Phe-Pro-D-Ala-2-Pya-Leu 624.0375604 625.0455604 647.0267604 625.21 15.6 
2-IBA-Lys-Pro-D-Ala-Lys-Gln 623.1329178 624.1409178 646.1221178 646.50 16.7 
2-IBA-Thr-Pro-D-Ala-hPhe-2-Pya 622.2282752 623.2362752 645.2174752 644.42 17.9 
2-IBA-Trp-Pro-D-Ala-2-Pya-1-Nap 621.3236326 622.3316326 644.3128326 643.51 NP 
2-IBA-1-Nap-Pro-D-Ala-2-Pya-Trp 620.41899 621.42699 643.40819 643.57 8.3 
2-IBA-Phe-Pro-D-Ala-2-Nap-Glu 619.5143473 620.5223473 642.5035473 642.84 5.4 
2-IBA-Val-Pro-D-Ala-Phg-hPhe 618.6097047 619.6177047 641.5989047 619.38 2.3 
2-IBA-Val-Pro-D-Ala-hPhe-Phg 617.7050621 618.7130621 640.6942621 640.85 1.5 
2-IBA-hPhe-Pro-D-Ala-Lys-Leu 616.8004195 617.8084195 639.7896195 617.97 6.8 
2-IBA-Leu-Pro-D-Ala-Nva-Glu 615.8957769 616.9037769 638.8849769 617.06 4.3 
2-IBA-Tyr-Pro-D-Ala-Asn-Nva 614.9911343 615.9991343 637.9803343 616.16 2.5 
2-IBA-Nva-Pro-D-Ala-Tyr-Asn 614.0864917 615.0944917 637.0756917 615.25 5.6 
2-IBA-Phg-Pro-D-Ala-Tyr-Asn 613.1818491 614.1898491 636.1710491 636.33 0 
2-IBA-Tyr-Pro-D-Ala-Asn-Phg 612.2772065 613.2852065 635.2664065 634.47 1.3 
 
 
 
 
A26 
2-IBA-Trp-Pro-D-Ala-Ile-hPhe 611.3725639 612.3805639 634.3617639 634.70 2.8 
2-IBA-Trp-Pro-D-Ala-hPhe-Trp 610.4679213 611.4759213 633.4571213 633.84 3.2 
2-IBA-Tyr-Pro-D-Ala-Tyr-Asn 609.5632787 610.5712787 632.5524787 632.93 6 
2-IBA-Tyr-Pro-D-Ala-Asn-Phg 608.6586361 609.6666361 631.6478361 631.99 0 
2-IBA-Ile-Pro-D-Ala-Tle-Orn 607.7539935 608.7619935 630.7431935 631.08 3.4 
2-IBA-hPhe-Pro-D-Ala-Phg-Asp 606.8493509 607.8573509 629.8385509 630.00 1.3 
2-IBA-tPhe-Pro-D-Ala-Phg-Phg 605.9447083 606.9527083 628.9339083 606.72 6.6 
2-IBA-Tyr-Pro-D-Ala-Tle-Thr 605.0400657 606.0480657 628.0292657 627.85 5.7 
2-IBA-Val-Pro-D-Ala-Orn-Bip 604.1354231 605.1434231 627.1246231 626.94 NP 
2-IBA-tPhe-Pro-D-Ala-Phg-Nle 603.2307805 604.2387805 626.2199805 626.04 10 
2-IBA-Trp-Pro-D-Ala-tPhe-Nle 602.3261379 603.3341379 625.3153379 603.10 NP 
2-IBA-3-Pya-Pro-D-Ala-1-Nap-Abu 601.4214953 602.4294953 624.4106953 602.59 7.9 
2-IBA-2-Nap-Pro-D-Ala-1-Nap-Val 600.5168527 601.5248527 623.5060527 601.68 8.2 
2-IBA-Orn-Pro-D-Ala-Bip-Thr 599.6122101 600.6202101 622.6014101 600.78 8.4 
2-IBA-Gln-Pro-D-Ala-Lys-Val 598.7075675 599.7155675 621.6967675 620.90 8.6 
2-IBA-Thr-Pro-D-Ala-Tle-Leu 597.8029249 598.8109249 620.7921249 621.17 8.9 
2-IBA-dPhe-Pro-D-Ala-Lys-2-Pya 596.8982823 597.9062823 619.8874823 597.67 9.1 
2-IBA-Val-Pro-D-Ala-Orn-Bip 595.9936397 597.0016397 618.9828397 619.14 9.3 
2-IBA-Nle-Pro-D-Ala-Nle-Ile 595.0889971 596.0969971 618.0781971 617.90 9.6 
2-IBA-Val-Pro-D-Ala-Abu-Dap 594.1843545 595.1923545 617.1735545 616.99 9.8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A27 
Table A3: 2nd Generation Peptides Screened in the a-Oxytosylation of Propiophenone 
 
Sequence Exact Mass 
Calc. 
[M+H]+ Calc. [M+Na]+ 
Observed 
[M+H]+ or 
[M+Na]+ % ee of II-2 
      
2-IBA-Ile-Pro-D-Ala-Asp-Ile 756.2344 757.2424 779.2236 779.38 16.2 
2-IBA-Ile-Pro-D-Ala-Asp-Val 742.2187 743.2267 765.2079 742.99 17.8 
2-IBA-Ile-Pro-D-Ala-Asp-Phe 790.2187 791.2267 813.2079 813.33 18.4 
2-IBA-Ile-Pro-D-Ala-Asp-Dap 729.1983 730.2063 752.1875 752.57 21.8 
2-IBA-Ile-Pro-D-Ala-Asp-Asp 758.1772 759.1852 781.1664 781.33 6.3 
2-IBA-Ile-Pro-D-Ala-Asp-Abu 728.2031 729.2111 751.1923 729.47 8.2 
2-IBA-Ile-Pro-D-Ala-Asp-tPhe 846.2813 847.2893 869.2705 869.43 10.4 
2-IBA-Ile-Pro-D-Ala-Asp-Ser 730.1823 731.1903 753.1715 753.29 22.5 
2-IBA-Ile-Pro-D-Ala-Asp-Ala 714.1874 715.1954 737.1766 737.56 18.4 
2-IBA-Ile-Pro-D-Ala-Asp-Trp 829.2296 830.2376 852.2188 830.50 22.8 
2-IBA-Ile-Pro-D-Ala-Asp-Glu 772.1929 773.2009 795.1821 795.34 13.2 
2-IBA-Ile-Pro-D-Ala-Asp-Nva 742.2187 743.2267 765.2079 743.49 16.7 
2-IBA-Ile-Pro-D-Ala-Asp-Leu 756.2344 757.2424 779.2236 779.38 8.7 
2-IBA-Ile-Pro-D-Ala-Asp-Bip 865.2548 866.2628 888.244 888.40 4.2 
2-IBA-Ile-Pro-D-Ala-Asp-Tle 756.2344 757.2424 779.2236 757.50 9.4 
2-IBA-Ile-Pro-D-Ala-Asp-His 780.2092 781.2172 803.1984 780.98 10.2 
2-IBA-Ile-Pro-D-Ala-Asp-Asn 757.1932 758.2012 780.1824 780.30 11.6 
2-IBA-Ile-Pro-D-Ala-Asp-Tyr 806.2136 807.2216 829.2028 829.58 12.8 
2-IBA-Ile-Pro-D-Ala-Asp-Phg 776.2031 777.2111 799.1923 776.98 3.2 
2-IBA-Ile-Pro-D-Ala-Asp-Thr 744.198 745.206 767.1872 744.97 0 
2-IBA-Ile-Pro-D-Ala-Asp-Lys 771.2453 772.2533 794.2345 772.17 9.3 
2-IBA-Ile-Pro-D-Ala-Asp-Nle 756.2344 757.2424 779.2236 757.01 2.6 
2-IBA-Ile-Pro-D-Ala-Asp-Orn 757.2296 758.2376 780.2188 780.34 18.3 
2-IBA-Ile-Pro-D-Ala-Asp-hPhe 804.2344 805.2424 827.2236 827.60 18.4 
2-IBA-Ile-Pro-D-Ala-Asp-dPhe 866.25 867.258 889.2392 867.52 22.6 
2-IBA-Ile-Pro-D-Ala-Asp-1-Nap 840.2344 841.2424 863.2236 863.38 18.4 
2-IBA-Ile-Pro-D-Ala-Asp-4-Pya 791.214 792.222 814.2032 792.48 14.2 
2-IBA-Ile-Pro-D-Ala-Asp-2-Nap 840.2344 841.2424 863.2236 863.38 16.4 
2-IBA-Ile-Pro-D-Ala-Asp-3-Pya 791.214 792.222 814.2032 792.04 17.4 
2-IBA-Ile-Pro-D-Ala-Asp-2-Pya 791.214 792.222 814.2032 791.99 3.2 
2-IBA-Ile-Pro-D-Ala-Asp-Abu 769.266 770.274 792.2552 792.64 8.9 
2-IBA-Ile-Pro-D-Ala-Val-Gln 755.2503 756.2583 778.2395 756.18 10.2 
2-IBA-Ile-Pro-D-Ala-Phe-Gln 803.2503 804.2583 826.2395 826.40 12.6 
 
 
 
 
A28 
2-IBA-Ile-Pro-D-Ala-Dap-Gln 742.2299 743.2379 765.2191 743.50 3.4 
2-IBA-Ile-Pro-D-Ala-Abu-Gln 741.2347 742.2427 764.2239 764.38 7.8 
2-IBA-Ile-Pro-D-Ala-tPhe-Gln 859.3129 860.3209 882.3021 860.09 16.7 
2-IBA-Ile-Pro-D-Ala-Gln-Gln 784.2405 785.2485 807.2297 807.35 3.2 
2-IBA-Ile-Pro-D-Ala-Ser-Gln 743.214 744.222 766.2032 766.58 21.4 
2-IBA-Ile-Pro-D-Ala-Ala-Gln 727.219 728.227 750.2082 750.37 18.6 
2-IBA-Ile-Pro-D-Ala-Trp-Gln 842.2612 843.2692 865.2504 865.37 10.2 
2-IBA-Ile-Pro-D-Ala-Glu-Gln 785.2245 786.2325 808.2137 808.47 4.8 
2-IBA-Ile-Pro-D-Ala-Nva-Gln 755.2503 756.2583 778.2395 756.18 9.3 
2-IBA-Ile-Pro-D-Ala-Leu-Gln 769.266 770.274 792.2552 770.53 NP 
2-IBA-Ile-Pro-D-Ala-Bip-Gln 879.2816 880.2896 902.2708 902.43 6.8 
2-IBA-Ile-Pro-D-Ala-Tle-Gln 769.266 770.274 792.2552 770.04 9 
2-IBA-Ile-Pro-D-Ala-His-Gln 793.2408 794.2488 816.23 794.01 4.3 
2-IBA-Ile-Pro-D-Ala-Asn-Gln 770.2249 771.2329 793.2141 771.00 12.7 
2-IBA-Ile-Pro-D-Ala-Tyr-Gln 819.2453 820.2533 842.2345 842.35 18.9 
2-IBA-Ile-Pro-D-Ala-Phg-Gln 789.2347 790.2427 812.2239 812.60 6.8 
2-IBA-Ile-Pro-D-Ala-Thr-Gln 757.2296 758.2376 780.2188 758.50 3.4 
2-IBA-Ile-Pro-D-Ala-Lys-Gln 784.2769 785.2849 807.2661 807.43 0 
2-IBA-Ile-Pro-D-Ala-Nle-Gln 769.266 770.274 792.2552 792.52 2.6 
2-IBA-Ile-Pro-D-Ala-Orn-Gln 770.2612 771.2692 793.2504 793.73 8.9 
2-IBA-Ile-Pro-D-Ala-hPhe-Gln 817.266 818.274 840.2552 840.42 10.2 
2-IBA-Ile-Pro-D-Ala-dPhe-Gln 879.2816 880.2896 902.2708 902.75 8.9 
2-IBA-Ile-Pro-D-Ala-1-Nap-Gln 853.266 854.274 876.2552 854.19 3.7 
2-IBA-Ile-Pro-D-Ala-4-Pya-Gln 804.2456 805.2536 827.2348 827.49 3.2 
2-IBA-Ile-Pro-D-Ala-2-Nap-Gln 853.266 854.274 876.2552 876.42 10.2 
2-IBA-Ile-Pro-D-Ala-3-Pya-Gln 804.2456 805.2536 827.2348 805.02 4.8 
2-IBA-Ile-Pro-D-Ala-2-Pya-Gln 804.2456 805.2536 827.2348 805.02 8.7 
2-IBA-Val-Pro-D-Ala-Asp-Gln 757.1932 758.2012 780.1824 758.46 4.6 
2-IBA-Phe-Pro-D-Ala-Asp-Gln 805.1932 806.2012 828.1824 828.34 2.3 
2-IBA-Dap-Pro-D-Ala-Asp-Gln 744.1728 745.1808 767.162 767.32 16.8 
2-IBA-Asp-Pro-D-Ala-Asp-Gln 773.1517 774.1597 796.1409 774.08 14.2 
2-IBA-Abu-Pro-D-Ala-Asp-Gln 743.1776 744.1856 766.1668 766.43 6.8 
2-IBA-tPhe-Pro-D-Ala-Asp-Gln 861.2558 862.2638 884.245 862.03 5.3 
2-IBA-Gln-Pro-D-Ala-Asp-Gln 786.1834 787.1914 809.1726 809.29 2.9 
2-IBA-Ser-Pro-D-Ala-Asp-Gln 745.1568 746.1648 768.146 768.53 7.2 
2-IBA-Ala-Pro-D-Ala-Asp-Gln 729.1619 730.1699 752.1511 729.94 0 
2-IBA-Trp-Pro-D-Ala-Asp-Gln 844.2041 845.2121 867.1933 844.98 2.6 
2-IBA-Glu-Pro-D-Ala-Asp-Gln 787.1674 788.1754 810.1566 810.32 4.3 
 
 
 
 
A29 
2-IBA-Nva-Pro-D-Ala-Asp-Gln 757.1932 758.2012 780.1824 758.46 9.5 
2-IBA-Leu-Pro-D-Ala-Asp-Gln 777.2089 778.2169 800.1981 800.36 10.2 
2-IBA-Bip-Pro-D-Ala-Asp-Gln 881.2245 882.2325 904.2137 904.37 18.3 
2-IBA-Tle-Pro-D-Ala-Asp-Gln 771.2089 772.2169 794.1981 794.68 16.4 
2-IBA-His-Pro-D-Ala-Asp-Gln 795.1837 796.1917 818.1729 796.11 2.8 
2-IBA-Asn-Pro-D-Ala-Asp-Gln 772.1677 773.1757 795.1569 795.32 8.3 
2-IBA-Tyr-Pro-D-Ala-Asp-Gln 821.1881 822.1961 844.1773 822.12 6.5 
2-IBA-Phg-Pro-D-Ala-Asp-Gln 791.1776 792.1856 814.1668 791.95 12.7 
2-IBA-Thr-Pro-D-Ala-Asp-Gln 759.1725 760.1805 782.1617 782.28 4.2 
2-IBA-Lys-Pro-D-Ala-Asp-Gln 786.2198 787.2278 809.209 809.59 13.2 
2-IBA-Nle-Pro-D-Ala-Asp-Gln 771.2089 772.2169 794.1981 794.36 19.5 
2-IBA-Orn-Pro-D-Ala-Asp-Gln 772.2041 773.2121 795.1933 773.13 20.2 
2-IBA-hPhe-Pro-D-Ala-Asp-Gln 819.2089 820.2169 842.1981 842.36 9.3 
2-IBA-dPhe-Pro-D-Ala-Asp-Gln 881.2245 882.2325 904.2137 882.49 5.6 
2-IBA-1-Nap-Pro-D-Ala-Asp-Gln 855.2089 856.2169 878.1981 878.36 2.5 
2-IBA-4-Pya-Pro-D-Ala-Asp-Gln 806.1885 807.1965 829.1777 829.34 0 
2-IBA-2-Nap-Pro-D-Ala-Asp-Gln 855.2089 856.2169 878.1981 856.48 2.3 
2-IBA-3-Pya-Pro-D-Ala-Asp-Gln 806.1885 807.1965 829.1777 829.34 11.4 
2-IBA-2-Pya-Pro-D-Ala-Asp-Gln 806.1885 807.1965 829.1777 807.12 8.7 
      
2-IBA-hPhe-Pro-D-Ala-Phg-Ile 822.2602 823.2682 845.2494 823.03 13.3 
2-IBA-hPhe-Pro-D-Ala-Phg-Val 808.2445 809.2525 831.2337 809.02 2.4 
2-IBA-hPhe-Pro-D-Ala-Phg-Phe 856.2445 857.2525 879.2337 857.02 7.8 
2-IBA-hPhe-Pro-D-Ala-Phg-Dap 795.2241 796.2321 818.2133 796.68 9.6 
2-IBA-hPhe-Pro-D-Ala-Phg-Abu 794.2289 795.2369 817.2181 795.10 10.4 
2-IBA-hPhe-Pro-D-Ala-Phg-tPhe 912.3071 913.3151 935.2963 913.08 3.4 
2-IBA-hPhe-Pro-D-Ala-Phg-Gln 837.2347 838.2427 860.2239 838.69 6.4 
2-IBA-hPhe-Pro-D-Ala-Phg-Ser 796.2081 797.2161 819.1973 819.36 8.9 
2-IBA-hPhe-Pro-D-Ala-Phg-Ala 780.2132 781.2212 803.2024 780.99 2.1 
2-IBA-hPhe-Pro-D-Ala-Phg-Trp 895.2554 896.2634 918.2446 896.03 0 
2-IBA-hPhe-Pro-D-Ala-Phg-Glu 838.2187 839.2267 861.2079 838.99 3.8 
2-IBA-hPhe-Pro-D-Ala-Phg-Nva 808.2445 809.2525 831.2337 809.70 12.2 
2-IBA-hPhe-Pro-D-Ala-Phg-Leu 822.2602 823.2682 845.2494 823.72 4.6 
2-IBA-hPhe-Pro-D-Ala-Phg-Bip 932.2758 933.2838 955.265 955.43 2.6 
2-IBA-hPhe-Pro-D-Ala-Phg-Tle 822.2602 823.2682 845.2494 845.41 5.4 
2-IBA-hPhe-Pro-D-Ala-Phg-His 846.235 847.243 869.2242 847.69 13.2 
2-IBA-hPhe-Pro-D-Ala-Phg-Asn 823.219 824.227 846.2082 824.09 7.8 
2-IBA-hPhe-Pro-D-Ala-Phg-Tyr 872.2394 873.2474 895.2286 873.01 12.5 
 
 
 
 
A30 
2-IBA-hPhe-Pro-D-Ala-Phg-Phg 842.2289 843.2369 865.2181 865.38 0 
2-IBA-hPhe-Pro-D-Ala-Phg-Thr 810.2238 811.2318 833.213 811.68 7.6 
2-IBA-hPhe-Pro-D-Ala-Phg-Lys 837.2711 838.2791 860.2603 860.42 4.8 
2-IBA-hPhe-Pro-D-Ala-Phg-Nle 822.2602 823.2682 845.2494 823.03 3.4 
2-IBA-hPhe-Pro-D-Ala-Phg-Orn 823.2554 824.2634 846.2446 824.03 8.2 
2-IBA-hPhe-Pro-D-Ala-Phg-hPhe 870.2602 871.2682 893.2494 871.03 2.7 
2-IBA-hPhe-Pro-D-Ala-Phg-dPhe 932.2758 933.2838 955.265 933.73 NP 
2-IBA-hPhe-Pro-D-Ala-Phg-1-
Nap 906.2602 907.2682 929.2494 929.41 11.2 
2-IBA-hPhe-Pro-D-Ala-Phg-4-Pya 857.2398 858.2478 880.229 880.39 10.7 
2-IBA-hPhe-Pro-D-Ala-Phg-2-
Nap 906.2602 907.2682 929.2494 907.13 4.5 
2-IBA-hPhe-Pro-D-Ala-Phg-3-Pya 857.2398 858.2478 880.229 858.01 3.4 
2-IBA-hPhe-Pro-D-Ala-Phg-2-Pya 857.2398 858.2478 880.229 858.70 7.9 
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Appendix B 
Supplementary Information for Chapter 3 
 
HYPERVALENT IODOARENE PEPTIDES FOR THE a-OXYTOSYLATION OF 1-
INDANONE 
 
1H NMR Spectra of Racemic III-8, 1-oxo-2,3-dihydro-1H-inden-2-yl 4-
methylbenzenesulfonate 
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 A32 
13C NMR Spectra of Racemic III-8, 1-oxo-2,3-dihydro-1H-inden-2-yl 4-
methylbenzenesulfonate 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
220 200 180 160 140 120 100 80 60 40 20 0 ppm
2
1
.
7
5
3
3
.
9
1
7
8
.
2
5
1
2
4
.
7
2
1
2
6
.
6
9
1
2
8
.
2
5
1
2
8
.
4
5
1
2
9
.
9
0
1
3
3
.
2
2
1
3
3
.
6
4
1
3
6
.
3
7
1
4
5
.
2
2
1
4
9
.
9
6
1
9
7
.
5
6
 A33 
1H NMR Spectra of Racemic III-32, 1-oxo-2,3-dihydro-1H-inden-2-yl naphthalene-1-
sulfonate 
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 A34 
13C NMR Spectra of Racemic III-32, 1-oxo-2,3-dihydro-1H-inden-2-yl naphthalene-1-
sulfonate 
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 A35 
1H NMR Spectra of Racemic III-33, 1-oxo-2,3-dihydro-1H-inden-2-yl methanesulfonate 
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 A36 
13C NMR Spectra of Racemic III-33, 1-oxo-2,3-dihydro-1H-inden-2-yl methanesulfonate 
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 A37 
HPLC Chromatogram of Racemic III-8, 1-oxo-2,3-dihydro-1H-inden-2-yl 4-
methylbenzenesulfonate 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 A38 
HPLC Chromatogram of  III-8 from “hit” peptide III-10, 48% ee 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 A39 
HPLC Chromatogram of  III-8 from “hit” peptide III-10 under optimized reaction 
conditions , 65% ee 
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Non-Polar (Hexanes and Toluene) Co-Solvent Screen 
HPLC Chromatogram for Racemic Product III-8 
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Table 3.6, Entry 1: Product III-8, 22% ee 
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Table 3.6, Entry 2: Product III-8, 22% ee 
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Table 3.6, Entry 3: Product III-8, 28% ee 
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Table 3.6, Entry 4: Product III-8, 27% ee 
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Table 3.6, Entry 5: Product III-8, 15% ee 
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Table 3.6, Entry 6: Product III-8, 14% ee 
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Table 3.6, Entry 7: Product III-8, 28% ee 
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Table 3.6, Entry 8: Product III-8, 26% ee 
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Table 3.6, Entry 9: Product III-8, 22% ee 
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Table 3.6, Entry 10: Product III-8, 24% ee 
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Peptides Screened in the α-sulfonylation of 1-indanone reaction using alternative 
nucleophiles 
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HPLC Chromatograms for Product III-32 
Chiral HPLC Spectra of Racemic III-32, 1-oxo-2,3-dihydro-1H-inden-2-yl naphthalene-
1-sulfonate 
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HPLC Trace for Peptide III-8, 11% ee  
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HPLC Trace for Peptide III-26, 17% ee  
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HPLC Trace for Peptide III-27, 9% ee  
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HPLC Trace for Peptide III-28, 22% ee  
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HPLC Trace for Peptide III-29, 21% ee  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 A58 
 
 
HPLC Trace for Peptide III-30, 15% ee  
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HPLC Trace for Peptide III-31, 6% ee 
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HPLC Trace for Peptide III-32, 17% ee 
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HPLC Trace for Peptide III-33, 12% ee  
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HPLC Trace for Peptide III-34, NP 
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HPLC Trace for Peptide III-35, 19% ee  
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Chiral HPLC Spectra of Racemic III-33, 1-oxo-2,3-dihydro-1H-inden-2-yl 
methanesulfonate 
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HPLC Chromatograms for Product III-33 
HPLC Trace for Peptide III-8, 28% ee  
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HPLC Trace for Peptide III-26, 35% ee  
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HPLC Trace for Peptide III-27, 26% ee  
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HPLC Trace for Peptide III-28, 21% ee  
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HPLC Trace for Peptide III-29, 17% ee  
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HPLC Trace for Peptide III-30, 20% ee  
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HPLC Trace for Peptide III-31, 23% ee  
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HPLC Trace for Peptide III-32, 24% ee  
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HPLC Trace for Peptide III-33, 20% ee  
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HPLC Trace for Peptide III-34, 14% ee  
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HPLC Trace for Peptide III-35, 15% ee  
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Table B1: Peptides Screened in the a-Oxytosylation of 1-Indanone 
Sequence Exact Mass 
Calc. 
[M+H]+ 
Calc. 
[M+Na]+ 
Observed 
[M+H]+ or 
[M+Na]+ 
% ee of II-8 
            
Ac-Ser-4-I-Phe-Pro-D-Ala-Phg-hPhe 881.2609 882.2689 904.2501 882.11 8.7 
Ac-Ala-4-I-Phe-Pro-D-Ala-Phg-hPhe 865.266 866.274 888.2552 888.43 9 
Ac-Trp-4-I-Phe-Pro-D-Ala-Phg-hPhe 980.3082 981.3162 1003.2974 1003.44 5.6 
Ac-Glu-4-I-Phe-Pro-D-Ala-Phg-hPhe 923.2715 924.2795 946.2607 946.44 4.5 
Ac-Nva-4-I-Phe-Pro-D-Ala-Phg-hPhe 893.2973 894.3053 916.2865 916.47 7 
Ac-Leu-4-I-Phe-Pro-D-Ala-Phg-hPhe 907.3129 908.3209 930.3021 930.48 3.4 
Ac-Bip-4-I-Phe-Pro-D-Ala-Phg-hPhe 1017.3286 1018.3366 1040.3178 1040.50 5.6 
Ac-Tle-4-I-Phe-Pro-D-Ala-Phg-hPhe 907.3129 908.3209 930.3021 930.48 3.2 
Ac-His-4-I-Phe-Pro-D-Ala-Phg-hPhe 931.2878 932.2958 954.277 954.46 3.5 
Ac-Asn-4-I-Phe-Pro-D-Ala-Phg-hPhe 908.2718 909.2798 931.261 931.44 1.2 
Ac-Tyr-4-I-Phe-Pro-D-Ala-Phg-hPhe 957.2922 958.3002 980.2814 980.46 0 
Ac-Phg-4-I-Phe-Pro-D-Ala-Phg-hPhe 927.2816 928.2896 950.2708 950.45 3.4 
Ac-Thr-4-I-Phe-Pro-D-Ala-Phg-hPhe 895.2766 896.2846 918.2658 918.45 9.1 
Ac-Lys-4-I-Phe-Pro-D-Ala-Phg-hPhe 922.3238 923.3318 945.313 945.49 3 
Ac-Nle-4-I-Phe-Pro-D-Ala-Phg-hPhe 907.3129 908.3209 930.3021 930.48 4.5 
Ac-Orn-4-I-Phe-Pro-D-Ala-Phg-hPhe 908.3082 909.3162 931.2974 931.48 7.8 
Ac-hPhe-4-I-Phe-Pro-D-Ala-Phg-hPhe 955.3129 956.3209 978.3021 978.48 8 
Ac-dPhe-4-I-Phe-Pro-D-Ala-Phg-hPhe 1017.3286 1018.3366 1040.3178 1040.32 6 
Ac-1-Nap-4-I-Phe-Pro-D-Ala-Phg-hPhe 991.3129 992.3209 1014.3021 1014.17 6.7 
Ac-4-Pya-4-I-Phe-Pro-D-Ala-Phg-hPhe 942.2925 943.3005 965.2817 965.10 6.5 
2-IBA-hPhe-Pro-D-Ala-Lys-Leu 817.3024 818.3104 840.2916 840.11 12.1 
2-IBA-Tyr-Pro-D-Ala-Asn-Phg 825.1983 826.2063 848.1875 848.01 10 
2-IBA-Leu-Pro-D-Ala-Nva-Glu 756.2344 757.2424 779.2236 779.04 NP 
2-IBA-Val-Pro-D-Ala-hPhe-Phg 822.2602 823.2682 845.2494 845.07 19.7 
2-IBA-Ala-Pro-D-Ala-Orn-hPhe 747.2241 748.2321 770.2133 770.03 18.4 
2-IBA-Tyr-Pro-D-Ala-Asn-Nva 791.214 792.222 814.2032 814.02 0 
2-IBA-Nva-Pro-D-Ala-Tyr-Asn 791.214 792.222 814.2032 814.43 7.3 
2-IBA-Phe-Pro-D-Ala-Val-Ile 774.2602 775.2682 797.2494 797.07 10 
 A77 
Ac-Val-4-I-Phe-Pro-D-Ala-Phg-hPhe 893.2973 894.3053 916.2865 894.15 11 
Ac-hPhe-4-I-Phe-Pro-D-Ala-Bip-Ala 955.3129 956.3209 978.3021 956.16 2.5 
2-IBA-hPhe-Pro-D-Ala-Orn-Phg 808.2445 809.2525 831.2337 809.09 0 
2-IBA-Ile-Pro-D-Ala-Asp-tPhe 846.2813 847.2893 869.2705 847.13 3 
2-IBA-Ile-Pro-D-Ala-Asp-Asp 758.1772 759.1852 781.1664 759.03 5 
2-IBA-Ile-Pro-D-Ala-1-Nap-Gln 853.266 854.274 876.2552 854.17 0 
2-IBA-Ile-Pro-D-Ala-Asp-Orn 757.2296 758.2376 780.2188 758.08 0 
2-IBA-Ile-Pro-D-Ala-Asp-Thr 744.198 745.206 767.1872 745.26 8.1 
2-IBA-Nle-Pro-D-Ala-Orn-Ala 713.2398 714.2478 736.229 714.14 3.4 
2-IBA-Nva-Pro-D-Ala-Orn-Ala 699.2241 700.2321 722.2133 700.53 0 
2-IBA-Abu-Pro-D-Ala-Asp-Dap 701.167 702.175 724.1562 702.26 10.4 
2-IBA-Ile-Pro-D-Ala-Asp-Leu 756.2344 757.2424 779.2236 757.84 3.2 
2-IBA-hPhe-Pro-D-Ala-Orn-Phe 837.2711 838.2791 860.2603 838.17 5.1 
2-IBA-Ile-Pro-D-Ala-Asp-Nle 756.2344 757.2424 779.2236 757.08 7 
2-IBA-Ile-Pro-D-Ala-Asp-Val 742.2187 743.2267 765.2079 743.67 10.2 
2-IBA-hPhe-Pro-D-Ala-Orn-Orn 804.282 805.29 827.2712 805.13 8.6 
2-IBA-hPhe-Pro-D-Ala-Tyr-Ala 810.2238 811.2318 833.213 811.71 NP 
2-IBA-hPhe-Pro-D-Ala-Phg-Nle 822.2602 823.2682 845.2494 823.18 5.8 
2-IBA-hPhe-Pro-D-Ala-Phg-His 846.235 847.243 869.2242 847.83 6.7 
2-IBA-hPhe-Pro-D-Ala-Phg-Val 808.2445 809.2525 831.2337 809.25 3.5 
2-IBA-Thr-Pro-D-Ala-tPhe-Abu 804.2707 805.2787 827.2599 805.17 5.4 
2-IBA-Val-Pro-D-Ala-hPhe-Phg 822.2602 823.2682 845.2494 823.82 2.8 
2-IBA-Orn-Pro-D-Ala-Ile-Tle 755.2867 756.2947 778.2759 756.47 48 
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Table B2: Peptides Screened in the a-Oxytosylation of 1-Indanone from the Optimization 
of Peptide III-10 
Sequence Exact Mass Calc. 
[M+H]+ 
Calc. 
[M+Na]+ 
Observed 
[M+H]+ or 
[M+Na]+ 
% ee of II-
8 
2-IBA-Orn-Pro-D-Ala-Ile-Ile 755.2867 756.2947 778.2759 778.59 32 
2-IBA-Orn-Pro-D-Ala-Ile-Val 741.2711 742.2791 764.2603 764.43 28 
2-IBA-Orn-Pro-D-Ala-Ile-Phe 789.2711 790.2791 812.2603 812.83 0 
2-IBA-Orn-Pro-D-Ala-Ile-Dap 728.2507 729.2587 751.2399 751.59 21 
2-IBA-Orn-Pro-D-Ala-Ile-Asp 757.2296 758.2376 780.2188 780.38 3 
2-IBA-Orn-Pro-D-Ala-Ile-Abu 727.2554 728.2634 750.2446 750.46 30 
2-IBA-Orn-Pro-D-Ala-Ile-tPhe 845.3337 846.3417 868.3229 868.42 26 
2-IBA-Orn-Pro-D-Ala-Ile-Gln 770.2612 771.2692 793.2504 793.74 19 
2-IBA-Orn-Pro-D-Ala-Ile-Ser 729.2347 730.2427 752.2239 752.49 23 
2-IBA-Orn-Pro-D-Ala-Ile-Ala 713.2398 714.2478 736.229 736.09 27 
2-IBA-Orn-Pro-D-Ala-Ile-Trp 828.282 829.29 851.2712 851.12 20 
2-IBA-Orn-Pro-D-Ala-Ile-Glu 771.2453 772.2533 794.2345 794.55 25 
2-IBA-Orn-Pro-D-Ala-Ile-Nva 741.2711 742.2791 764.2603 764.80 26 
2-IBA-Orn-Pro-D-Ala-Ile-Leu 755.2867 756.2947 778.2759 778.09 29 
2-IBA-Orn-Pro-D-Ala-Ile-Bip 865.3024 866.3104 888.2916 888.16 15 
2-IBA-Orn-Pro-D-Ala-Ile-His 779.2616 780.2696 802.2508 802.76 25 
2-IBA-Orn-Pro-D-Ala-Ile-Asn 756.2456 757.2536 779.2348 779.82 20 
2-IBA-Orn-Pro-D-Ala-Ile-Tyr 805.266 806.274 828.2552 828.52 25 
2-IBA-Orn-Pro-D-Ala-Ile-Phg 775.2554 776.2634 798.2446 798.64 24 
2-IBA-Orn-Pro-D-Ala-Ile-Thr 743.2503 744.2583 766.2395 766.59 15 
2-IBA-Orn-Pro-D-Ala-Ile-Lys 770.2976 771.3056 793.2868 793.18 12 
2-IBA-Orn-Pro-D-Ala-Ile-Nle 755.2867 756.2947 778.2759 778.59 18 
2-IBA-Orn-Pro-D-Ala-Ile-Orn 756.282 757.29 779.2712 779.92 20 
2-IBA-Orn-Pro-D-Ala-Ile-hPhe 803.2867 804.2947 826.2759 826.59 20 
2-IBA-Orn-Pro-D-Ala-Ile-dPhe 865.3024 866.3104 888.2916 888.16 17 
2-IBA-Orn-Pro-D-Ala-Ile-1-Nap 839.2867 840.2947 862.2759 862.59 26 
2-IBA-Orn-Pro-D-Ala-Ile-4-Pya 790.2663 791.2743 813.2555 813.75 30 
2-IBA-Orn-Pro-D-Ala-Ile-2-Nap 839.2867 840.2947 862.2759 862.59 24 
2-IBA-Orn-Pro-D-Ala-Ile-3-Pya 790.2663 791.2743 813.2555 813.55 24 
2-IBA-Orn-Pro-D-Ala-Ile-2-Pya 790.2663 791.2743 813.2555 813.43 28 
            
2-IBA-Orn-Pro-D-Ala-Val-Tle 741.2711 742.2791 764.2603 764.03 38 
2-IBA-Orn-Pro-D-Ala-Phe-Tle 789.2711 790.2791 812.2603 812.87 28 
2-IBA-Orn-Pro-D-Ala-Dap-Tle 728.2507 729.2587 751.2399 751.63 28 
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2-IBA-Orn-Pro-D-Ala-Asp-Tle 757.2296 758.2376 780.2188 780.08 32 
2-IBA-Orn-Pro-D-Ala-Abu-Tle 727.2554 728.2634 750.2446 750.46 0 
2-IBA-Orn-Pro-D-Ala-tPhe-Tle 845.3337 846.3417 868.3229 868.42 41 
2-IBA-Orn-Pro-D-Ala-Gln-Tle 770.2612 771.2692 793.2504 793.74 24 
2-IBA-Orn-Pro-D-Ala-Ser-Tle 729.2347 730.2427 752.2239 752.39 33 
2-IBA-Orn-Pro-D-Ala-Ala-Tle 713.2398 714.2478 736.229 736.49 35 
2-IBA-Orn-Pro-D-Ala-Trp-Tle 828.282 829.29 851.2712 851.82 4.6 
2-IBA-Orn-Pro-D-Ala-Glu-Tle 771.2453 772.2533 794.2345 794.45 6.2 
2-IBA-Orn-Pro-D-Ala-Nva-Tle 741.2711 742.2791 764.2603 764.03 0 
2-IBA-Orn-Pro-D-Ala-Leu-Tle 755.2867 756.2947 778.2759 778.64 27 
2-IBA-Orn-Pro-D-Ala-Bip-Tle 865.3024 866.3104 888.2916 888.16 26 
2-IBA-Orn-Pro-D-Ala-Tle-Tle 755.2867 756.2947 778.2759 778.59 25 
2-IBA-Orn-Pro-D-Ala-His-Tle 779.2616 780.2696 802.2508 802.78 24 
2-IBA-Orn-Pro-D-Ala-Asn-Tle 756.2456 757.2536 779.2348 779.58 23 
2-IBA-Orn-Pro-D-Ala-Tyr-Tle 805.266 806.274 828.2552 828.52 6 
2-IBA-Orn-Pro-D-Ala-Phg-Tle 775.2554 776.2634 798.2446 798.66 0 
2-IBA-Orn-Pro-D-Ala-Thr-Tle 743.2503 744.2583 766.2395 766.35 NS 
2-IBA-Orn-Pro-D-Ala-Lys-Tle 770.2976 771.3056 793.2868 793.18 6.8 
2-IBA-Orn-Pro-D-Ala-Nle-Tle 755.2867 756.2947 778.2759 778.59 15 
2-IBA-Orn-Pro-D-Ala-Orn-Tle 756.282 757.29 779.2712 779.32 28 
2-IBA-Orn-Pro-D-Ala-hPhe-Tle 887.2867 888.2947 910.2759 910.59 37 
2-IBA-Orn-Pro-D-Ala-dPhe-Tle 865.3024 866.3104 888.2916 888.16 27 
2-IBA-Orn-Pro-D-Ala-1-Nap-Tle 839.2867 840.2947 862.2759 862,99 NP 
2-IBA-Orn-Pro-D-Ala-4-Pya-Tle 790.2663 791.2743 813.2555 813.55 9.3 
2-IBA-Orn-Pro-D-Ala-2-Nap-Tle 839.2867 840.2947 862.2759 862.59 5.6 
2-IBA-Orn-Pro-D-Ala-3-Pya-Tle 790.2663 791.2743 813.2555 813.54 0 
2-IBA-Orn-Pro-D-Ala-2-Pya-Tle 790.2663 791.2743 813.2555 813.75 20 
            
2-IBA-Ile-Pro-D-Ala-Ile-Tle 754.2915 755.2995 777.2807 777.17 17 
2-IBA-Val-Pro-D-Ala-Ile-Tle 740.2758 741.2838 763.265 763.85 10 
2-IBA-Phe-Pro-D-Ala-Ile-Tle 788.2758 789.2838 811.265 811.05 NP 
2-IBA-Dap-Pro-D-Ala-Ile-Tle 727.2554 728.2634 750.2446 750.46 5.7 
2-IBA-Asp-Pro-D-Ala-Ile-Tle 756.2344 757.2424 779.2236 779.43 NP 
2-IBA-Abu-Pro-D-Ala-Ile-Tle 726.2602 727.2682 749.2494 749.04 NP 
2-IBA-tPhe-Pro-D-Ala-Ile-Tle 844.3384 845.3464 867.3276 867.76 0 
2-IBA-Gln-Pro-D-Ala-Ile-Tle 769.266 770.274 792.2552 792.72 25 
2-IBA-Ser-Pro-D-Ala-Ile-Tle 728.2394 729.2474 751.2286 751.86 20 
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2-IBA-Ala-Pro-D-Ala-Ile-Tle 712.2445 713.2525 735.2337 735.37 10 
2-IBA-Trp-Pro-D-Ala-Ile-Tle 827.2867 828.2947 850.2759 850.59 20 
2-IBA-Glu-Pro-D-Ala-Ile-Tle 770.25 771.258 793.2392 793.52 9.4 
2-IBA-Nva-Pro-D-Ala-Ile-Tle 740.2758 741.2838 763.265 763.85 16 
2-IBA-Leu-Pro-D-Ala-Ile-Tle 754.2915 755.2995 777.2807 777.17 22 
2-IBA-Bip-Pro-D-Ala-Ile-Tle 864.3071 865.3151 887.2963 887.13 0 
2-IBA-Tle-Pro-D-Ala-Ile-Tle 754.2915 755.2995 777.2807 777.76 15 
2-IBA-His-Pro-D-Ala-Ile-Tle 778.2663 779.2743 801.2555 801.55 14 
2-IBA-Asn-Pro-D-Ala-Ile-Tle 755.2503 756.2583 778.2395 778.95 19 
2-IBA-Tyr-Pro-D-Ala-Ile-Tle 804.2707 805.2787 827.2599 827.79 5 
2-IBA-Phg-Pro-D-Ala-Ile-Tle 774.2602 775.2682 797.2494 797.45 19 
2-IBA-Thr-Pro-D-Ala-Ile-Tle 742.2551 743.2631 765.2443 765.63 4.5 
2-IBA-Lys-Pro-D-Ala-Ile-Tle 769.3024 770.3104 792.2916 792.16 14 
2-IBA-Nle-Pro-D-Ala-Ile-Tle 754.2915 755.2995 777.2807 777.17 0 
2-IBA-hPhe-Pro-D-Ala-Ile-Tle 802.2915 803.2995 825.2807 825.14 16 
2-IBA-dPhe-Pro-D-Ala-Ile-Tle 864.3071 865.3151 887.2963 887.13 23 
2-IBA-1-Nap-Pro-D-Ala-Ile-Tle 838.2915 839.2995 861.2807 861.17 4.2 
2-IBA-4-Pya-Pro-D-Ala-Ile-Tle 789.2711 790.2791 812.2603 812.83 18 
2-IBA-2-Nap-Pro-D-Ala-Ile-Tle 838.2915 839.2995 861.2807 861.17 0 
2-IBA-3-Pya-Pro-D-Ala-Ile-Tle 789.2711 790.2791 812.2603 812.08 21 
2-IBA-2-Pya-Pro-D-Ala-Ile-Tle 789.2711 790.2791 812.2603 812.65 8.6 
 
